parthenolide has been researched along with sesquiterpenes in 527 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (1.71) | 18.7374 |
1990's | 24 (4.55) | 18.2507 |
2000's | 187 (35.48) | 29.6817 |
2010's | 240 (45.54) | 24.3611 |
2020's | 67 (12.71) | 2.80 |
Authors | Studies |
---|---|
Chan, YM; el-Feraly, FS | 1 |
Cole, JR; Hoffmann, JJ; Torrance, SJ; Widehopf, RM | 1 |
Hausen, BM; Schmidt-Löffler, P; Schulz, KH; Wallhöfer, L | 1 |
Hoult, JR; Knight, DW; Salan, U; Sumner, H | 1 |
Awang, DV; Dawson, BA; Heptinstall, S; Kindack, D; Knight, DW; May, J | 1 |
Barsby, RW; Hoult, JR; Knight, DW; Salan, U | 1 |
Groenewegen, WA; Heptinstall, S | 1 |
Hausen, BM | 1 |
Che, CT; Farnsworth, NR; Fong, HH; Mondranondra, IO; Rimando, AM; Vajrodaya, S | 1 |
Groenewegen, WA; Heptinstall, S; Loesche, W; Spangenberg, P | 1 |
Pugh, WJ; Sambo, K | 1 |
Barrett, ML; Lewis, GP; O'Neill, LA | 1 |
Hausen, BM; Osmundsen, PE | 1 |
Atal, CK; Dhar, KL; Sethi, VK; Thappa, RK | 1 |
Konopa, J; Woynarowski, JM | 1 |
Hamburger, M; Hay, AJ; Hostettmann, K; Hoult, JR | 1 |
Castañeda-Acosta, J; Fischer, NH; Vargas, D | 1 |
Béjar, E | 1 |
Fischer, NH; Hwang, D; Jang, BC; Kim, JK; Lee, W; Tak, H | 1 |
Carty, HC | 1 |
Hayataka, K; O'Connor, MF; Parker, KK; Weber, JT | 1 |
Colson, N; Hayataka, K; Medora, R; O'Connor, MF; Parker, KK; Russo, EB; Weber, JT | 1 |
Andersen, KE; Menné, T; Orion, E; Paulsen, E | 1 |
Cantrell, CL; Castañeda-Acosta, J; Fischer, NH; Franzblau, SG; Lu, T; Quijano, L | 1 |
Giner, RM; Máñez, S; Mordujovich de Buschiazzo, P; Recio, MC; Ríos, JL; Schinella, GR | 1 |
Arnason, JT; Birnboim, HC; Ross, JJ | 1 |
Buschiazzo, H; de Balsa, EM; Mañez, S; Mordujovich de Buschiazzo, P; Schinella, G; Tournier, H | 1 |
Menendez, IY; Wong, HR | 1 |
Kou, X; Stevenson, D; Zhou, JZ | 1 |
Castellano, D; Galindo, JC; Macías, FA; Velasco, RF | 1 |
Dröge, W; Hehner, SP; Hofmann, TG; Schmitz, ML | 1 |
Bugno, M; Kasza, A; Kordula, T; Sobota, R; Szwed, M | 1 |
Jain, NK; Kulkarni, SK | 1 |
Dietrich, JB; Kuchler-Bopp, S; Zaepfel, M | 2 |
Fiedler, MA; Mazor, RL; Menendez, IY; Ryan, MA; Wong, HR | 1 |
Doppler, W; Geymayer, S | 1 |
Lentsch, AB; Miller, RD; Molestina, RE; Ramirez, JA; Summersgill, JT | 1 |
Akao, S; Fujiwara, H; Fukuda, K; Hibiya, Y; Mutoh, M; Ohno, Y; Yamashita, K | 1 |
Bhat-Nakshatri, P; Boswell, SH; Gelfanov, V; Goulet, RJ; Nakshatri, H; Newton, TR; Nozaki, S; Patel, NM; Rice, S; Shortle, NH; Sledge, GW | 1 |
Bonilla, LE; Cutlan, AR; Erwin, JE; Simon, JE | 1 |
Hong, YS; Kim, HS; Kim, KW; Koo, TH; Lee, JH; Lee, JJ; Park, YJ | 1 |
Nakshatri, H; Nozaki, S; Sledge, GW | 1 |
Chung, SW; Kang, BY; Kim, TS | 1 |
Liu, X; Piela-Smith, TH | 1 |
Blum, D; Nissou, MF; Torch, S; Verna, JM | 1 |
Castro, V; García-Piñeres, AJ; Merfort, I; Mora, G; Pahl, HL; Schmidt, TJ; Strunck, E | 1 |
Crews, CM; Elofsson, M; Koh, B; Kwok, BH; Ndubuisi, MI | 1 |
Cabrini, G; Melotti, P; Nicolis, E; Pavirani, A; Rolfini, R; Tamanini, A | 1 |
Datta, A; Mittra, S; Singh, A; Singh, SK | 1 |
Cai, Y; Liu, XY; Lu, Y; Song, XK; Tu, PF; Wu, LJ; Zheng, QT; Zhu, H | 1 |
Abourashed, EA; Khan, IA | 1 |
Denenberg, A; Hake, PW; Wong, HR; Zingarelli, B | 1 |
Chung, SW; Kang, SN; Kim, HJ; Kim, SH; Kim, TS; Lee, MH | 1 |
Bolay, H; Chiarugi, A; Moskowitz, MA; Reuter, U | 1 |
Bömmel, H; Duschl, A; Heim, M; Moser, R; Panski, A; Schnyder, B; Schnyder-Candrian, S | 1 |
Hake, PW; Malhotra, V; O'Connor, M; Sheehan, M; Wong, HR; Zingarelli, B | 1 |
Crews, CM; Elofsson, M; Koh, BD; Kwok, BH; Ndubuisil, MI; Vervoort, J | 1 |
Choi, YK; Kim, DG; Liu, MJ; Won, YS; You, KR | 1 |
Kim, DG; Lee, SY; Song, CH; Wen, J; You, KR | 1 |
Arrighi, JF; Aubry, JP; Furue, M; Hauser, C; Uchi, H | 1 |
Cobb, SE; Nelson, MH; Shelton, J | 1 |
Blanco, J; Egido, J; Gómez-Guerrero, C; Hernández-Vargas, P; Kopp, J; López-Franco, O; Sanjuán, G; Suzuki, Y; Yo, Y | 1 |
Baumann, S; Giaisi, M; Krammer, PH; Li-Weber, M; Treiber, MK | 1 |
Engels, S; Fiebich, BL; Heinrich, M; Lieb, K | 1 |
Bogdanowicz, P; Dudhia, J; Legendre, F; Pujol, JP | 1 |
Giaisi, M; Krammer, PH; Li-Weber, M; Treiber, MK | 1 |
Chiarugi, A | 1 |
Beranek, JT | 1 |
D'Ambrosio, M; Guerriero, A; Kaneider, NC; Neukirch, H; Wiedermann, CJ | 1 |
Cory, AH; Cory, JG; Edwards, CC; Hall, JG | 1 |
Egido, J; Esbrit, P; Hernández-Presa, MA; Martín-Ventura, JL; Ortega, L; Ortego, M | 1 |
Darzynkiewicz, Z; Halicka, DH; Pozarowski, P | 1 |
Pestka, JJ; Smolinski, AT | 1 |
Hake, PW; Sheehan, M; Wong, HR; Zingarelli, B | 1 |
Fink, MP | 1 |
Aldieri, E; Atragene, D; Bergandi, L; Bosia, A; Costamagna, C; Ghigo, D; Riganti, C | 1 |
Koj, A; Witek-Zawada, B | 1 |
Abourashed, EA; Khan, IA; Khan, SI; Walker, LA | 1 |
Arribas, A; Blanco-Colio, LM; Egido, J; Gómez-Hernández, A; Martín-Ventura, JL; Muñoz-García, B; Ortega, L; Tuñón, J | 1 |
Devaraj, S; Jialal, I; Kumaresan, PR | 1 |
Chung, KS; Hoe, KL; Jang, YJ; Kim, DU; Maeng, PJ; Oh, GT; Park, SK; Ryoo, SW; Won, M; Yoo, HS | 1 |
Ong, CN; Shen, HM; Shi, X; Won, YK | 1 |
Armstrong, V; Curry, EA; Fife, K; Murry, DJ; Nakshatri, H; O'Connell, M; Sweeney, CJ; Yoder, C | 1 |
Fu, GS; Lin, XX; Shan, J; Weng, SX | 1 |
Ong, CN; Shen, HM; Zhang, S | 2 |
Chandrasekar, B; deGraffenried, LA; Donzis, E; Freeman, JW; Friedrichs, WE; Hidalgo, M; Silva, J; Weiss, GR | 1 |
Chilvers, ER; Cowburn, AS; Deighton, J; Walmsley, SR | 1 |
García-Piñeres, AJ; Lindenmeyer, MT; Merfort, I | 1 |
Groesdonk, HV; Senftleben, U | 1 |
Lin, ZN; Ong, CN; Shen, HM; Shi, X; Yang, CF; Zhang, S | 1 |
Bhat-Nakshatri, P; Nakshatri, H; Rice, SE | 1 |
An, W; Chen, L; Cui, W; Du, J; Hao, YM; Li, YJ; Liu, F; Liu, SY; Tian, ZJ; Zhang, H; Zu, XG | 1 |
Feng, HT; Joyce, DA; Steer, JH; Xu, J; Yip, KH; Zheng, MH | 1 |
Feltenstein, MW; Fischer, NH; Schühly, W; Sufka, KJ; Warnick, JE | 1 |
Bocca, C; Bozzo, F; Gabriel, L; Miglietta, A | 1 |
de Souza, W; Dias Filho, BP; Garcia Cortez, DA; Morgado-Díaz, JA; Nakamura, CV; Tiuman, TS; Ueda-Nakamura, T | 1 |
Chilvers, ER; Condliffe, AM; Cowburn, AS; Cramer, T; Farahi, N; Johnson, N; Johnson, RS; Peyssonnaux, C; Print, C; Sobolewski, A; Walmsley, SR | 1 |
Clarke, R; Nehra, R; Riggins, RB; Zwart, A | 1 |
Chiao, P; Su, H; Xiao, Y; Zhong, G; Zhong, Y; Zhou, Z | 1 |
Guzman, ML; Howard, DS; Jordan, CT; Karnischky, L; Li, X; Peterson, DR; Rossi, RM | 1 |
Giaisi, M; Krammer, PH; Li-Weber, M; Palfi, K | 1 |
Akao, Y; Iinuma, M; Matsuura, N; Nakagawa, Y; Nakayama, T; Naoi, M; Nozawa, Y; Yi, K | 1 |
Jang, JH; Surh, YJ | 1 |
Guzdek, A; Koj, A; Rokicki, M; Stalińska, K | 1 |
Kim, DG; Kim, IH; Kim, JH; Liu, L; Park, JH; You, KR | 1 |
Chen, C; Jain, MR; Jeong, WS; Keum, YS; Kim, JH; Kong, AN; Li, W; Shen, G | 1 |
Marshall, MS; Nakshatri, H; Schmidt, CM; Sweeney, CJ; Wiebke, EA; Yip-Schneider, MT | 1 |
Antolín, I; García-Santos, G; Herrera, F; Martin, V; Rodriguez, C; Rodriguez-Blanco, J | 1 |
D'Arcangelo, C; Di Primio, R; Mazzanti, L; Salvolini, E; Trubiani, O; Vignini, A | 1 |
Fonseca, JM; Rajapakse, NC; Riley, MB; Rushing, JW; Thomas, RL | 1 |
Badve, S; Campbell, RA; Kumar, S; Mehrotra, S; Murry, DJ; Nakshatri, H; Roman, Y; Sadaria, MR; Sheridan, C; Shortle, NH; Sweeney, CJ | 1 |
Bogdanowicz, P; Boumediene, K; Legendre, F; Pujol, JP | 1 |
Kim, DG; Kim, JH; Kim, YT; Lee, SO; Liu, L; You, KR | 1 |
Asamitsu, K; Hasegawa, J; Okamoto, T; Tanaka, K | 1 |
Greco, R; Morazzoni, P; Nappi, G; Riva, A; Sandrini, G; Tassorelli, C | 1 |
Jia, Y; Turek, JJ | 1 |
Ong, CN; Shen, HM; Won, YK | 1 |
Hanakawa, Y; Hashimoto, K; Kagami, S; Kakinuma, T; Komine, M; Tamaki, K | 1 |
Guzman, ML; Jordan, CT | 1 |
Laguna, JC; Merlos, M; Planavila, A; Sánchez, RM; Vázquez-Carrera, M | 1 |
Jové, M; Laguna, JC; Merlos, M; Planavila, A; Sánchez, RM; Vázquez-Carrera, M | 1 |
Frankfater, C; Fronczek, FR; Schühly, W; Slattery, M | 1 |
Kozak, A; Kozak, W; Wrotek, S | 1 |
Asahina, A; Kagami, S; Kakinuma, T; Komine, M; Nakamura, K; Saeki, H; Sasaki, K; Tamaki, K; Tsunemi, Y | 1 |
Zhong, D; Zhong, M; Zhu, R | 1 |
Asaba, K; Hashimoto, K; Iwasaki, Y; Nishiyama, M; Taguchi, T; Takao, T | 1 |
Chen, F; Haley-Zitlin, V; He, G; Huang, G; Kim, HJ; Rushing, JW; Wang, X; Wu, C | 1 |
Duke, VM; Ganeshaguru, K; Hoffbrand, AV; Jones, DT; Kottaridis, PD; Lowdell, MW; Mehta, AB; North, JM; Prentice, AG; Steele, AJ; Wickremasinghe, RG; Yogashangary, BC | 1 |
Bruze, M; Gruvberger, B; Hindsén, M; Lundh, K; Möller, H; Svensson, A | 1 |
Choi, JH; Heon Seo, K; Im, SY; Jun Park, S; Kim, HA; Kim, KJ; Ko, HM; Lee, HK | 1 |
Crews, CM; Gough, JD | 1 |
Cui, X; Eichacker, PQ; Fitz, Y; Hsu, L; Li, X; Li, Y | 1 |
Blanco, J; Egido, J; Gómez-Guerrero, C; Hernández-Vargas, P; López-Franco, O; Ortega, L; Ortiz-Muñoz, G; Sanjuán, G; Suzuki, Y | 1 |
Gage, EA; Klein, PJ; Ralstin, MC; Schmidt, CM; Wiebke, EA; Yip-Schneider, MT | 1 |
Baguley, BC; Ching, LM; Wang, LC; Woon, ST | 1 |
Crawford, S; Kraak, MM; Nobert, GS | 1 |
Avula, B; Joshi, VC; Khan, IA; Navarrete, A | 1 |
Chung, EY; Kim, BH; Kim, Y; Kim, YS; Lee, CK; Lee, JY; Min, KR; Reddy, AM; Ryu, SY; Seo, JH | 1 |
Bhat-Nakshatri, P; Cheng, L; DeGrado, T; Gokmen-Polar, Y; Hutchins, GD; Jayaprakasan, V; Kelich, S; Miller, KD; Miller, MA; Nakshatri, H; Shanmugam, R; Sledge, GW; Sweeney, CJ; Yip-Schneider, M; Zheng, QH | 1 |
Basalo, C; Hamburger, M; Mohn, T | 1 |
Adachi, M; Hayashi, T; Imai, K; Ishida, T; Kawamura, R; Sakamoto, H; Shinomura, Y; Wang, W | 1 |
Chen, ZC; Li, QB; Lü, J; Shao, J; You, Y; Zhong, ZD; Zou, P | 1 |
Coimbra, TM; Costa, RS; Francescato, HD; Scavone, C | 1 |
Figulla, HR; Foerster, M; Fritzenwanger, M; Krack, A; Kuethe, F; Meusel, K | 1 |
Kishida, Y; Myoui, A; Yoshikawa, H | 1 |
El Mabrouk, M; Sylvester, J; Zafarullah, M | 1 |
Berger, M; DiDonato, J; Li, J; Masters, S; Saadane, A | 1 |
Booz, GW; Bowers, MC; Dado, J; Kurdi, M | 1 |
Hamilton, T; Mandal, P | 1 |
Cho, ML; Jhun, JY; Jung, YO; Kang, CM; Kim, HY; Min, JK; Oh, HJ; Park, JS; Park, SH | 1 |
Arai, Y; Inoue, H; Nakai, Y; Nakayama, M; Nishimura, K; Nonomura, N; Oka, D; Okuyama, A; Shiba, M; Takayama, H | 1 |
Andersen, KE; Christensen, LP; Paulsen, E | 1 |
Jordan, CT | 1 |
Feng, L; Shao, X; Tang, X; Wu, N; Yao, H; Yao, K | 1 |
Donauer, J; Kern, C; Kreutz, C; Lindenmeyer, MT; Merfort, I; Porath, D; Schwager, J; Sparna, T; Timmer, J; Wilpert, J | 1 |
Auh, S; Blokh, L; Gagnon, I; Hamann, KJ; Long, C; Qin, Y | 1 |
Booz, GW; Kurdi, M | 1 |
Kobori, H; Ozawa, Y | 1 |
Ausseil, F; Barette, C; Cintrat, JC; David, B; Fonrose, X; Lafanechère, L; Massiot, G; Masson, V; Pouny, I; Rousseau, B; Soleilhac, E | 1 |
Ducore, JM; Storms, DH; Zunino, SJ | 2 |
Crooks, PA; Nakshatri, H; Neelakantan, S; Noble, S; Ralstin, M; Schmidt, CM; Sweeney, CJ; Wu, H; Yiannoutsos, C; Yip-Schneider, MT | 1 |
Czyz, M; Duechler, M; Stańczyk, M; Stepnik, M | 1 |
Arora, TS; Gopal, YN; Van Dyke, MW | 1 |
Becker, MW; Bennett, JM; Carroll, M; Corbett, CA; Crooks, PA; Guzman, ML; Hassane, DC; Jordan, CT; Lachowicz, JL; Li, X; Liesveld, JL; Matthews, W; Neelakantan, S; Rossi, RM; Sullivan, E; Sweeney, CJ; Vaughan, A | 1 |
Crooks, PA; Fang, F; Rangnekar, VM; St Clair, DK; St Clair, WH; Sun, Y; Warren, GW | 1 |
Pajak, B | 1 |
Cortez, DA; Ferreira, IC; Filho, BP; Izumi, E; Morello, LG; Morgado-Díaz, JA; Nakamura, CV; Ueda-Nakamura, T; Yamada-Ogatta, SF | 1 |
Bai, J; Gu, P; Margolick, JB; Zhang, H; Zhang, Y; Zhou, J | 1 |
Inman, AO; Monteiro-Riviere, NA; Riviere, JE | 1 |
Ahlborg, N; Bruze, M; Gruvberger, B; Karlberg, AT; Masjedi, K; Wahlkvist, H; Zuber, B | 1 |
Anthonavage, M; Garay, M; Liebel, F; Lyte, P; Martin, K; Oddos, T; Shapiro, S; Southall, M; Sur, R; Tierney, N | 1 |
Benjamin, L; Chin-Sinex, H; Comerford, K; Datzman, N; Gomez-Millan, J; Hardacre, M; Mehta, S; Mendonca, MS; Nakshatri, H; Nye, M; Patino, F; Sweeney, C | 1 |
Augsburger, LL; Jin, P; Madieh, S | 1 |
Afshari, LK; Azam, M; Bidja, AH; Feeney, RB; Pagán, OR; Rowlands, AL; Roy, DM; Urban, KR | 1 |
Pagán, OR; Rowlands, AL | 1 |
Anderson, KN; Bejcek, BE | 1 |
Akao, Y; Fujita, Y; Hamada, N; Iinuma, M; Ito, M; Itoh, T; Matsuura, N; Nozawa, Y; Umemura, K | 1 |
Abboud, R; Carroll, M; Corbett, C; Guzman, ML; Hassane, DC; Jordan, CT; Li, X; Liesveld, JL; Young, F | 1 |
Abonour, R; Boswell, HS; Crean, CD; Farag, SS; Nakshatri, H; Shanmugam, R; Suvannasankha, A | 1 |
Hatashita, M; Hayashi, A; Hayashi, S; Kitai, R; Matsumoto, H; Shioura, H | 1 |
Endo, D; Gon, Y; Hashimoto, S; Matsumoto, K; Miyata, N; Nunomura, S; Ra, C; Yamashita, K | 1 |
Du, J; Guo, J; Li, T; Liu, Y; Lu, WL; Wang, GL; Wang, JC; Wu, JW; Zhang, Q; Zhang, X | 1 |
Breger, JC; Durfor, CN; Hitchins, VM; Langone, JJ; Lyle, DB; Shallcross, JC | 1 |
Berry, PA; Birnie, R; Bryce, SD; Collins, AT; Droop, A; Dussupt, V; Hyde, CF; Lang, SH; Lewis, JL; Maitland, NJ; Roome, C; Stower, MJ | 1 |
Diamandis, EP; Paliouras, M | 1 |
Gajkowska, B; Orzechowski, A; Pajak, B | 1 |
Brzana, W; Jabłoński, M; Majdan, M; Mitura, A; Parada-Turska, J; Rzeski, W | 1 |
Crooks, PA; Nasim, S | 1 |
Rk, W; Zhang, FC; Zhou, HQ | 1 |
Hashizume, M; Hayakawa, N; Mihara, M | 1 |
Chen, Z; Kong, F; Li, Q; Tian, X; You, Y; Yu, K; Zhao, J; Zou, P | 1 |
Mahesh, R; Pandey, DK; Radha, R; Rajkumar, R | 1 |
Bae, YM; Choi, MH; Hong, ST; Kim, YJ | 1 |
Limon-Flores, AY; Ramos, G; Ullrich, SE | 1 |
Liebel, F; Lyte, P; Martin, K; Shapiro, S; Southall, M; Sur, R | 1 |
Cortez, DA; Dias Filho, BP; Nakamura, CV; Onozato, T; Ueda-Nakamura, T | 1 |
Figulla, HR; Foerster, M; Fritzenwanger, M; Jung, C; Meusel, K | 1 |
Aimiuwu, J; Bhasin, D; Chan, KK; Chen, P; Fuchs, JR; Huang, TH; Li, C; Li, PK; Liu, S; Liu, Z; Marcucci, G; Neviani, P; Pang, J; Pavlovicz, RE; Perrotti, D; Plass, C; Rush, L; Wang, H; Wu, J; Wu, LC; Xie, Z | 1 |
Alvarez, LD; Clarêncio, J; Costa, MF; Costa, SL; El-Bachá, RS; Lima, RM | 1 |
Duhagon, MA; Farrar, WL; Hurt, EM; Kalathur, M; Kawasaki, BT; Kim, YS; Milner, JA | 1 |
Tallman, M | 1 |
Choudary, A; Ghosh, S; Hu, Y; Li, R; Musi, N | 1 |
Bosisio, E; D'Ambrosio, M; Dell'Agli, M; Galli, GV | 1 |
Chanchorn, E; Gopal, YN; Van Dyke, MW | 1 |
Bosia, A; Doublier, S; Ghigo, D; Miraglia, E; Pescarmona, G; Riganti, C; Viarisio, D | 1 |
Kiuchi, H; Miyagawa, Y; Nakayama, J; Nonomura, N; Okuyama, A; Takao, T; Tsujimura, A; Yamamoto, K | 1 |
Adachi, M; Wang, W; Zhang, R; Zhou, J; Zhu, D | 1 |
Chin-Sinex, H; Hughes, W; Losch, A; Mendonca, MS; Miller, DA; Sweeney, C; Watson, C | 1 |
Aroeira, LS; Carvajal, G; Egido, J; Mezzano, SA; Ortiz, A; Rayego, S; Rodrigues-Díez, R; Rodriguez, JS; Rodríguez-Vita, J; Ruiz-Ortega, M; Sánchez-López, E; Selgas, R | 1 |
Konia, MR; Liu, H; Schaefer, S | 1 |
Crooks, PA; Guzman, ML; Jordan, CT; Nasim, S; Neelakantan, S | 1 |
Barochia, A; Cui, X; Eichacker, PQ; Li, X; Li, Y; Su, J | 1 |
Guo, C; Guo, Z; Jin, X; Qiu, L; Zhang, D | 1 |
Chen, S; Fang, L; Ma, J; Shan, J; Sui, MH; Wang, JA; Weng, SX; Xu, G | 1 |
Altuwaijri, S; Bhanot, UK; Chang, C; Chen, L; Deng, F; Gerald, WL; Korets, R; Lal, P; Lilja, HG; Scher, HI; Wenske, S; Zhang, L | 1 |
Li, Y; Xu, YH; Zhao, LJ | 1 |
Fang, LJ; Lu, GH; Shao, XT; Wang, S; Xu, T; Zhou, JY | 1 |
Lei, ZN; Li, T; Wang, L; Zeng, SL; Zhu, JB | 1 |
Cho, ML; Ju, JH; Kang, CM; Kim, HY; Kim, KW; Lee, SH; Li, X; Min, JK; Oh, HJ; Park, SH | 1 |
Czyz, M; Düchler, M; Koprowska, K; Lesiak, K; Nejc, D; Zalesna, I | 1 |
Bernstein, SH; Briehl, MM; Brookes, PS; Guzman, ML; Hilchey, SP; Jordan, CT; Maggirwar, SB; Nadtochiy, SM; Skalska, J | 1 |
Hatashita, M; Hayashi, A; Hayashi, S; Sakurai, H; Shioura, H; Tanaka, Y | 1 |
Bui-Nguyen, TM; Kumar, R; Martin, E; Murad, F; Pakala, SB; Sirigiri, DR | 1 |
Cureton, E; Curran, B; Dozier, K; Kwan, RO; Sadjadi, J; Victorino, GP | 1 |
Alnemri, ES; Datta, P; Fernandes-Alnemri, T; Juliana, C; Latz, E; Meng, R; Quong, AA; Scott, CP; Solorzano, L; Wu, J; Yu, JW | 1 |
Fleming, A; Goldsmith, P; Jankowski, J | 1 |
Fu, ZQ; Shao, QL; Shen, JL; Yao, L; Zhang, YJ; Zhao, XX | 1 |
Crooks, PA; St Clair, DK; St Clair, WH; Sun, Y; Xu, Y | 1 |
Czyz, M; Koprowska, K | 1 |
Chen, J; Shi, J; Sun, J; Wei, H; Yi, J | 1 |
Abdul-Sater, AA; Ojcius, DM; Padilla, EV; Saïd-Sadier, N | 1 |
Gao, L; Mitra, AK; Zucker, IH | 1 |
Gao, ZW; Guo, CB; Zhang, DL | 1 |
Deck, LM; Ferguson, JE; Hunsaker, LA; Shah, VO; Vander Jagt, DL | 1 |
Czyz, M; Koprowska, K; Lesiak-Mieczkowska, K; Szulawska-Mroczek, A; Wozniak, M | 1 |
Bedirli, A; Ofluoglu, E; Pasaoglu, H; Sakrak, O; Salman, B | 1 |
de las Pozas, A; Parrondo, R; Perez-Stable, C; Rai, P; Reiner, T | 1 |
Idris, AI; Krishnan, M; Landao-Bassonga, E; Mollat, P; Ralston, SH; Simic, P; Vukicevic, S | 1 |
Appaiah, H; Cheng, L; Crooks, P; Klaunig, J; Kusumanchi, P; Matthews, W; Nakshatri, H; Neelakantan, S; Peat, T; Shanmugam, R; Sweeney, CJ | 1 |
Andersen, KE; Christensen, LP; Fretté, XC; Paulsen, E | 1 |
Cai, MX; Huang, DS; Liu, JW; Ma, J; Wu, QS; Xie, HY; Xin, Y; Yang, P | 1 |
Cheong, JW; Eom, JI; Jeung, HK; Kim, JS; Kim, SJ; Kim, YR; Min, YH | 1 |
Chen, S; Dai, Y; Dent, P; Grant, S; Guzman, ML; Jordan, CT; Pei, XY; Wang, L; Yeung, SK | 1 |
Bommana, A; Bui-Nguyen, TM; Kumar, R; Pakala, SB; Rangparia, SS; Reddy, SDN | 1 |
Aoyama, S; Hashida, C; Hirasawa, N; Hong, J; Ishihara, K; Kimura, M; Ohuchi, K; Seyama, T; Zee, O | 1 |
Dyugovskaya, L; Ginsberg, D; Lavie, L; Lavie, P; Polyakov, A | 1 |
Balys, M; Corbett, CA; Crooks, PA; Guzman, ML; Hassane, DC; Jordan, CT; Minhajuddin, M; Rossi, RM; Sen, S; Wei, L | 1 |
Kim, DG; Kim, IH; Kim, JH; Lee, MJ; Yu, GR; Yun, BR | 1 |
Dias Filho, BP; Izumi, E; Nakamura, CV; Pelizzaro-Rocha, KJ; Tiuman, TS; Ueda-Nakamura, T | 1 |
Battastini, AM; Braganhol, E; Dalmolin, RJ; de Souza, LH; Gelain, DP; Moreira, JC; Pasquali, MA; Schröder, R; Zanotto-Filho, A | 1 |
Antoine, B; Capeau, J; Chapron, C; Kadiri, S; Leroyer, S; Quette, J; Vatier, C | 1 |
Andersen, KE; Paulsen, E | 4 |
Alvarez, AL; Habtemariam, S; Jackson, C; Juan-Badaturuge, M; Parra, F | 1 |
Aro, J; Kerkelä, R; Leskinen, H; Ruskoaho, H; Rysä, J; Saiho, T; Serpi, R; Skoumal, R; Szokodi, I; Tóth, M; Ulvila, J | 1 |
Bernard, JJ; Blumberg, N; Phipps, RP; Sahler, J; Spinelli, SL | 1 |
Acres, OW; Kobori, H; Navar, LG; Satou, R | 1 |
Cheng, J; Falck, JR; Gotlinger, KH; Jat, JL; Kelkar, M; Schwartzman, ML; Wu, CC; Zhang, FF; Zhang, Y | 1 |
Bobbala, D; Fehrenbacher, B; Ghashghaeinia, M; Ghoreschi, K; Lang, F; Röcken, M; Rodemann, HP; Rupec, R; Saki, M; Schaller, M; Toulany, M; Wieder, T | 1 |
Park, SJ; Shin, HJ; Youn, HS | 1 |
Angileri, L; Carlisi, D; D'Anneo, A; Emanuele, S; Lauricella, M; Santulli, A; Tesoriere, G; Vento, R | 1 |
Barrios, FJ; Colby, DA; Glackin, CA; Gunn, EJ; Han, C; Huynh, DT; Iannotti, MJ; Kendall, S; Kirshner, J; Williams, JT | 1 |
Alegret, M; Laguna, JC; Merlos, M; Piera, L; Pou, J; Rebollo, A; Roglans, N | 1 |
Koh, YS; Mathema, VB; Sillanpää, M; Thakuri, BC | 1 |
Beekwilder, J; Bouwmeester, H; Cankar, K; Karimzadeh, G; Liu, Q; Majdi, M; Malboobi, MA; Simonović, A; Todorović, S; Vos, Rd | 1 |
Che, XF; Kawaguchi, T; Miyazawa, K; Moriya, S; Tomoda, A | 1 |
Hatashita, M; Hayashi, S; Jujo, Y; Koshiba, K; Sato, T; Shioura, H; Suzuki, R; Tanaka, Y | 1 |
Cheng, G; Xie, L | 1 |
Bai, S; Lu, J; Sheng, G; Wang, C; Wang, L; Wang, Y | 1 |
Bujnicki, T; Feldmann, F; Klempnauer, KH; Müller-Tidow, C; Schlenke, P; Schmidt, TJ; Schomburg, C; Wilczek, C | 1 |
Gach, K; Hrabec, E; Janecka, A; Janecki, T; Koszuk, J; Szemraj, J; Szewczyk, K; Wyrębska, A | 1 |
Gerstberger, R; Hübschle, T; Roth, J; Rummel, C | 1 |
Alavanja, T; Bieberich, AA; Colby, DA; Mo, H; Woods, JR | 1 |
Eliseev, RA; Giang, AH; O'Keefe, R; Rosier, R; Schwarz, E; Shapovalov, Y; Zuch, D | 1 |
Brun, R; Gökbulut, A; Kaiser, M; Sarer, E; Schmidt, TJ | 1 |
Gilmore, TD; Porco, JA; Yeo, AT | 1 |
Gan, HT; Huang, XL; Liu, L; Xiang, JY; Zhao, ZJ | 1 |
Benito-Martín, A; Blanco, J; Carrasco, S; Egido, J; Izquierdo, MC; Mezzano, S; Ortiz, A; Ruiz-Ortega, M; Sanchez-Niño, MD; Sanz, AB | 1 |
Díaz-Delfín, J; Domingo, P; Giralt, M; Villarroya, F; Wabitsch, M | 1 |
Beretta, G; Dozio, E; Maffei Facino, R; Magni, P; Rizzi, E; Ruscica, M | 1 |
Gill, KK; Kaddoumi, A; Nazzal, S | 1 |
Kim, W; Kim, YJ; Lee, CS; Lee, SA; Myung, SC | 1 |
Bach, D; Baker, D; Deats, S; Kotturu, D; Montgomery, E; Pagán, OR; Raffa, RB; Randolph, C; Rawls, S; Tallarida, C; Tenaglia, M; Wilk, G | 1 |
Kim, DG; Kim, IH; Kim, SH; Kim, SW; Lee, MJ; Lee, SO; Lee, ST; Park, WH | 1 |
Barroso, E; Chacón, MR; Garrido-Sánchez, L; Maymó-Masip, E; Palomer, X; Salvadó, L; Serrano-Marco, L; Tinahones, FJ; Vázquez-Carrera, M; Vendrell, J; Wabitsch, M | 1 |
Carlisi, D; D'Anneo, A; Di Fiore, R; Emanuele, S; Lauricella, M; Tesoriere, G; Vento, R | 1 |
Fu, M; Li, Y; Lu, Q; Niu, X; Pei, Y; Yao, Q; Zhang, K; Zhang, P; Zhang, Y; Zhuo, H | 1 |
Biavatti, MW; D'Herde, K; Grootjans, S; Kreuger, MR; Vandenabeele, P | 1 |
Chen, Y; Li, D; Lin, JP; Long, J; Qiu, CJ; Zhai, JD; Zhang, HL; Zhang, Q | 1 |
Guo, SF; Li, CJ; Shi, TM | 1 |
Kim, DG; Kim, IH; Kim, SH; Kim, SL; Kim, SW; Lee, SO; Lee, ST; Trang, KT | 2 |
Darwiche, N; Gali-Muhtasib, H; Ghantous, A; Rau, T; Saikali, M; Schneider-Stock, R | 1 |
Nakabayashi, H; Shimizu, K | 1 |
Gach, K; Janecka, A; Janecki, T; Koszuk, J; Piekielna, J; Szymański, J; Wyrębska, A | 1 |
Guo, S; Li, C; Shi, T | 1 |
Maharaja, K; Sharma, VK; Verma, P | 1 |
Czyz, M; Koprowska, K; Sztiller-Sikorska, M | 1 |
Jordan, CT; Pei, S | 1 |
Blair, A; Cox, CV; Diamanti, P; Moppett, JP | 1 |
Basheer, A; Datti, A; Gronda, M; Hurren, R; Lin, FH; MacLean, N; Schimmer, AD; Spagnuolo, PA; Wang, X; Wrana, J | 1 |
Kolter, R; Romero, D; Sanabria-Valentín, E; Vlamakis, H | 1 |
Chang, WC; Chen, BK; Huang, CR; Ko, SC; Shieh, JM; Yang, JH | 1 |
Kang, SB; Kim, DG; Kim, IH; Kim, SH; Kim, SL; Kim, SW; Lee, SO; Lee, ST; Trang, KT | 1 |
Li, Y; Liu, D; Liu, M; Liu, Y; Ran, L | 1 |
Ma, W; Su, Y; Wang, C | 1 |
Haque, A; Koide, N; Komatsu, T; Naiki, Y; Odkhuu, E; Tsolmongyn, B; Yokochi, T; Yoshida, T | 2 |
Becker, MW; Corbett, C; Guzman, ML; Hassane, DC; Jordan, CT; Sen, S | 1 |
Chaiswing, L; Clair, DK; Clair, WH; Crooks, PA; Fang, F; Holley, AK; Kiningham, KK; Miriyala, S; Noel, T; Oberley, TD; Xu, Y; Zhao, Y | 1 |
Darwiche, N; Ghantous, A; Herceg, Z; Sinjab, A | 1 |
Goto, M; Lee, KH; Li, Y; Morris-Natschke, SL; Su, J; Yao, ZJ; Zhao, QS; Zhao, Y | 1 |
Guo, C; Li, B; Li, Y; Liu, L; Wan, L; Yang, Q; Yu, Q; Zhou, Z | 1 |
Lan, L; Luo, L; Qi, S; Shen, L; Xin, Y; Xu, Y; Yin, F; Yin, Z | 1 |
Czyz, ME; Hartman, ML; Koprowska, K; Sztiller-Sikorska, M | 1 |
Amorim, MH; Bastos, MM; Gil da Costa, RM; Lopes, C | 1 |
Harada, T; Iwabe, T; Nakamura, K; Takai, E; Taniguchi, F; Uegaki, T | 1 |
Czyz, M; Hartman, ML; Nejc, D; Szulawska-Mroczek, A; Wozniak, M | 1 |
Andersson, DA; Appendino, G; Benemei, S; De Siena, G; Dussor, G; Fusi, C; Geppetti, P; Gualdani, R; Materazzi, S; Moncelli, MR; Nassini, R; Patacchini, R; Pollastro, F; Trevisan, G; Vastani, N; Wei, X | 1 |
Cui, L; Dong, L; Li, Y; Liu, Z; Qiao, H; Wang, C; Wang, L; Xing, Y; Zhang, X; Zhao, J; Zhu, C | 1 |
Augello, G; Carlisi, D; D'Anneo, A; De Blasio, A; Di Fiore, R; Drago-Ferrante, R; Giuliano, M; Tesoriere, G; Vento, R | 1 |
Boggs, AE; Charpentier, MS; Martin, SS; Thompson, K; Vitolo, MI; Whipple, RA | 1 |
Chen, Y; Ding, YH; Long, J; Wang, PP; Zhang, Q | 1 |
Kwak, SW; Lee, CS; Park, ES | 1 |
Biedermann, T; Bosman, GJ; Cluitmans, JC; Dreischer, P; Duszenko, M; Ghashghaeinia, M; Köberle, M; Lang, E; Lang, F; Saki, M; Toulany, M; Wieder, T | 1 |
Ashton, JM; Balys, M; Becker, MW; Benes, C; Callahan, KP; Corbett, C; Crooks, PA; Greninger, P; Hagen, FK; Jordan, CT; Lagadinou, ED; Li, Z; Liesveld, JL; Minhajuddin, M; Munger, J; Neering, SJ; O'Dwyer, KM; Pei, S; Settleman, J; Shi, L; Ye, H | 1 |
Burico, M; Galeotti, N; Ghelardini, C; Maidecchi, A; Mattoli, L | 1 |
Buttitta, G; Carlisi, D; D'Anneo, A; Di Fiore, R; Emanuele, S; Lauricella, M; Tesoriere, G; Vento, R | 1 |
Chen, S; Jia, Q; Li, H; Long, H; Wang, J; Xu, Z; Zhao, Y | 1 |
Gagare, PD; Helppi, MA; Nair, HN; Nicponski, DR; Ramachandran, PV; Schmidt, CM; Yip-Schneider, MT | 1 |
Carlisi, D; D'Anneo, A; Di Bella, S; Di Fiore, R; Di Marco, P; Emanuele, S; Guercio, A; Lauricella, M; Martinez, R; Puleio, R; Tesoriere, G; Vento, R | 1 |
Fasan, R; Jordan, CT; Kolev, JN; O'Dwyer, KM | 1 |
Li, Y; Mao, Y; Wang, H; Wang, X; Zhang, C; Zhou, X | 1 |
Cheon, YH; Kim, JY; Lee, MS; Oh, J; Yoon, KH | 1 |
Liu, X; Su, L; Zhao, X | 1 |
Cho, KM; Hwang, SY; Kim, HJ; Kim, SH; Kim, TS; Song, JH | 1 |
Kobori, H; Miyata, K; Navar, LG; Prieto, MC; Satou, R; Shao, W; Urushihara, M | 1 |
Qin, Y; Shi, YH; Zhou, RH; Zhu, FX | 1 |
Gach, K; Janecka, A; Wyrębska, A | 1 |
Hayashi, K; Ishihara, R; Matsuura, N; Mitsui, T; Nozaki, H; Sunadome, M | 1 |
Chauhan, PS; Garg, S; Gupta, M; Mahajan, VK; Mehta, KS; Sharma, V | 1 |
Jia, Y; Li, B; Liu, X; Lu, C; Tong, Z; Wang, W | 1 |
Gach, K; Janecka, A | 1 |
Cragle, CE; Crooks, PA; Janganati, V; MacNicol, AM; Penthala, NR | 1 |
Bankovic, J; Bouwmeester, H; de Vos, R; Ferrer, A; Liu, Q; Manzano, D; Pateraki, I; Pesic, M; Ricard, L; Tanić, N; van de Krol, S | 1 |
Buttitta, G; Carlisi, D; D'Anneo, A; Di Fiore, R; Emanuele, S; Lauricella, M; Martinez, R; Tesoriere, G; Vento, R | 1 |
Chen, XY; Chen, Y; Jia, YS; Liu, XD; Lu, C; Tong, ZS; Xu, HJ; Zhou, LY | 1 |
Alonso, A; Nakamura, CV; Tiuman, TS; Ueda-Nakamura, T | 1 |
Abdel-Wahab, O; Balys, M; Becker, MW; Corbett, CA; Guzman, ML; Hassane, DC; Jordan, CT; Levine, RL; Marcucci, G; Roboz, GJ; Sharma, KK; Steidl, U; Yang, N | 1 |
Akssira, M; Allouchi, H; Benharref, A; El Bouakher, A; El Hakmaoui, A; Guillaumet, G; Mathieu, V; Moumou, M | 1 |
Bao, YL; Chen, ZL; Huang, YX; Li, YX; Sun, J; Sun, Y; Wang, X; Wu, Y; Yu, CL; Zhang, C; Zheng, LH | 1 |
Chen, Y; Long, J; Wang, PP; Yang, ZJ; Zhang, Q; Zhang, SF; Zhang, XM | 1 |
Bommagani, S; Cragle, CE; Crooks, PA; Hardy, LL; Janganati, V; MacNicol, AM; MacNicol, KB; Madadi, NR; Penthala, NR | 1 |
Makuch, W; Mika, J; Pilat, D; Popiolek-Barczyk, K; Rojewska, E | 1 |
Angel, J; Busca, A; Iqbal, S; Kumar, A; Saxena, M | 1 |
Chen, S; Chen, X; Du, X; Huang, B; Jia, Q; Li, H; Long, H; Lu, L; Wang, J; Xu, Z; Zhao, Y | 1 |
Ahmad, A; Al-Fatlawi, AA; Irshad, M | 1 |
Buttitta, G; Carlisi, D; D'Anneo, A; di Fiore, R; Emanuele, S; Lauricella, M; Martinez, R; Rolfo, C; Tesoriere, G; Vento, R | 1 |
Li, Q; Wang, M | 1 |
Lin, Z; Liu, Q; Romas, E; Sims, NA; Tan, R; Xu, J; Zhao, J; Zheng, M; Zhou, H | 1 |
Cao, Y; Jia, H; Lan, B; Leng, QL; Liu, YH; Pan, S; Wan, YJ; Wang, Y; Yang, Y; Zhang, CZ | 1 |
Kim, DG; Kim, IH; Kim, SH; Kim, SL; Kim, SW; Lee, SO; Lee, ST; Liu, YC; Park, YR; Seo, SY | 1 |
Chen, HF; Gao, YF; He, CY; Hou, MJ; Huang, YJ; Li, XJ; Liao, K; Lin, YC; Lin, ZN; Ling, WH; Luo, B; Qiu, Y; Xia, B; Zhang, YJ; Zhuang, QY | 1 |
Ludwig, H; Nick, P; Schneider, N | 1 |
Cho, SD; Jeong, JH; Jung, JY; Lee, JS; Yu, HJ | 1 |
Cheng, L; Gao, X; Li, S; Shen, D; Tong, X; Wu, X; Wu, Z; Zhu, L | 1 |
Beaupere, C; Capeau, J; Fève, B; Garcia, M; Lagathu, C; Larghero, J | 1 |
Chiu, SC; Liao, MH; Lin, CW; Su, MJ; Tang, TK | 1 |
Langer, K; Plöger, M; Schmidt, TJ; Sendker, J | 1 |
Cantley, MD; Crotti, TN; Dharmapatni, AA; Haynes, DR; Marino, V; Perilli, E; Purdue, PE; Xu, J; Zawawi, MS | 1 |
Lee, CS; Lee, DH; Lee, MS; Nam, YJ | 1 |
Becker, CM; Harki, DA; Hexum, JK; Kempema, AM; Largaespada, DA; Ohlfest, JR | 1 |
Chen, WL; Chen, ZC; Kong, FC; Li, QB; Ren, WX; Wang, HX; Yan, GX; Zeng, C; Zhang, JQ | 1 |
Andrews, TE; Harki, DA; Hexum, JK; Kempema, AM; Largaespada, DA; Meece, FA; Noble, KE; Rathe, SK; Sachs, Z; Wang, D; Widen, JC | 1 |
Jurga, AM; Kolosowska, N; Makuch, W; Mika, J; Pilat, D; Piotrowska, A; Popiolek-Barczyk, K; Rojewska, E | 1 |
Abdollahi, MR; Majdi, M; Maroufi, A | 1 |
Chen, Y; Ge, WZ; Gong, JM; Kuang, BJ; Li, QY; Lu, Y; Wu, H; Xi, X; Yang, ZJ; Zhang, Q | 1 |
Chin, YE; Fu, GH; Huang, YN; Ye, H; Zeng, Z; Zhang, YC | 1 |
Borrelli, MJ; Crooks, PA; Janganati, V; Jordan, CT; Penthala, NR; Ponder, J | 1 |
Abdollahi, MR; Ashengroph, M; Majdi, M | 1 |
Chan, P; Cheng, KS; Leung, YM; Lou, SL; Su, TH; Tsai, TY; Wang, ML; Wong, KL | 1 |
Albayati, ZF; Crooks, PA; Ferrari, M; Gorenstein, DG; Guzman, ML; Liu, X; Mu, C; Roboz, GJ; Sen, S; Shen, H; Zhang, G; Zong, H | 1 |
Huo, XL; Pan, YY; Zhang, SQ; Zhao, AQ; Zhao, JH | 1 |
Bi, L; Hong, Y; Kong, H; Wang, H; Xie, W; Zhu, R | 1 |
Balaich, JN; Cheseto, X; Dinglasan, RR; Ebrahimi, B; Foster, WA; Jackson, BT; Mathias, DK; Tao, D; Tarimo, BB; Torto, B | 1 |
Czyz, M; Hartman, ML; Nejc, D; Sztiller-Sikorska, M; Talar, B | 1 |
Gach, K; Grądzka, I; Iwaneńko, T; Janecka, A; Janecki, T; Koszuk, J; Kruszewski, M; Męczyńska-Wielgosz, S; Szymański, J; Wasyk, I | 1 |
George, VC; Kumar, DR; Kumar, RA | 1 |
Duan, D; Fang, J; Liu, Y; Yao, J; Zhang, J | 1 |
Andreadaki, A; Diekmann, H; Fischer, D; Gobrecht, P; Heskamp, A; Leibinger, M | 1 |
Alas, MA; Bystrom, LM; Compadre, CM; Enriquez, RG; Guzman, ML; Jones, DE; Malagón, O; Ordóñez, PE; Sharma, KK | 1 |
Buttitta, G; Carlisi, D; Di Fiore, R; Drago-Ferrante, R; Scerri, C; Tesoriere, G; Vento, R | 1 |
Arockiam, AJ; Jeyamohan, S; Kannan, MK; Moorthy, RK | 1 |
Cheng, X; Da, Y; Fu, S; Huang, W; Kong, Y; Li, Y; Na, D; Wang, D; Wang, H; Xue, Z; Yang, F; Yang, L; Zhang, L; Zhang, Q; Zhang, R | 1 |
Alzoubi, K; Bernhardt, I; Bissinger, R; Dreischer, P; Ghashghaeinia, M; Giustarini, D; Hosseinzadeh, Z; Köberle, M; Koralkova, P; Lang, F; Mojzikova, R; Mrowietz, U; Rossi, R; Toulany, M; Wieder, T | 1 |
Behmanesh, M; Farzadfar, S; Hojati, M; Zarinkamar, F | 1 |
Datusalia, AK; Khare, P; Sharma, SS | 1 |
Adane, B; Ashton, JM; Crooks, PA; D'Alessandro, A; De, S; Gutman, JA; Hagen, FK; Hansen, KC; Jordan, CT; Khan, N; Minhajuddin, M; Nemkov, T; Pei, S; Pollyea, DA; Smith, C; Stevens, BM; Yadav, VK | 1 |
Arndt, HD; Freund, RR | 1 |
Back, MJ; Choi, JM; Fu, Z; Ha, HC; Jang, JM; Jang, YJ; Kim, DK; Lee, HK; Lee, JH; Won, JH | 1 |
Kong, QJ; Ou Yang, YP; Yang, C; Yang, QO; Yuan, W | 1 |
Chen, Y; Ding, Y; Gao, Y; Ge, W; Kang, N; Kuang, B; Lian, L; Wei, Y; Yang, Z; Zhang, Q | 1 |
Jeong, HJ; Kim, EM; Kim, IH; Kim, SH; Kim, SL; Kim, SW; Kim, YN; Lee, SO; Lee, ST; Liu, YC; Park, YR; Seo, SY | 1 |
Blair, A; Collins, AM; Deller, RC; Diamanti, P; Ede, BC; Le Vay, K; Morrison, G; Perriman, AW; Reilly, J; Richardson, R | 1 |
Ayares, D; Cooper, DKC; Esmon, CT; Ezzelarab, M; Hara, H; Huang, H; Iwase, H; Lee, W; Li, T; Long, C; Wang, Y | 1 |
Iranshahi, M; Nasseri, MA; Taleghani, A | 1 |
Du, J; Duan, RS; Li, H; Li, XL; Liu, RT; Liu, Y; Yang, CL; Yue, LT; Zhang, M; Zhang, N; Zhang, P | 1 |
Li, HB; Liang, F; Shi, LL; Tian, YF; Xu, H; Xu, X; Yang, K; Zhang, JF; Zhang, L; Zhao, Y; Zhao, ZH | 1 |
Hamedi Asl, D; Hamidollah, G; Mohammadi, S; Nikbakht, M; Nikugoftar, M; Rahmani, B; Shaiegan, M; Zahedpanah, M | 1 |
Bezak, E; Morel, KL; Ormsby, RJ; Sweeney, CJ; Sykes, PJ | 1 |
Bi, H; Huang, W; Lin, M; Liu, Y; Ma, J; Tang, S; Yan, Y; Zhang, G; Zhang, J; Zhang, L | 1 |
Golas, MM; Llamas Luceño, N; Sander, B; Yuan, J | 1 |
Chen, Y; Ding, YH; Gao, HE; Gao, YD; Ji, Q; Li, YH; Liu, XL; Long, J; Sun, Y; Yang, M; Zhang, Q | 1 |
Bahabadi, M; Goudarzi, F; Hashemnia, M; Karimi, J; Khodadadi, I; Mohammadalipour, A; Sheikh, N; Solgi, G | 1 |
Abhishek, A; Baskaran, N; Selvam, GS; Yuvaraj, S | 1 |
Alwaseem, H; Fasan, R; Frisch, BJ | 1 |
Chen, Q; Chen, Z; Fan, C; Liu, J; Mao, X; Wei, Q; Zhang, X | 1 |
Ke, J; Li, X; Liu, B; Lv, X; Yang, H; Zhang, Y | 1 |
Bishop, RT; Idris, AI; Logan, JG; Marino, S; Mollat, P | 1 |
Kim, SL; Kim, SW; Lee, ST; Park, YR | 1 |
Mehrotra, E; Saraf, SK; Sonar, PK; Tripathi, AC; Vishwakarma, J | 1 |
Bozkurt, M; Dagli, AZ; Irtegun Kandemir, S; Kalkanli-Tas, S; Tekin, MA | 1 |
Cooney, RN; Du, X; Meng, Q; Ren, H; Sarpong, JO; Yepuri, N | 1 |
Chen, L; Gallucci, JC; Kinghorn, AD; Li, X; Ren, Y; Yu, J | 1 |
Hao, X; Li, C; Li, L; Nie, F; Song, X; Tian, C; Wu, D; Yuan, C; Zeng, R; Zhu, X | 1 |
Enferadi, ST; Jafari, N; Nazeri, S | 1 |
Agarwal, V; Kalia, M; Narvi, SS; Sharma, D; Singh, PK; Yadav, VK | 1 |
Mao, W; Zhu, Z | 1 |
Chen, Y; Li, P; Wang, S; Yu, Z; Yuan, Y; Zhou, G | 1 |
Asmaro, RR; Blair, A; Diamanti, P; Ede, BC; Moppett, JP | 1 |
Cao, Y; Feng, X; Liu, F; Wang, B; Wang, Q; Wang, X; Xu, S; Yin, M; Zhao, X | 1 |
Gao, JJ; Li, XH; Liu, HJ; Qin, Y; Xiao, T; Yang, JH; Zhou, HG | 1 |
Hu, L; Liu, M; Sun, M; Tan, M; Xiao, C; Yu, Q | 1 |
Andersen, KE; Christensen, LP; El-Houri, RB; Paulsen, E | 1 |
Cordes, N; Klebe, S; Morel, KL; Ormsby, RJ; Solly, EL; Sweeney, CJ; Sykes, PJ; Tran, LNK | 1 |
Blair, A; Diamanti, P; Ede, BC; Perriman, AW; Ridolfo, R; van Hest, JCM; White, PB; Williams, DS | 1 |
Benassi-Zanqueta, É; Dias Filho, BP; Marques, CF; Nakamura, CV; Nocchi, SR; Ueda-Nakamura, T | 1 |
Hao, Q; Li, X; Liu, Q; Qiu, W; Wang, H; Wen, Y; Zhang, L; Zhang, W | 1 |
Aviles-Vazquez, S; Ayala-Sanchez, M; Chávez-González, A; Crooks, PA; Flores-Lopez, G; Guzman, ML; Mayani, H; Moreno-Lorenzana, D; Torres-Martinez, H | 1 |
Chen, Y; Ding, Y; Ge, W; Kuang, B; Xu, J; Yang, J; Yang, Z; Zhang, Q | 1 |
Al Kury, LT; Talib, WH | 1 |
Jin, X; Lv, H; Zhang, Z; Zhou, J | 1 |
Cipolla, GA; Hwang, CY; Kuh, HJ; Lee, DJ; Moeng, S; Park, JK; Seo, HA | 1 |
Beyraghdar Kashkooli, A; Bouwmeester, H; de Vos, RCH; Franssen, MCR; Guallar, V; Kolkman, P; Liu, Q; Lucas, MF; Manzano, D; Pateraki, I; Richard, L; van der Krol, A | 1 |
Fu, ZW; Gao, WF; Li, SN; Li, YX; Liu, G; Liu, LN; Liu, NR; Tao, R; Wang, YJ; Yin, TT; Zhang, CZ; Zhang, H; Zhang, WH; Zhang, XP; Zhao, LZ | 1 |
Coppi, E; De Logu, F; Geppetti, P; Landini, L; Li Puma, S; Macedo, SJ; Marone, IM; Materazzi, S; Nassini, R; Patacchini, R; Seravalli, V | 1 |
Chen, N; Chen, Y; Ding, Y; Ge, W; Han, F; Hao, X; Liu, Z; Wang, M; Wang, T; Zhang, Q | 1 |
Beyraghdar Kashkooli, A; Bouwmeester, H; Dickschat, JS; Rabe, P; van der Krol, AR | 1 |
Bishop, RT; Carrasco, G; Idris, AI; Li, B; Logan, JG; Marino, S | 1 |
Chen, X; Chen, Y; Ding, Y; Ge, W; Guo, H; Li, S; Liu, Z; Sun, Y; Wang, M; Wang, T; Zhang, Q | 1 |
Chen, J; Gu, W; Hao, XJ; Huang, LJ; Jian, JY; Li, YM; Li, YN; Qiu, J; Wen, M; Yuan, CM | 1 |
Choi, HS; Kang, B; Kim, CY; Suh, HJ | 1 |
Altobelli, CR; Berdan, CA; Demeulenaere, SG; Ho, R; Hu, X; Huffman, TR; Lehtola, HS; Maimone, TJ; Nomura, DK; Olzmann, JA; Petri, Y; To, M | 1 |
Anuchapreeda, S; Berkland, C; Chiampanichayakul, S; Katekunlaphan, T; Khounvong, J; Rungrojsakul, M; Saosathan, S; Tima, S | 1 |
Anber, N; Azmy, E; Bharali, DJ; Darwish, NHE; El-Ghaffar, HAA; Elbaz, O; Godugu, K; Mousa, SA; Sudha, T | 1 |
Baldacchino, S; De Blasio, A; Di Fiore, R; Drago-Ferrante, R; Grech, G; Pratelli, G; Saliba, C; Scerri, C; Tesoriere, G; Vento, R | 1 |
Araújo, TG; Brandão, DC; Campos, IM; Ferreira, EA; Filho, AADS; Guimarães, GS; Lima, PMAP; Ribeiro, MA; Vecchi, L | 1 |
Tong, ML; Wang, JA; Xi, DH; Yang, JP; Zhao, B; Zhu, G | 1 |
Chen, T; Chen, Y; Ding, Y; Ge, W; Li, S; Liu, Z; Wang, M; Zhang, Q; Zhang, X | 1 |
Che, Y; Feng, X; Liu, Q; Tang, X; Zhang, S; Zhu, D | 1 |
Arndt, HD; Fischer, D; Freund, RRA; Gobrecht, P; Moser, P | 1 |
Florek, E; Gornowicz-Porowska, J; Kaczerowska-Pietrzak, K; Napierała, M; Nawrot, J; Nowak, G; Pelant, E | 1 |
Arndt, HD; Fischer, D; Freund, RRA; Gobrecht, P | 1 |
Chen, Y; Gong, W; Huang, Q; Li, S; Long, H; Luo, C; Peng, F; Peng, X; Wang, Y; Wu, J; Xiao, J; Yin, B; Zhang, Y; Zhou, W | 1 |
Cai, N; Jin, X; Yang, Q; Zhang, Z | 1 |
Bedi, K; Caporizzo, MA; Chen, CY; Margulies, KB; Prosser, BL | 1 |
Chen, Y; Ding, Y; Ge, W; Guo, H; Hao, X; Hu, K; Li, A; Li, J; Li, Y; Liu, S; Wang, D; Wang, T; Xue, Q; Zhang, Q; Zhang, Y | 1 |
An, T; Cai, B; Chen, L; Duan, A; Ju, X; Kong, L; Li, X; Li, Y; Yang, Q | 1 |
Cong, C; Gao, D; Gao, W; He, Y; Li, L; Luo, L; Zhang, X | 1 |
Chai, Z; Li, J; Lu, L; Lu, W; Mao, J; Ran, D; Wu, S; Xie, C; Zhan, C; Zhang, Y; Zhou, J | 1 |
Contreras, JI; Karpf, AR; Kizhake, S; Kour, S; Natarajan, A; Rana, S; Robb, CM; Sonawane, YA; Zahid, M | 1 |
Jiang, S; Liang, P; Lv, H; Wu, H; Zhang, Z | 1 |
Gao, D; Gao, W; Li, C; Li, L; Li, Z; Wei, S; Zhang, X | 1 |
Jin, X; Lu, X; Lv, H; Zhang, Z | 1 |
Bahrami, M; Dadmehr, M; Kamalinejad, M; Latifi, SA; Seif, F | 1 |
Wang, J; Wang, Z; Yuan, L; Zhang, D | 1 |
Du, G; Jia, X; Li, Y; Liu, Q; Wang, S; Zeng, B; Zhang, C | 1 |
Chen, Y; Li, Q; Sun, S; Wang, J; Yu, L; Zhang, C | 1 |
Aghaee, A; Ahmadi, SZ; Ghorbanpour, M; Hadian, J | 1 |
Ghorbani-Abdi-Saedabad, A; Hanafi-Bojd, MY; Hoshyar, R; Mollaei, H; Parsamanesh, N; Tayarani-Najaran, Z | 1 |
Chen, C; Gan, X; Sun, L; Tang, J; Wen, G; Xu, F; Yu, B; Yuan, W; Zeng, Q; Zhang, W; Zhu, L | 1 |
Botha, CJ; Ferreira, GCH; Mathe, YZ; Venter, EA | 1 |
Chen, H; Hu, W; Ou, Y; Sun, P; Wu, D; Wu, N; Yang, Z | 1 |
Byun, JH; Hwang, SC; Kang, YH; Oh, SH; Park, JH | 1 |
Bajrami, B; Deng, B; Howell, AR; Riel, LP; Wang, L; Yao, X | 1 |
Mehri, S; Mohammadi, S; Nikbakht, M; Sahmani, M; Zahedpanah, M | 1 |
Cao, Y; Li, Y; Liu, D; Liu, M; Yang, Y | 1 |
Fan, S; Han, Y; Li, L; Liu, D; Liu, L; Qin, T; Ren, X; Zhang, H | 1 |
Glaspole, I; Jaffar, J; Symons, K; Westall, G | 1 |
Krzyściak, W; Papież, MA; Siodłak, O | 1 |
He, Y; Liu, Q; Wang, W | 1 |
Cheng, Y; Hu, J; Li, Y; Liu, S; Pan, X; Shen, L; Zeng, B; Zheng, K | 1 |
Fan, D; Ju, X; Kong, L; Li, Y; Su, G; Yang, Q; Zhang, S; Zhu, Y | 1 |
Cui, ZY; Dou, JY; Jiang, YC; Lian, LH; Nan, JX; Song, J; Wang, G; Wu, YL; Zhang, J | 1 |
Brodowski, L; Meyer, N; Schröder-Heurich, B; von Kaisenberg, C; von Versen-Höynck, F | 1 |
Fontes-Ribeiro, CA; Leitão, RA; Silva, AP | 1 |
Chinta, PK; Nandave, M; Pal, AK; Tambe, S; Umrani, D | 1 |
Darbahani, M; Ebrahimi, A; Khosrowshahli, M; Rahaie, M | 1 |
Cui, M; Huang, LT; Wang, JH; Wang, Z | 1 |
Cao, Y; Chen, Y; Feng, X; Hu, J; Jia, Y; Li, L; Liu, F; Qiao, S; Wang, B; Xu, S; Zhou, Q; Zhou, Y | 1 |
Zhang, K; Zhang, M; Zhang, R; Zhang, X; Zhang, Z | 1 |
An, T; Liu, F; Lu, Y; Yin, H | 1 |
Al-Harrasi, A; Gollahon, LS; Halim, SA; Hussain, F; Khan, A; Khan, ZS; Munir, MT; Rahman, SM; Santos, JM; Sufian, HB; Zahid, MK | 1 |
Dong, T; Shi, Y; Wang, Y; Xiao, W; Xie, Z; Yao, M; Yuan, Y; Zeng, B | 1 |
Cai, C; Ding, W; Jiang, Q; Wang, J; Zhu, X | 1 |
Lei, H; Shan, H; Shi, Y; Sun, D; Wan, J; Wu, Y; Xia, L; Xu, H; Xu, Z; Zhou, A; Zou, Z | 1 |
Dong, Y; Li, J; Qian, X | 1 |
Deng, Y; Gao, W; Gu, H; Jiang, X; Li, A; Wen, J; Zhang, X; Zhu, Y | 1 |
Fan, X; Liu, G; Liu, J; Miao, L; Peng, Q; Song, W; Yang, B; Zhang, P; Zhang, Y | 1 |
Chang, J; Han, N; Hu, X; Li, H; Li, J; Liang, B; Liu, W; Lu, C; Meng, J; Shi, L; Wang, C; Wang, X; Xing, D; Yang, S; Zeng, J; Zhang, R | 1 |
Bouwmeester, H; Kashkooli, AB; van der Krol, A; van Dijk, ADJ | 1 |
Gao, Z; Liu, X; Shen, Y; Wang, X | 1 |
Liu, X; Wang, X | 1 |
Linares-González, L; Navarro-Triviño, FJ; Prados-Carmona, Á; Ruiz-Villaverde, R; Velasco-Amador, JP | 1 |
Albalawi, RS; Bagher, AM; Binmahfouz, LS; Hareeri, RH; Shaik, RA | 1 |
Choi, JS; Jung, J; Kim, JM; Kim, SH; Yeo, SG | 1 |
Feng, L; Gao, J; Hu, J; Li, A; Liu, L; Qiu, B; Shen, Z; Zhang, C; Zhu, Y | 1 |
Alves, R; Geraldes, C; Gonçalves, AC; Jorge, J; Neves, J; Sarmento-Ribeiro, AB | 1 |
Bayram, C; Budak, H; Hacımüftüoğlu, A; Özkaraca, M; Sezen, S; Toraman, E | 1 |
Bouchal, P; Bouchalova, P; Janacova, L; Jilkova, K; Lapcik, P; Müller, P; Potesil, D; Sulc, P | 1 |
Elwany, NE; Kabil, SL; Mohamed, NM; Rashed, HE | 1 |
Ávila-Gálvez, MÁ; Bosch, D; Brito, MA; Cankar, K; Dos Santos, CN; Figueira, I; Marques, D | 1 |
21 review(s) available for parthenolide and sesquiterpenes
Article | Year |
---|---|
Probing protein function with small molecules.
Topics: Animals; Biotinylation; Combinatorial Chemistry Techniques; Drug Design; Drug Evaluation, Preclinical; Genomics; Green Fluorescent Proteins; Humans; Ketones; Models, Chemical; Molecular Probe Techniques; Nanotechnology; Oligopeptides; Phosphorylation; Protein Binding; Proteins; Receptors, Androgen; Recombinant Fusion Proteins; Serine; Sesquiterpenes; Signal Transduction; Ubiquitin-Protein Ligases | 2006 |
The leukemic stem cell.
Topics: Antineoplastic Agents; Drug Evaluation, Preclinical; Humans; Leukemia; Neoplastic Stem Cells; Sesquiterpenes; Thiadiazoles | 2007 |
Antiapoptotic proteins as targets for bioactive compounds.
Topics: Butyrates; Colonic Neoplasms; Fatty Acids; Humans; Immunotherapy; Phytotherapy; Sesquiterpenes; Tanacetum parthenium | 2007 |
Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells.
Topics: Animals; Apoptosis; Humans; Mitochondria; Neoplasms; NF-kappa B; Sesquiterpenes; STAT Transcription Factors | 2008 |
Can we predict the effects of NF-kappaB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Humans; Mice; NF-kappa B; Pyruvates; Sepsis; Sesquiterpenes | 2009 |
[Molecular mechanisms of parthenolide's action: Old drug with a new face].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Neoplasms; Neoplastic Stem Cells; Sesquiterpenes | 2010 |
Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Cytochromes c; Humans; I-kappa B Kinase; Inflammation; Neoplasms; NF-kappa B; Plant Extracts; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction; STAT Transcription Factors; Tanacetum parthenium; Transcription, Genetic | 2012 |
Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Humans; Molecular Structure; Neoplasms; NF-kappa B; Plants, Medicinal; Quantitative Structure-Activity Relationship; Sesquiterpenes; Xenograft Model Antitumor Assays | 2012 |
Parthenium dermatitis.
Topics: Allergens; Asteraceae; Dermatitis, Allergic Contact; DNA Adducts; Humans; Lactones; Sesquiterpenes; Thymidine; Ultraviolet Rays | 2013 |
How close are we to targeting the leukemia stem cell?
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Death; Drug Delivery Systems; Glutathione; Humans; Leukemia; Neoplastic Stem Cells; Oxidative Stress; Sesquiterpenes | 2012 |
Parthenolide: from plant shoots to cancer roots.
Topics: Animals; Antineoplastic Agents, Phytogenic; Humans; Molecular Structure; Neoplastic Stem Cells; Phytotherapy; Plant Shoots; Plants, Medicinal; Sesquiterpenes; Structure-Activity Relationship; Tanacetum parthenium | 2013 |
Sesquiterpene lactones: adverse health effects and toxicity mechanisms.
Topics: Animals; Anti-Infective Agents; Antimalarials; Artemisinins; Cardiovascular System; Central Nervous System; DNA Damage; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Tract; Insecta; Kidney; Lactones; Liver; Mammals; Plant Extracts; Plant Leaves; Sesquiterpenes; Skin Diseases; Teratogenesis | 2013 |
Combined effect of parthenolide and various anti-cancer drugs or anticancer candidate substances on malignant cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Drug Interactions; Humans; Neoplasms; Sesquiterpenes | 2014 |
α-Methylene-γ-lactones as a novel class of anti-leukemic agents.
Topics: Animals; Antineoplastic Agents; Humans; Lactones; Leukemia; Neoplastic Stem Cells; Plant Extracts; Sesquiterpenes; Sesquiterpenes, Guaiane | 2014 |
Parthenolide could become a promising and stable drug with anti-inflammatory effects.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Humans; Inflammation; Sesquiterpenes | 2015 |
Sesquiterpene lactone engineering in microbial and plant platforms: parthenolide and artemisinin as case studies.
Topics: Artemisinins; Bacteria; Biosynthetic Pathways; Metabolic Engineering; Plants; Sesquiterpenes | 2016 |
Parthenolide and its Analogues: A New Potential Strategy for the Treatment of Triple-Negative Breast Tumors.
Topics: Apoptosis; Cell Line, Tumor; Humans; Neoplasm Recurrence, Local; Sesquiterpenes; Triple Negative Breast Neoplasms | 2020 |
Advances in chemistry and bioactivity of parthenolide.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Carboxypeptidases; Cyclization; Humans; Mitochondria; Molecular Structure; Sesquiterpenes; Sesquiterpenes, Germacrane; Stereoisomerism | 2020 |
The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Neoplastic Stem Cells; Sesquiterpenes | 2022 |
Sesquiterpene Lactones and Cancer: New Insight into Antitumor and Anti-inflammatory Effects of Parthenolide-Derived Dimethylaminomicheliolide and Micheliolide.
Topics: Anti-Inflammatory Agents; Humans; Lactones; Neoplasms; Sesquiterpenes; Sesquiterpenes, Guaiane | 2022 |
Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents.
Topics: Antineoplastic Agents; Neoplasms; Plant Extracts; Sesquiterpenes; Tanacetum parthenium | 2022 |
5 trial(s) available for parthenolide and sesquiterpenes
Article | Year |
---|---|
Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Mass Spectrometry; Middle Aged; Neoplasms; Phytotherapy; Plant Preparations; Sesquiterpenes; Tanacetum parthenium | 2004 |
Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium).
Topics: Adult; Animals; Anti-Inflammatory Agents; Cells, Cultured; Dermatitis; Erythema; Female; Humans; Inflammation; Inflammation Mediators; Keratinocytes; Leukocytes, Mononuclear; Macrophages; Male; Mice; Middle Aged; Plant Extracts; Sesquiterpenes; Tanacetum parthenium; Young Adult | 2009 |
TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes.
Topics: Active Transport, Cell Nucleus; Adipocytes; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cell Nucleus; Cells, Cultured; Female; Gene Expression Regulation, Enzymologic; Humans; Inflammation; Interleukin-6; Intra-Abdominal Fat; Male; Metabolic Syndrome; Middle Aged; Obesity; PPAR delta; PPAR-beta; Sesquiterpenes; Sirtuin 1; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2012 |
Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Cell Line, Tumor; Ciclopirox; Drug Synergism; Female; Humans; Leukemia, Myeloid, Acute; Male; Pyridones; Sesquiterpenes; TOR Serine-Threonine Kinases | 2013 |
Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD34; Dioxolanes; Female; Glutamate-Cysteine Ligase; Glutathione; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Leukemia, Myeloid, Acute; Male; Oxidation-Reduction; Oxidative Stress; Sesquiterpenes; Tumor Cells, Cultured | 2013 |
501 other study(ies) available for parthenolide and sesquiterpenes
Article | Year |
---|---|
Isolation and characterization of the sesquiterpene lactones costunolide, parthenolide, costunolide diepoxide, santamarine, and reynosin from Magnolia grandiflora L.
Topics: Cyclization; Epoxy Compounds; Lactones; Oxidation-Reduction; Plant Extracts; Sesquiterpenes | 1978 |
Cytotoxic agents from Michelia champaca and Talauma ovata: parthenolide and costunolide.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Survival; Cells, Cultured; Humans; Neoplasms, Experimental; Phytotherapy; Plants, Medicinal; Sesquiterpenes | 1977 |
Chrysanthemum allergy. Pt. II: Experimental studies on the causative agents.
Topics: Adjuvants, Immunologic; Allergens; Animals; Benzofurans; Chromatography, Thin Layer; Chrysanthemum cinerariifolium; Dermatitis, Contact; Guinea Pigs; Humans; Immunologic Techniques; Injections, Intradermal; Insecticides; Lactones; Male; Plant Extracts; Plants; Sesquiterpenes; Skin Tests; Turpentine | 1975 |
Inhibition of 5-lipoxygenase and cyclo-oxygenase in leukocytes by feverfew. Involvement of sesquiterpene lactones and other components.
Topics: Animals; Cyclooxygenase Inhibitors; Cysteine; Lactones; Leukocytes; Leukotriene B4; Lipoxygenase Inhibitors; Plant Extracts; Plants, Medicinal; Rats; Rats, Inbred Strains; Sesquiterpenes; Tanacetum parthenium; Thromboxane B2 | 1992 |
Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products.
Topics: Capsules; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Magnetic Resonance Spectroscopy; Plant Extracts; Plants, Medicinal; Quality Control; Sesquiterpenes; Tablets; Tanacetum parthenium | 1992 |
Feverfew extracts and parthenolide irreversibly inhibit vascular responses of the rabbit aorta.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Endothelium, Vascular; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Plant Extracts; Plants, Medicinal; Rabbits; Sesquiterpenes | 1992 |
A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro.
Topics: Blood Platelets; Calcimycin; Humans; Plant Extracts; Plants, Medicinal; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin; Serotonin Antagonists; Sesquiterpenes; Tanacetum parthenium | 1990 |
A simple method of isolating parthenolide from Tanacetum and other sensitizing plants.
Topics: Humans; Plants, Medicinal; Sesquiterpenes; Solubility | 1991 |
Sesquiterpene lactones and other constituents from a cytotoxic extract of Michelia floribunda.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aporphines; Glucosides; Lactones; Phenylpropionates; Plant Extracts; Sesquiterpenes; Tumor Cells, Cultured | 1990 |
Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Blood Protein Electrophoresis; Cysteine; Humans; In Vitro Techniques; Indicators and Reagents; Plant Extracts; Plants, Medicinal; Platelet Aggregation; Sesquiterpenes; Sulfhydryl Compounds | 1987 |
Prostaglandin synthetase inhibitors in feverfew.
Topics: Bridged Bicyclo Compounds; Cyclooxygenase Inhibitors; Monoterpenes; Plants, Medicinal; Prostaglandins; Sesquiterpenes | 1988 |
Extracts of feverfew inhibit mitogen-induced human peripheral blood mononuclear cell proliferation and cytokine mediated responses: a cytotoxic effect.
Topics: Drug Antagonism; Humans; In Vitro Techniques; Interleukin-1; Interleukin-2; Lymphocyte Activation; Lymphocytes; Mitogens; Plants, Medicinal; Sesquiterpenes; Synovial Membrane; Tanacetum parthenium | 1987 |
Contact allergy to parthenolide in Tanacetum parthenium (L.) Schulz-Bip. (feverfew, Asteraceae) and cross-reactions to related sesquiterpene lactone containing Compositae species.
Topics: Animals; Cross Reactions; Dermatitis, Contact; Female; Guinea Pigs; Humans; Male; Middle Aged; Plant Extracts; Plants, Medicinal; Sesquiterpenes; Tanacetum parthenium | 1983 |
Constituents of Michelia champaca and Lewis acid catalysed transformations of parthenolide into guaianolides.
Topics: Chemical Phenomena; Chemistry; Lactones; Plants, Medicinal; Sesquiterpenes | 1984 |
Inhibition of DNA biosynthesis in HeLa cells by cytotoxic and antitumor sesquiterpene lactones.
Topics: Antineoplastic Agents, Phytogenic; DNA Replication; DNA, Neoplasm; HeLa Cells; Humans; Phosphorylation; Sesquiterpenes; Thymidine; Time Factors; Uridine | 1981 |
Toxic inhibition of smooth muscle contractility by plant-derived sesquiterpenes caused by their chemically reactive alpha-methylenebutyrolactone functions.
Topics: Animals; Aorta, Thoracic; Chromatography, High Pressure Liquid; Cysteine; In Vitro Techniques; Lactones; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Phorbols; Plants; Rabbits; Sesquiterpenes | 1994 |
Biomimetic transformations of parthenolide.
Topics: Cyclization; Magnetic Resonance Spectroscopy; Sesquiterpenes; Sesquiterpenes, Guaiane; Structure-Activity Relationship | 1993 |
Parthenolide inhibits the contractile responses of rat stomach fundus to fenfluramine and dextroamphetamine but not serotonin.
Topics: Animals; Dextroamphetamine; Fenfluramine; Gastric Fundus; In Vitro Techniques; Muscle Contraction; Plants, Medicinal; Prazosin; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Antagonists; Sesquiterpenes | 1996 |
Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Cyclooxygenase 2; Cytokines; Enzyme Induction; Enzyme Inhibitors; Gene Expression; Interleukin-1; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; Macrophages, Alveolar; Male; Mice; Mitogen-Activated Protein Kinases; Molecular Structure; Plants, Medicinal; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 1996 |
Herbal preparations under scientific scrutiny.
Topics: Canada; Drug Approval; Humans; Migraine Disorders; Phytotherapy; Sesquiterpenes | 1996 |
Rabbit cerebral cortex 5HT1a receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Binding Sites; Binding, Competitive; Cerebral Cortex; CHO Cells; Cricetinae; Dioxanes; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Kinetics; Propranolol; Rabbits; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Sesquiterpenes; Spiro Compounds; Tritium | 1997 |
Activity of Parthenolide at 5HT2A receptors.
Topics: Animals; Binding, Competitive; Brain Chemistry; Cells, Cultured; In Vitro Techniques; Ketanserin; Kinetics; Rabbits; Rats; Receptors, Serotonin; Serotonin Antagonists; Sesquiterpenes | 1997 |
Comparison of simultaneous patch testing with parthenolide and sesquiterpene lactone mix.
Topics: Asteraceae; Dermatitis, Allergic Contact; Humans; Patch Tests; Plants, Medicinal; Sesquiterpenes | 1998 |
Antimycobacterial evaluation of germacranolides.
Topics: Anti-Bacterial Agents; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Sesquiterpenes | 1998 |
Anti-inflammatory effects of South American Tanacetum vulgare.
Topics: Animals; Anti-Inflammatory Agents; Carcinogens; Edema; Female; Flavonoids; Mice; Plant Extracts; Sesquiterpenes; South America; Structure-Activity Relationship; Tetradecanoylphorbol Acetate | 1998 |
Low concentrations of the feverfew component parthenolide inhibit in vitro growth of tumor lines in a cytostatic fashion.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Division; Humans; Mice; Sesquiterpenes; Tumor Cells, Cultured | 1999 |
Effect of the chloroform extract of Tanacetum vulgare and one of its active principles, parthenolide, on experimental gastric ulcer in rats.
Topics: Animals; Chloroform; Dose-Response Relationship, Drug; Ethanol; Gastric Mucosa; Male; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar; Sesquiterpenes; Severity of Illness Index; Solvents; Stomach Ulcer; Sulfhydryl Compounds | 1999 |
Sesquiterpene lactones inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Cell Compartmentation; Cell Nucleus; DNA-Binding Proteins; Gene Expression Regulation, Enzymologic; I-kappa B Proteins; Interferon-gamma; Lactones; Lipopolysaccharides; Muscle, Smooth, Vascular; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Rats; Sesquiterpenes | 1999 |
Rapid extraction and high-performance liquid chromatographic determination of parthenolide in feverfew (Tanacetum parthenium).
Topics: Chromatography, High Pressure Liquid; Indicators and Reagents; Plant Extracts; Plants, Medicinal; Sesquiterpenes; Tanacetum parthenium | 1999 |
Sesquiterpene lactones with potential use as natural herbicide models (I): trans,trans-germacranolides.
Topics: Herbicides; Humans; Lactones; Plants, Edible; Sesquiterpenes | 1999 |
The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Enzyme Activation; HeLa Cells; Humans; I-kappa B Kinase; I-kappa B Proteins; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinases; NF-kappa B; NF-kappaB-Inducing Kinase; Phosphorylation; Protein Serine-Threonine Kinases; Sesquiterpenes; Signal Transduction; Tumor Necrosis Factor-alpha | 1999 |
Parthenolide inhibits activation of signal transducers and activators of transcription (STATs) induced by cytokines of the IL-6 family.
Topics: Acute-Phase Proteins; alpha 1-Antichymotrypsin; Carcinoma, Hepatocellular; Cytokines; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1; Interleukin-6; Liver Neoplasms; NF-kappa B; Oncostatin M; Peptides; Recombinant Fusion Proteins; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor; Trans-Activators; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 2000 |
Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats.
Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Body Temperature; Carrageenan; Dose-Response Relationship, Drug; Drug Interactions; Edema; Female; Foot; Male; Mice; Motor Activity; Naloxone; Narcotic Antagonists; Plant Extracts; Plants, Medicinal; Rats; Sesquiterpenes; Sleep; Tanacetum parthenium; Time Factors | 1999 |
Dexamethasone represses 3,5,3'-triiodothyronine-stimulated expression of intercellular adhesion molecule-1 in the human cell line ECV 304.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Cell Line; Dexamethasone; Gene Expression Regulation; Humans; Inflammation; Intercellular Adhesion Molecule-1; Kinetics; Microscopy, Immunoelectron; Sesquiterpenes; Triiodothyronine | 1999 |
Sesquiterpene lactones are potent inhibitors of interleukin 8 gene expression in cultured human respiratory epithelium.
Topics: Anti-Inflammatory Agents; Biological Transport; DNA-Binding Proteins; Epithelium; Gene Expression Regulation; Humans; I-kappa B Proteins; Interleukin-8; Lung; NF-kappa B; NF-KappaB Inhibitor alpha; Plants, Medicinal; Promoter Regions, Genetic; RNA, Messenger; Sesquiterpenes; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
Activation of NF-kappaB p50/p65 is regulated in the developing mammary gland and inhibits STAT5-mediated beta-casein gene expression.
Topics: Animals; Caseins; Cell Line; Cell Nucleus; DNA; DNA-Binding Proteins; Female; Gene Expression Regulation, Developmental; Janus Kinase 2; Lactation; Mammary Glands, Animal; Mice; Milk Proteins; NF-kappa B; NF-kappa B p50 Subunit; Phosphorylation; Phosphotyrosine; Pregnancy; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, Prolactin; Sesquiterpenes; STAT5 Transcription Factor; Trans-Activators; Transcription Factor RelA; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2000 |
Requirement for NF-kappaB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells.
Topics: Arteriosclerosis; Base Sequence; Cells, Cultured; Chemokine CCL2; Chlamydia trachomatis; Chlamydophila pneumoniae; DNA Primers; Endothelium, Vascular; Humans; NF-kappa B; RNA, Messenger; Sesquiterpenes; Signal Transduction; Transcriptional Activation | 2000 |
Inhibition by parthenolide of phorbol ester-induced transcriptional activation of inducible nitric oxide synthase gene in a human monocyte cell line THP-1.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Drug Interactions; Humans; Monocytes; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Sesquiterpenes; Tetradecanoylphorbol Acetate; Transcriptional Activation | 2000 |
Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Northern; Blotting, Western; Breast Neoplasms; Caenorhabditis elegans Proteins; DNA; DNA-Binding Proteins; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; Inhibitor of Apoptosis Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Paclitaxel; Plants, Medicinal; Protein Binding; Proteins; Repressor Proteins; Sesquiterpenes; Superoxide Dismutase; TNF Receptor-Associated Factor 1; Tumor Cells, Cultured | 2000 |
Expression of intercellular adhesion molecule-1 in C6 glioma cells is up-regulated by thyroid hormone.
Topics: Actins; Animals; Blood-Brain Barrier; Cell Division; Dexamethasone; Encephalitis; Gene Expression Regulation, Neoplastic; Glial Fibrillary Acidic Protein; Glioma; Intercellular Adhesion Molecule-1; Interleukin-1; Lipopolysaccharides; Models, Animal; Neuroglia; Rats; Sesquiterpenes; Triiodothyronine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Up-Regulation; Vimentin | 2000 |
Intra-specific variability of feverfew: correlations between parthenolide, morphological traits and seed origin.
Topics: Plants, Medicinal; Seeds; Sesquiterpenes; Species Specificity; Tanacetum parthenium | 2000 |
A sesquiterpene lactone, costunolide, from Magnolia grandiflora inhibits NF-kappa B by targeting I kappa B phosphorylation.
Topics: Animals; Cell Line; Dose-Response Relationship, Drug; Gene Expression Regulation; I-kappa B Proteins; Lipopolysaccharides; Macrophages; Mice; Molecular Structure; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phosphorylation; Plant Leaves; Plants, Medicinal; Sesquiterpenes | 2001 |
Repression of GADD153/CHOP by NF-kappaB: a possible cellular defense against endoplasmic reticulum stress-induced cell death.
Topics: Animals; Apoptosis; Breast Neoplasms; Calcimycin; CCAAT-Enhancer-Binding Proteins; Endoplasmic Reticulum; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Ionophores; Mice; NF-kappa B; Sesquiterpenes; Stress, Physiological; Transcription Factor CHOP; Transcription Factors; Transfection; Tumor Cells, Cultured; Tunicamycin | 2001 |
Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by parthenolide, a predominant sesquiterpene lactone in Tanacetum parthenium: involvement of nuclear factor-kappaB.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Cell Line; Female; Interleukin-12; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice; Mice, Inbred DBA; NF-kappa B; Plants, Medicinal; Promoter Regions, Genetic; Sesquiterpenes; Tanacetum parthenium; Transfection | 2001 |
Feverfew extracts and the sesquiterpene lactone parthenolide inhibit intercellular adhesion molecule-1 expression in human synovial fibroblasts.
Topics: Anti-Inflammatory Agents; Cell Adhesion; Drug Antagonism; Fibroblasts; Gene Expression; Humans; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-1; Lactones; Plant Extracts; Plants, Medicinal; Sesquiterpenes; Synovial Membrane; Tanacetum parthenium; Tumor Necrosis Factor-alpha | 2001 |
6-hydroxydopamine-induced nuclear factor-kappa B activation in PC12 cells.
Topics: Animals; Apoptosis; Drug Interactions; Minor Histocompatibility Antigens; Nerve Degeneration; NF-kappa B; Oxidative Stress; Oxidopamine; PC12 Cells; Plant Extracts; Protective Agents; Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Sesquiterpenes | 2001 |
Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cysteine; DNA-Binding Proteins; Drug Design; I-kappa B Proteins; Lactones; NF-kappa B; NF-KappaB Inhibitor alpha; Protein Binding; Protein Subunits; Quercetin; Sesquiterpenes; Transcription Factor RelA | 2001 |
The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase.
Topics: Animals; Anti-Inflammatory Agents; Biotinylation; Edema; HeLa Cells; Humans; I-kappa B Kinase; Luciferases; Mice; Mutation; NF-kappa B; Plants, Medicinal; Protein Serine-Threonine Kinases; Sesquiterpenes; Structure-Activity Relationship; Tanacetum parthenium; Transfection; Tumor Necrosis Factor-alpha | 2001 |
Activation of NF-kB mediates ICAM-1 induction in respiratory cells exposed to an adenovirus-derived vector.
Topics: Acetylcysteine; Adenoviridae; Antioxidants; Cell Line; Chloramphenicol O-Acetyltransferase; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Expression; Genetic Therapy; Genetic Vectors; Humans; Intercellular Adhesion Molecule-1; Lung; NF-kappa B; Peptides; Pyrrolidines; RNA, Messenger; Sesquiterpenes; Thiocarbamates; Translocation, Genetic | 2001 |
5-Hydroxytryptamine-inhibiting property of Feverfew: role of parthenolide content.
Topics: Drug Stability; Gastric Fundus; Ileum; Muscle Contraction; Plant Extracts; Plants, Medicinal; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Serotonin Antagonists; Sesquiterpenes; Tanacetum parthenium | 2000 |
A new sesquiterpene lactone from Tsoongiodendron odorum Chun.
Topics: Antineoplastic Agents, Phytogenic; Chromatography, Gel; Crystallography, X-Ray; Formazans; Gas Chromatography-Mass Spectrometry; HeLa Cells; HL-60 Cells; Humans; KB Cells; Lactones; Magnetic Resonance Spectroscopy; Magnoliaceae; Models, Molecular; Plant Roots; Sesquiterpenes; Sesquiterpenes, Eudesmane; Terpenes; Tetrazolium Salts | 2001 |
GC determination of parthenolide in feverfew products.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Capsules; Chromatography, Gas; Chromatography, High Pressure Liquid; Quality Control; Sesquiterpenes; Tablets; Tanacetum parthenium | 2001 |
Sesquiterpene lactone parthenolide, an inhibitor of IkappaB kinase complex and nuclear factor-kappaB, exerts beneficial effects in myocardial reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; DNA-Binding Proteins; Hemodynamics; I-kappa B Proteins; Lipid Peroxidation; Male; Myocardial Reperfusion Injury; Neutrophil Infiltration; NF-kappa B; NF-KappaB Inhibitor alpha; Rats; Rats, Wistar; Sesquiterpenes | 2002 |
Enhancement of 1 alpha,25-dihydroxyvitamin D(3)-induced differentiation of human leukaemia HL-60 cells into monocytes by parthenolide via inhibition of NF-kappa B activity.
Topics: Cell Differentiation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; HL-60 Cells; Humans; Monocytes; NF-kappa B; Santonin; Sesquiterpenes; Time Factors; Vitamin D | 2002 |
Nuclear factor-kappaB as a molecular target for migraine therapy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; DNA-Binding Proteins; Dura Mater; I-kappa B Proteins; Macrophages; Male; Migraine Disorders; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroglycerin; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Sesquiterpenes; Vasodilator Agents | 2002 |
Phytochemical inhibition of interleukin-4-activated Stat6 and expression of VCAM-1.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; B-Lymphocytes; Cell Line; DNA; Dose-Response Relationship, Drug; Endothelium, Vascular; Genes, Reporter; Humans; Integrin alpha4beta1; Integrins; Interleukin-4; Janus Kinase 2; Leukocytes; Mice; NF-kappa B; Phosphorylation; Plant Extracts; Protein Binding; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, Lymphocyte Homing; Sesquiterpenes; Signal Transduction; STAT6 Transcription Factor; Trans-Activators; Vascular Cell Adhesion Molecule-1 | 2002 |
Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Apoptosis; Disease Models, Animal; DNA; DNA-Binding Proteins; Endotoxins; Enzyme Activation; Hypertension; I-kappa B Proteins; Lung; Male; Neutrophils; NF-kappa B; NF-KappaB Inhibitor alpha; Nitrates; Nitric Oxide; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Sesquiterpenes; Shock, Septic; Tyrosine | 2002 |
Characterization of a novel mammalian phosphatase having sequence similarity to Schizosaccharomyces pombe PHO2 and Saccharomyces cerevisiae PHO13.
Topics: 4-Nitrophenylphosphatase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biotin; Cations, Divalent; Cations, Monovalent; Cell Line; Enzyme Activation; Enzyme Inhibitors; Fungal Proteins; HeLa Cells; Homeodomain Proteins; Humans; Metals; Mice; NF-kappa B; Phosphoprotein Phosphatases; Saccharomyces cerevisiae Proteins; Schizosaccharomyces pombe Proteins; Sequence Homology, Amino Acid; Sesquiterpenes; Substrate Specificity; Trans-Activators; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vanadates | 2002 |
GADD153-mediated anticancer effects of N-(4-hydroxyphenyl)retinamide on human hepatoma cells.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Cell Cycle; DNA Fragmentation; Fenretinide; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation; Genes, Reporter; Humans; Neoplasms; NF-kappa B; Sesquiterpenes; Transcription Factor CHOP; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured | 2002 |
Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Carcinoma, Hepatocellular; Caspases; CCAAT-Enhancer-Binding Proteins; Cell Cycle; Cell Division; Cytochrome c Group; Flow Cytometry; Glutathione; Humans; Membrane Potentials; Oxidative Stress; Sesquiterpenes; Transcription Factor CHOP; Transcription Factors; Tumor Cells, Cultured | 2002 |
The sesquiterpene lactone parthenolide inhibits LPS- but not TNF-alpha-induced maturation of human monocyte-derived dendritic cells by inhibition of the p38 mitogen-activated protein kinase pathway.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Antigens, CD1; B7-1 Antigen; B7-2 Antigen; Biological Transport; Calcium-Calmodulin-Dependent Protein Kinases; CD40 Antigens; CD83 Antigen; Cell Differentiation; Cells, Cultured; Dendritic Cells; Down-Regulation; Endocytosis; Histocompatibility Antigens Class II; Humans; I-kappa B Proteins; Immunoglobulins; Interleukin-12; Lipopolysaccharides; MAP Kinase Kinase 3; MAP Kinase Kinase 6; MAP Kinase Signaling System; Membrane Glycoproteins; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Monocytes; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein-Tyrosine Kinases; Sesquiterpenes; Tumor Necrosis Factor-alpha; Up-Regulation | 2002 |
Variations in parthenolide content and daily dose of feverfew products.
Topics: Capsules; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Product Labeling; Quality Control; Sesquiterpenes; Tablets; Tanacetum parthenium | 2002 |
Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Cells, Cultured; Chemokine CCL2; Disease Progression; Gene Expression Regulation; Gliotoxin; Glomerular Mesangium; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Humans; Inflammation; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Proteinuria; Rats; Sesquiterpenes | 2002 |
The anti-inflammatory sesquiterpene lactone parthenolide suppresses CD95-mediated activation-induced-cell-death in T-cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; fas Receptor; Humans; Jurkat Cells; NF-kappa B; Promoter Regions, Genetic; Sesquiterpenes; T-Lymphocytes | 2002 |
Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells.
Topics: Animals; Cells, Cultured; Enzyme Activation; I-kappa B Proteins; Lipopolysaccharides; Microglia; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Wistar; Sesquiterpenes; Transcription Factor RelA | 2002 |
JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression.
Topics: Aggrecans; Animals; Base Sequence; Cartilage, Articular; Cattle; Cells, Cultured; Chondrocytes; Collagen Type II; Extracellular Matrix Proteins; Gene Expression Regulation; High Mobility Group Proteins; Humans; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Kinetics; Lectins, C-Type; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NF-kappa B; Oligonucleotide Probes; Phosphotyrosine; Proteins; Proteoglycans; Receptors, Interleukin-6; Recombinant Proteins; Sesquiterpenes; Signal Transduction; SOX9 Transcription Factor; Transcription Factors; Transcription, Genetic | 2003 |
The anti-inflammatory sesquiterpene lactone parthenolide suppresses IL-4 gene expression in peripheral blood T.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Down-Regulation; Humans; In Vitro Techniques; Interferon-gamma; Interleukin-2; Interleukin-4; Jurkat Cells; Lymphocyte Activation; NF-kappa B; Plants, Medicinal; Promoter Regions, Genetic; Protein Binding; RNA, Messenger; Sesquiterpenes; T-Lymphocytes; Transcription, Genetic | 2002 |
Characterization of the molecular events following impairment of NF-kappaB-driven transcription in neurons.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Caspases; Cells, Cultured; Cerebral Cortex; Cytochrome c Group; DNA; DNA-Binding Proteins; Homeostasis; Mitochondria; Neurons; NF-kappa B; Nitriles; Organic Chemicals; Peptides; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Binding; Protein Precursors; Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Replication Protein C; Sesquiterpenes; Sesquiterpenes, Guaiane; Sulfones; Transcription, Genetic | 2002 |
Sesquiterpene lactone parthenolide, an inhibitor of IkappaB kinase complex and nuclear factor-kappaB, exerts beneficial effects in myocardial reperfusion injury. Shock 17(2):127-134, 2002.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; I-kappa B Kinase; Myocardial Reperfusion Injury; Myocardium; NF-kappa B; Protein Serine-Threonine Kinases; Rats; Sesquiterpenes | 2003 |
Parthenolide and its photochemically synthesized 1(10)Z isomer: chemical reactivity and structure-activity relationship studies in human leucocyte chemotaxis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Catalysis; Chemotaxis, Leukocyte; Humans; In Vitro Techniques; Indicators and Reagents; Isomerism; Models, Molecular; Molecular Conformation; Photochemistry; Sesquiterpenes; Structure-Activity Relationship | 2003 |
Inhibitors of diverse metabolic steps cause increased apoptosis in deoxyadenosine-resistant mouse leukemia L1210 cells that lack p53 expression: convergence at caspase-3 activation.
Topics: Androstadienes; Animals; Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Butyrates; Caspase 3; Caspases; Cell Cycle; Cell Line, Tumor; Coloring Agents; Deoxyadenosines; DNA Damage; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Genistein; Isoxazoles; Leflunomide; Mice; Models, Biological; Purines; RNA, Messenger; Roscovitine; Sesquiterpenes; Time Factors; Tumor Suppressor Protein p53; Wortmannin | 2003 |
Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis.
Topics: Aged; Animals; Arteriosclerosis; Carotid Artery Diseases; Cells, Cultured; Chemokine CCL2; Cytokines; Electrophoretic Mobility Shift Assay; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Inflammation Mediators; Male; Muscle, Smooth, Vascular; NF-kappa B; Parathyroid Hormone-Related Protein; Peptide Fragments; Peptide Hormones; Precipitin Tests; Proteins; Rats; Receptor, Parathyroid Hormone, Type 1; Receptors, Parathyroid Hormone; RNA, Messenger; Sesquiterpenes | 2003 |
NF-kappaB inhibitor sesquiterpene parthenolide induces concurrently atypical apoptosis and cell necrosis: difficulties in identification of dead cells in such cultures.
Topics: Acridine Orange; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Caspases; Cell Membrane; Coloring Agents; DNA; Flow Cytometry; HL-60 Cells; Humans; Immunohistochemistry; Necrosis; NF-kappa B; Propidium; RNA; Sesquiterpenes; Time Factors | 2003 |
Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb(1) (ginseng) and parthenolide (feverfew).
Topics: Animals; Apigenin; Cell Line; Chamomile; Cytokines; Enzyme-Linked Immunosorbent Assay; Flavonoids; Ginsenosides; Interleukin-6; Lipopolysaccharides; Macrophages; Mice; Panax; Sesquiterpenes; Tanacetum parthenium; Tumor Necrosis Factor-alpha | 2003 |
Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis.
Topics: Animals; Biopsy, Needle; Disease Models, Animal; Hemodynamics; Immunohistochemistry; Inflammation Mediators; Injections, Intraperitoneal; Male; Multiple Organ Failure; NF-kappa B; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Sepsis; Sesquiterpenes; Survival Rate; Treatment Outcome | 2003 |
Nuclear factor-kappaB: is it a therapeutic target for the adjuvant treatment of sepsis?
Topics: Animals; Chemotherapy, Adjuvant; Clinical Trials as Topic; Critical Care; Disease Models, Animal; Female; Humans; Male; Mice; NF-kappa B; Prognosis; Rats; Sepsis; Sesquiterpenes; Severity of Illness Index; Treatment Outcome | 2003 |
Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation.
Topics: Animals; Antimalarials; Artemisinins; Base Sequence; Cell Line; Cytokines; DNA, Complementary; Enzyme Inhibitors; Humans; Lipopolysaccharides; Mice; Neuroglia; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Sesquiterpenes | 2003 |
Regulation of expression of stromyelysin-1 by proinflammatory cytokines in mouse brain astrocytes.
Topics: Animals; Astrocytes; Brain; Brain Chemistry; Cell Culture Techniques; Curcumin; Cytokines; Drug Synergism; Epidermal Growth Factor; Gene Expression Regulation; Inflammation Mediators; Interferon-gamma; Interleukin-1; Matrix Metalloproteinase 3; Mice; NF-kappa B; Pyrrolidines; RNA, Messenger; Sesquiterpenes; Thiocarbamates; Time Factors; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2003 |
Transport of parthenolide across human intestinal cells (Caco-2).
Topics: Biological Transport, Active; Caco-2 Cells; Chromatography, High Pressure Liquid; Humans; Intestinal Mucosa; Phytotherapy; Sesquiterpenes; Tanacetum parthenium | 2003 |
NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Carotid Artery Diseases; Caspase 3; Caspases; Cells, Cultured; Cytotoxicity Tests, Immunologic; Fas Ligand Protein; Gene Expression Regulation; Genes, Reporter; Humans; Jurkat Cells; Leukocytes, Mononuclear; Membrane Glycoproteins; Mice; NF-kappa B; RNA, Messenger; Sesquiterpenes; T-Lymphocytes; Transfection | 2004 |
Effect of C-reactive protein on chemokine expression in human aortic endothelial cells.
Topics: Aorta; Arteriosclerosis; C-Reactive Protein; Cell Adhesion; Cells, Cultured; Chemokine CCL2; Endothelial Cells; Gene Expression Regulation; Humans; Interleukin-8; NF-kappa B; Peptides; RNA, Messenger; Sesquiterpenes | 2004 |
Native LDL induces interleukin-8 expression via H2O2, p38 Kinase, and activator protein-1 in human aortic smooth muscle cells.
Topics: Aorta; Caffeic Acids; Cells, Cultured; Coronary Vessels; Dactinomycin; Dose-Response Relationship, Drug; Flavonoids; Humans; Hydrogen Peroxide; Imidazoles; Interleukin-8; Lipoproteins, LDL; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phenylethyl Alcohol; Pyridines; Sesquiterpenes; Time Factors; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2004 |
Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Celecoxib; Cell Death; Cyclooxygenase 2; Dinoprostone; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epidermal Cells; Female; Immunohistochemistry; Isoenzymes; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Mice, Hairless; Mitogen-Activated Protein Kinases; Models, Chemical; Neoplasms, Radiation-Induced; p38 Mitogen-Activated Protein Kinases; Papilloma; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein Binding; Pyrazoles; Sesquiterpenes; Skin Neoplasms; Sulfonamides; Time Factors; Transcription Factor AP-1; Transcription, Genetic; Transcriptional Activation; Ultraviolet Rays | 2004 |
[Sbudies on the effect of parthenolide on the proliferation of rat vascular smooth muscle cells and the mechanism].
Topics: Animals; Aorta, Thoracic; Asteraceae; Cell Cycle; Cell Division; Cells, Cultured; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Plants, Medicinal; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-myc; Rats; Rats, Sprague-Dawley; Sesquiterpenes | 2003 |
Critical roles of intracellular thiols and calcium in parthenolide-induced apoptosis in human colorectal cancer cells.
Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Buthionine Sulfoximine; Calcium; Cell Line, Tumor; Colorectal Neoplasms; Dose-Response Relationship, Drug; Endoplasmic Reticulum Chaperone BiP; Humans; Oxidation-Reduction; Reactive Oxygen Species; Sesquiterpenes; Sulfhydryl Compounds | 2004 |
NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; I-kappa B Proteins; NF-kappa B; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Sesquiterpenes; Signal Transduction; Tamoxifen | 2004 |
The survival effect of TNF-alpha in human neutrophils is mediated via NF-kappa B-dependent IL-8 release.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Western; Cell Communication; Cell Survival; Chromones; Enzyme Inhibitors; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; I-kappa B Proteins; Interleukin-8; Morpholines; Neutrophils; NF-kappa B; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Sulfones; Tumor Necrosis Factor-alpha | 2004 |
Role of cysteine residues of p65/NF-kappaB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium-Binding Proteins; Cysteine; DNA-Binding Proteins; Ethylmaleimide; HeLa Cells; Humans; I-kappa B Kinase; Jurkat Cells; Macrophages; Membrane Glycoproteins; Mice; Mutation; Nerve Tissue Proteins; NF-kappa B; Protein Serine-Threonine Kinases; Sesquiterpenes; Synaptotagmin I; Synaptotagmins; Transcription Factor RelA; Transcriptional Activation; Transfection | 2004 |
Modulation of inhibitor kappaB kinase/ nuclear factor kappaB signaling during critical illness: a double-edged sword.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Critical Care; Critical Illness; Disease Models, Animal; Humans; Inflammation; Multiple Organ Failure; NF-kappa B; Sepsis; Sesquiterpenes; Signal Transduction | 2004 |
Involvement of proapoptotic Bcl-2 family members in parthenolide-induced mitochondrial dysfunction and apoptosis.
Topics: Apoptosis; Caspase 8; Caspases; Colorectal Neoplasms; Genes, bcl-2; Humans; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Signal Transduction; Tanacetum parthenium; Tumor Cells, Cultured; Up-Regulation | 2004 |
Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Enzyme Activation; Female; Humans; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; NF-kappa B; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2004 |
Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis Regulatory Proteins; Breast Neoplasms; Cell Division; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Fibroblasts; Humans; JNK Mitogen-Activated Protein Kinases; Membrane Glycoproteins; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; NF-kappa B; Oxidative Stress; Sesquiterpenes; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha | 2004 |
Different contributions of STAT3, ERK1/2, and PI3-K signaling to cardiomyocyte hypertrophy by cardiotrophin-1.
Topics: Androstadienes; Animals; Animals, Newborn; Butadienes; Cardiomegaly; Cell Size; Cells, Cultured; Cytokines; DNA-Binding Proteins; Heart Ventricles; Leucine; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor; Trans-Activators; Wortmannin | 2004 |
Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Western; Bone and Bones; Bone Resorption; Cell Differentiation; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Regulation; Genes, Reporter; Glycoproteins; Green Fluorescent Proteins; Interleukin-1; Lactones; Lipopolysaccharides; Luciferases; Macrophages; Mice; Mice, Inbred C57BL; Microscopy, Confocal; NF-kappa B; Osteoclasts; Osteolysis; Osteoprotegerin; Protein Transport; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Time Factors; TNF Receptor-Associated Factor 6; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2004 |
Anti-inflammatory and anti-hyperalgesic effects of sesquiterpene lactones from Magnolia and Bear's foot.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Asteraceae; Carrageenan; Indomethacin; Inflammation; Lactones; Magnolia; Male; Molecular Structure; Rats; Rats, Sprague-Dawley; Sesquiterpenes | 2004 |
Microtubule-interfering activity of parthenolide.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Colchicine; Cytoskeleton; Dose-Response Relationship, Drug; Female; Humans; Microscopy, Electron; Microscopy, Fluorescence; Microtubules; Paclitaxel; Plant Extracts; Sesquiterpenes; Tanacetum parthenium; Tubulin | 2004 |
Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium.
Topics: Animals; Antiprotozoal Agents; Cell Line; Lactones; Leishmania; Macrophages; Mice; Parasitic Sensitivity Tests; Plant Extracts; Sesquiterpenes; Tanacetum parthenium | 2005 |
Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity.
Topics: Animals; Apoptosis; Blotting, Western; Cell Survival; Chemokine CCL4; Cytokines; DNA Primers; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Gliotoxin; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Macrophage Inflammatory Proteins; Mice; Mice, Knockout; Mixed Function Oxygenases; Neutrophils; NF-kappa B p50 Subunit; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Oligonucleotides; Polymerase Chain Reaction; Protein Binding; Repressor Proteins; Sesquiterpenes; Transcription Factors | 2005 |
The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Division; Cell Line, Tumor; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; NF-kappa B; Sesquiterpenes | 2005 |
NF-kappa B activation is not required for Chlamydia trachomatis inhibition of host epithelial cell apoptosis.
Topics: Apoptosis; Chlamydia trachomatis; Cycloheximide; Diterpenes; Epithelial Cells; Gene Deletion; HeLa Cells; Humans; Immunity, Innate; NF-kappa B; Sesquiterpenes; Signal Transduction; Staurosporine; Transcription Factor RelA | 2005 |
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blast Crisis; Cells, Cultured; Humans; Lactones; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Neoplastic Stem Cells; NF-kappa B; Reactive Oxygen Species; Sesquiterpenes; Transplantation, Heterologous; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 2005 |
Dual role of the anti-inflammatory sesquiterpene lactone: regulation of life and death by parthenolide.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Humans; Jurkat Cells; Oxidative Stress; Sesquiterpenes | 2005 |
A potent apoptosis-inducing activity of a sesquiterpene lactone, arucanolide, in HL60 cells: a crucial role of apoptosis-inducing factor.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Inducing Factor; Asteraceae; Cell Line, Tumor; Flavoproteins; Growth Inhibitors; HL-60 Cells; Humans; Lactones; Membrane Potentials; Membrane Proteins; Mitochondria; Plant Extracts; Sesquiterpenes; Sesquiterpenes, Germacrane | 2005 |
Possible role of NF-kappaB in Bcl-X(L) protection against hydrogen peroxide-induced PC12 cell death.
Topics: Animals; Apoptosis; bcl-X Protein; Cell Death; DNA-Binding Proteins; Heat-Shock Proteins; Heme Oxygenase (Decyclizing); Hydrogen Peroxide; NF-kappa B; Oxidation-Reduction; Oxidative Stress; Oxygenases; PC12 Cells; Proto-Oncogene Proteins c-bcl-2; Rats; Sesquiterpenes; Tosylphenylalanyl Chloromethyl Ketone; Transfection | 2004 |
Transcription factors as targets of the anti-inflammatory treatment. A cell culture study with extracts from some Mediterranean diet plants.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Cells, Cultured; Curcumin; Diet, Mediterranean; Electrophoretic Mobility Shift Assay; Endothelial Cells; Humans; Interleukin-1; Interleukin-6; Mitogen-Activated Protein Kinases; NF-kappa B; Phosphorylation; Plant Extracts; Quercetin; Sesquiterpenes; STAT Transcription Factors; Transcription Factor AP-1 | 2005 |
Identification of the genes involved in enhanced fenretinide-induced apoptosis by parthenolide in human hepatoma cells.
Topics: Amino Acid Sequence; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Base Sequence; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Drug Synergism; Fenretinide; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Molecular Sequence Data; Muscle Proteins; NF-kappa B; Nuclear Proteins; Polymerase Chain Reaction; Repressor Proteins; RNA, Messenger; Sesquiterpenes; Up-Regulation | 2005 |
Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural chemopreventive compounds in HepG2 human hepatoma cells.
Topics: Anticarcinogenic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA-Binding Proteins; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Isothiocyanates; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; Membrane Proteins; NF-E2-Related Factor 2; Proteins; Sesquiterpenes; Sulfoxides; Thiocyanates; Trans-Activators; Transcriptional Activation | 2005 |
Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Humans; Models, Biological; NF-kappa B; Pancreatic Neoplasms; Phosphorylation; Protein Binding; Sesquiterpenes; Sulindac; Transcription, Genetic; Transfection | 2005 |
Intracellular redox state regulation by parthenolide.
Topics: Animals; Antioxidants; Apoptosis; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Glutathione; Hippocampus; Homeostasis; Intracellular Fluid; Mice; Neurons; Oxidation-Reduction; Sesquiterpenes | 2005 |
NF-kappaB and NOS may play a role in human RPMI-8402 cell apoptosis.
Topics: Apoptosis; Biological Transport; Cell Line, Tumor; Cell Nucleus; Dimethyl Sulfoxide; Flow Cytometry; Humans; Microscopy, Electron; NF-kappa B; Nitric Oxide Synthase; Nitrites; Sesquiterpenes; Time Factors | 2005 |
Parthenolide and abscisic acid synthesis in feverfew are associated but environmental factors affect them dissimilarly.
Topics: Abscisic Acid; Carotenoids; Circadian Rhythm; Flowers; Light; Sesquiterpenes; Tanacetum parthenium; Time Factors; Water | 2005 |
The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer.
Topics: Adipocytes; Animals; Breast Neoplasms; Cell Death; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Humans; Interferon-gamma; Interleukin-6; Interleukin-8; Lactones; Mice; Mice, Nude; Neoplasm Metastasis; Sesquiterpenes; Survival Rate; Taxoids; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2005 |
Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular.
Topics: ADAM Proteins; ADAMTS4 Protein; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cartilage, Articular; Cattle; Cells, Cultured; Chondrocytes; Collagenases; DNA-Binding Proteins; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation, Enzymologic; Interleukin-6; MAP Kinase Signaling System; Matrix Metalloproteinase 1; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; Matrix Metalloproteinases; Metalloendopeptidases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Procollagen N-Endopeptidase; Receptors, Interleukin-6; Sesquiterpenes; STAT1 Transcription Factor; STAT3 Transcription Factor; Trans-Activators; Transcriptional Activation; Up-Regulation | 2005 |
Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Cytochromes c; Drug Resistance, Neoplasm; Fas Ligand Protein; fas Receptor; Humans; Membrane Glycoproteins; Membrane Potentials; Mitochondria; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Sesquiterpenes; Tumor Suppressor Protein p53 | 2005 |
Prevention of the ultraviolet B-mediated skin photoaging by a nuclear factor kappaB inhibitor, parthenolide.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Count; Cell Division; Cell Proliferation; Cells, Cultured; Fibroblast Growth Factor 2; Fibroblasts; Genes, Reporter; Humans; Luciferases; Matrix Metalloproteinase 1; Melanocytes; Mice; Mice, Inbred DBA; NF-kappa B; Plasmids; Sesquiterpenes; Skin Aging; Transfection; Ultraviolet Rays | 2005 |
Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Disease Models, Animal; Immunohistochemistry; Male; Migraine Disorders; Neurons; NF-kappa B; Nitroglycerin; Oncogene Proteins v-fos; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tanacetum parthenium; Vasodilator Agents | 2005 |
Altered NF-kappaB gene expression and collagen formation induced by polyunsaturated fatty acids.
Topics: Animals; Arachidonic Acid; Collagen; Eicosapentaenoic Acid; Gene Expression; Gene Expression Profiling; Lipopolysaccharides; Mice; NF-kappa B; Sesquiterpenes; Swiss 3T3 Cells | 2005 |
Parthenolide sensitizes ultraviolet (UV)-B-induced apoptosis via protein kinase C-dependent pathways.
Topics: Animals; Apoptosis; Cell Membrane; Cells, Cultured; Dose-Response Relationship, Drug; Epidermal Cells; Epidermis; Genes, Dominant; Mice; p38 Mitogen-Activated Protein Kinases; Protein Kinase C; Protein Kinase C-delta; Protein Transport; Sesquiterpenes; Signal Transduction; Ultraviolet Rays | 2005 |
Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin.
Topics: Anti-Bacterial Agents; Cells, Cultured; Chemokine CCL17; Chemokines, CC; ErbB Receptors; Humans; Interferon-gamma; Keratinocytes; NF-kappa B; Nitriles; p38 Mitogen-Activated Protein Kinases; Quinazolines; Roxithromycin; Sesquiterpenes; Signal Transduction; Sulfones; Tumor Necrosis Factor-alpha | 2005 |
Feverfew: weeding out the root of leukaemia.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Humans; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; NF-kappa B; Plants, Medicinal; Sesquiterpenes; Tanacetum parthenium; Xenograft Model Antitumor Assays | 2005 |
Atorvastatin prevents peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) downregulation in lipopolysaccharide-stimulated H9c2 cells.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Cell Line; Chemokine CCL2; Down-Regulation; Fatty Acids; Heptanoic Acids; Lipopolysaccharides; Muscle Cells; NF-kappa B; PPAR gamma; PPAR-beta; Protein Binding; Protein Kinases; Pyrroles; Rats; Sesquiterpenes; Transcription Factors; Transcriptional Activation | 2005 |
Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation.
Topics: Alkaloids; Animals; Benzophenanthridines; Biological Transport; Cell Line; Enzyme Inhibitors; Glucose; Mice; Muscle, Skeletal; Naphthalenes; NF-kappa B; Palmitic Acid; Phenanthridines; Protein Kinase C; Pyrrolidines; Sesquiterpenes; Thiocarbamates; Tumor Necrosis Factor-alpha | 2006 |
Processing of a sesquiterpene lactone by Papilio glaucus caterpillars.
Topics: Adaptation, Physiological; Animals; Lactones; Larva; Lepidoptera; Magnetic Resonance Spectroscopy; Plant Leaves; Plants, Toxic; Sesquiterpenes | 2005 |
Pyrogenicity of CpG-DNA in mice: role of interleukin-6, cyclooxygenases, and nuclear factor-kappaB.
Topics: Animals; CpG Islands; Dinoprostone; DNA; Fever; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NF-kappa B; Prostaglandin-Endoperoxide Synthases; Pyrogens; Sesquiterpenes; Signal Transduction; Temperature; Toll-Like Receptors | 2006 |
CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27.
Topics: Cell Line; Chemokine CCL27; Chemokines; Chemokines, CC; Dermatitis; Humans; Imidazoles; Interleukin-1; Keratinocytes; Ligands; MAP Kinase Signaling System; NF-kappa B; Pyridines; Receptors, CCR10; Receptors, Chemokine; Sesquiterpenes; Signal Transduction; Tumor Necrosis Factor-alpha | 2006 |
[Effects of parthenolide on the activity and expression of urokinase type plasminogen activator in PGCL3 cells].
Topics: Actins; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; NF-kappa B; Plants, Medicinal; Sesquiterpenes; Tanacetum; Urokinase-Type Plasminogen Activator | 2005 |
Suppressive effects of dehydroepiandrosterone and the nuclear factor-kappaB inhibitor parthenolide on corticotroph tumor cell growth and function in vitro and in vivo.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Corticosterone; Dehydroepiandrosterone; Estradiol; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; NF-kappa B; Pituitary Neoplasms; Pro-Opiomelanocortin; Repressor Proteins; RNA, Messenger; RNA, Neoplasm; Sesquiterpenes; Survivin; Testosterone; Transcription, Genetic; Tumor Cells, Cultured | 2006 |
Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apigenin; Breast Neoplasms; Camphor; Cell Division; Cell Line, Tumor; Drug Synergism; Female; Humans; Luteolin; Neoplasms; Plant Extracts; Sesquiterpenes; Tanacetum parthenium; Uterine Cervical Neoplasms | 2006 |
The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro.
Topics: Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hematopoietic Stem Cells; Humans; Lactones; Leukemia, Lymphocytic, Chronic, B-Cell; Mitochondria; NF-kappa B; Sesquiterpenes; T-Lymphocytes; Tumor Suppressor Protein p53; Up-Regulation | 2006 |
Contact allergy to herbal teas derived from Asteraceae plants.
Topics: Adult; Aged; Asteraceae; Case-Control Studies; Dermatitis, Allergic Contact; Female; Humans; Lactones; Male; Middle Aged; Patch Tests; Plant Extracts; Sesquiterpenes; Time Factors | 2006 |
Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; bcl-X Protein; Caspase Inhibitors; Caspases; Cell Line, Tumor; Drug Interactions; Etoposide; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; NF-kappa B; Platelet Activating Factor; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Sesquiterpenes; Up-Regulation | 2006 |
Parthenolide has limited effects on nuclear factor-kappa beta increases and worsens survival in lipopolysaccharide-challenged C57BL/6J mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cytokines; Disease Models, Animal; Lipopolysaccharides; Mice; Mice, Inbred C57BL; NF-kappa B; Sesquiterpenes; Shock, Septic; Signal Transduction; Survival Rate | 2006 |
Parthenolide modulates the NF-kappaB-mediated inflammatory responses in experimental atherosclerosis.
Topics: Animals; Apoptosis; Atherosclerosis; Cell Division; Cells, Cultured; Dietary Fats; Humans; Inflammation; Mice; NF-kappa B; Sesquiterpenes | 2006 |
Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cyclooxygenase Inhibitors; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Humans; I-kappa B Proteins; Interphase; NF-kappa B; Nitrobenzenes; Sesquiterpenes; Sulfonamides; Transcription, Genetic | 2006 |
Inhibition of DMXAA-induced tumor necrosis factor production in murine splenocyte cultures by NF-kappaB inhibitors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cells, Cultured; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Interferon-gamma; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Salicylates; Sesquiterpenes; Spleen; Tumor Necrosis Factor-alpha; Xanthones | 2006 |
Estrogen dependent growth inhibitory effects of tamoxifen but not genistein in solid tumors derived from estrogen receptor positive (ER+) primary breast carcinoma MCF7: single agent and novel combined treatment approaches.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estradiol; Female; Genistein; Humans; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Sesquiterpenes; Spheroids, Cellular; Tamoxifen; Tretinoin | 2006 |
Quantification of parthenolide in Tanacetum species by LC-UV/LC-MS and microscopic comparison of Mexican/US feverfew samples.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calibration; Chromatography, High Pressure Liquid; Mass Spectrometry; Mexico; Microscopy, Fluorescence; Reference Standards; Sesquiterpenes; Spectrophotometry, Ultraviolet; Tanacetum; Tanacetum parthenium; United States | 2006 |
Artemisolide from Artemisia asiatica: nuclear factor-kappaB (NF-kappaB) inhibitor suppressing prostaglandin E2 and nitric oxide production in macrophages.
Topics: Animals; Anti-Inflammatory Agents; Artemisia; Cell Line; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Genes, Reporter; Lipopolysaccharides; Macrophages; Mice; NF-kappa B p50 Subunit; Nitric Oxide; Nitric Oxide Synthase Type II; Plant Components, Aerial; Sesquiterpenes; Transcription Factor RelA; Transfection; Triterpenes | 2006 |
Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model.
Topics: Androgen Antagonists; Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Bridged-Ring Compounds; Cell Line, Tumor; Docetaxel; Drug Synergism; Endothelium, Vascular; Fibroblast Growth Factor 2; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Nitriles; Prostatic Neoplasms; Radionuclide Imaging; Sesquiterpenes; Taxoids; TNF Receptor-Associated Factor 1; TNF Receptor-Associated Factor 2; Tosyl Compounds; Umbilical Veins; Vascular Endothelial Growth Factor A | 2006 |
Are extraction methods in quantitative assays of pharmacopoeia monographs exhaustive? A comparison with pressurized liquid extraction.
Topics: Aporphines; Atropa belladonna; Atropine; Caffeine; Chemistry Techniques, Analytical; Cola; Flavonoids; Peumus; Pharmacopoeias as Topic; Plant Extracts; Sesquiterpenes; Tanacetum parthenium; Vitex | 2006 |
Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activity.
Topics: Acetylcysteine; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Catalase; Cell Survival; Enzyme Inhibitors; Humans; Multiple Myeloma; Onium Compounds; Oxidative Stress; Reactive Oxygen Species; Sesquiterpenes | 2006 |
[Proliferation inhibiting and apoptosis inducing effects of parthenolide on human multiple myeloma cells].
Topics: Actihaemyl; Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Humans; Multiple Myeloma; Sesquiterpenes | 2006 |
Parthenolide reduces cisplatin-induced renal damage.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Cell Nucleus; Cisplatin; Electrophoretic Mobility Shift Assay; Glomerular Filtration Rate; Immunohistochemistry; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; Kidney Diseases; Kidney Function Tests; Kidney Medulla; Kidney Tubules; Lipid Peroxidation; Lipid Peroxides; Male; NF-kappa B; Nuclear Proteins; Oxidative Stress; Rats; Rats, Wistar; Sesquiterpenes; Superoxides | 2007 |
Cardiotrophin-1 induces interleukin-6 synthesis in human umbilical vein endothelial cells.
Topics: Antibodies, Monoclonal; Cells, Cultured; Cycloheximide; Cytokines; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Gene Expression; Humans; Imidazoles; Interleukin-6; Janus Kinase 2; Kinetics; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; STAT3 Transcription Factor; Stilbenes; Tyrphostins; Umbilical Cord | 2006 |
Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Luciferases; Male; Mice; Mice, Inbred C3H; Neoplasm Metastasis; NF-kappa B; Osteosarcoma; Protein Binding; Sesquiterpenes | 2007 |
Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes.
Topics: ADAM Proteins; ADAMTS4 Protein; Arteries; Cartilage; Cells, Cultured; Chondrocytes; DNA; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Enzymologic; Humans; Interleukin-1; Janus Kinases; Matrix Metalloproteinase 13; Oncostatin M; Phosphatidylinositol 3-Kinases; Procollagen N-Endopeptidase; Protein Binding; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Sesquiterpenes; Signal Transduction; STAT Transcription Factors | 2007 |
Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.
Topics: Active Transport, Cell Nucleus; Animals; Bronchoalveolar Lavage Fluid; Cell Line; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; I-kappa B Kinase; Inflammation; Interleukin-1beta; Interleukin-8; Lipopolysaccharides; Lung; Male; Mice; Mice, Knockout; NF-kappa B; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2007 |
Parthenolide induces a distinct pattern of oxidative stress in cardiac myocytes.
Topics: Animals; Enzyme Activation; Glutathione; Membrane Potentials; Mitogen-Activated Protein Kinases; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sesquiterpenes; STAT3 Transcription Factor | 2007 |
Signaling in lipopolysaccharide-induced stabilization of formyl peptide receptor 1 mRNA in mouse peritoneal macrophages.
Topics: 3' Untranslated Regions; Androstadienes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell-Free System; Chromones; Female; Gene Expression Regulation; I-kappa B Kinase; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Morpholines; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Receptors, Formyl Peptide; Ribosomal Protein S6 Kinases, 70-kDa; RNA Stability; RNA, Messenger; Sesquiterpenes; Signal Transduction; Toll-Like Receptor 4; TOR Serine-Threonine Kinases; Wortmannin | 2007 |
Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts.
Topics: Antibodies; Arthritis, Rheumatoid; Fibroblasts; Humans; Interleukin-15; NF-kappa B; Sesquiterpenes; Synovial Membrane; Toll-Like Receptor 2; Toll-Like Receptor 4; Up-Regulation | 2007 |
Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
Topics: Animals; Apoptosis; Blotting, Western; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Immunohistochemistry; Interleukin-8; Lactones; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; NF-kappa B; Phosphorylation; Sesquiterpenes; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2007 |
Compositae dermatitis from airborne parthenolide.
Topics: Adult; Aged; Air Pollutants; Allergens; Dermatitis, Allergic Contact; Environmental Monitoring; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Patch Tests; Sesquiterpenes; Tanacetum parthenium; Volatilization | 2007 |
Parthenolide protects human lens epithelial cells from oxidative stress-induced apoptosis via inhibition of activation of caspase-3 and caspase-9.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Caspase 9; Caspase Inhibitors; Cells, Cultured; Enzyme Activation; Epithelial Cells; Humans; Lens, Crystalline; Oxidative Stress; Rabbits; Sesquiterpenes | 2007 |
Microarray analysis reveals influence of the sesquiterpene lactone parthenolide on gene transcription profiles in human epithelial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Dose-Response Relationship, Drug; Epithelial Cells; Gene Expression Profiling; Gene Expression Regulation; Humans; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Sesquiterpenes; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2007 |
TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Apoptosis; Electrophoretic Mobility Shift Assay; Eosinophils; Fas Ligand Protein; Humans; I-kappa B Kinase; Leukemia, Myeloid; NF-kappa B; Nitriles; Sesquiterpenes; Sulfones; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; X-Linked Inhibitor of Apoptosis Protein | 2007 |
Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS.
Topics: Acetylcysteine; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cytokine Receptor gp130; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Heart Ventricles; Interleukin-6; Janus Kinase 1; Janus Kinase 2; Leukemia Inhibitory Factor; Leukemia Inhibitory Factor Receptor alpha Subunit; Myocytes, Cardiac; Oxidative Stress; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor | 2007 |
Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Blotting, Western; Body Weight; Chemokine CCL2; Collagen; Electrophoretic Mobility Shift Assay; Hypertension, Renal; Kidney; Macrophages; Male; Monocytes; NF-kappa B; Proteinuria; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Rho Factor; RNA, Messenger; Sesquiterpenes; Transcription Factor RelA; Transforming Growth Factor beta1; Vasoconstrictor Agents | 2007 |
Parthenolide inhibits tubulin carboxypeptidase activity.
Topics: Carboxypeptidases; Drug Interactions; HeLa Cells; Humans; NF-kappa B; Paclitaxel; Sesquiterpenes; Structure-Activity Relationship; Tubulin | 2007 |
Parthenolide induces significant apoptosis and production of reactive oxygen species in high-risk pre-B leukemia cells.
Topics: Apoptosis; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Membrane Potential, Mitochondrial; Nitric Oxide; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Risk Factors; Sesquiterpenes; Tumor Cells, Cultured | 2007 |
Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclin D1; Humans; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Prostaglandin-Endoperoxide Synthases; Sesquiterpenes; Sulindac | 2007 |
Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Cell Death; Cell Line, Tumor; DNA Fragmentation; Drug Synergism; Flow Cytometry; Glutamate-Cysteine Ligase; Glutathione; Humans; Leukemia; Mice; Microscopy, Fluorescence; NF-kappa B; Oxides; Reactive Oxygen Species; Sesquiterpenes | 2008 |
Parthenolide specifically depletes histone deacetylase 1 protein and induces cell death through ataxia telangiectasia mutated.
Topics: Acetylation; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Death; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; DNA-Binding Proteins; Histone Deacetylases; Histones; Humans; Hydrolysis; Phosphatidylinositol 3-Kinases; Proteasome Endopeptidase Complex; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2007 |
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.
Topics: Animals; Biological Availability; Dogs; Drug Design; Humans; Leukemia, Myeloid, Acute; Mice; Neoplastic Stem Cells; NF-kappa B; Oxidative Stress; Sesquiterpenes; Structure-Activity Relationship; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2007 |
The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN.
Topics: Blotting, Western; Electrophoretic Mobility Shift Assay; Gamma Rays; Gene Expression Regulation, Neoplastic; Humans; Male; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphorylation; Promoter Regions, Genetic; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Radiation Tolerance; Sesquiterpenes; Signal Transduction; Superoxide Dismutase; Tumor Cells, Cultured | 2007 |
Trypanosoma cruzi: antiprotozoal activity of parthenolide obtained from Tanacetum parthenium (L.) Schultz Bip. (Asteraceae, Compositae) against epimastigote and amastigote forms.
Topics: Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Hemolysis; Inhibitory Concentration 50; Macaca mulatta; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Plant Extracts; Sesquiterpenes; Tanacetum parthenium; Trypanosoma cruzi | 2008 |
NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Ditiocarb; Female; Humans; Mice; Mice, Nude; Neoplastic Stem Cells; NF-kappa B; Paclitaxel; Pyrrolidines; Sesquiterpenes; Spheroids, Cellular; Thiocarbamates; Time Factors; Xenograft Model Antitumor Assays | 2008 |
Inhibition of jet fuel aliphatic hydrocarbon induced toxicity in human epidermal keratinocytes.
Topics: Alkanes; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Cytokines; Humans; Hydrocarbons; Imidazoles; Interleukin-10; Irritants; Keratinocytes; NF-kappa B; Protein Kinase Inhibitors; Pyridines; Recombinant Proteins; Sesquiterpenes; Substance P; Time Factors | 2008 |
The lipophilic hapten parthenolide induces interferon-gamma and interleukin-13 production by peripheral blood-derived CD8+ T cells from contact allergic subjects in vitro.
Topics: Adult; CD8-Positive T-Lymphocytes; Cells, Cultured; Dermatitis, Allergic Contact; Dose-Response Relationship, Immunologic; Enzyme-Linked Immunosorbent Assay; Female; Haptens; Humans; Immunophenotyping; Interferon-gamma; Interleukin-13; Lymphocyte Activation; Male; Middle Aged; Patch Tests; Sesquiterpenes | 2008 |
Parthenolide-depleted Feverfew (Tanacetum parthenium) protects skin from UV irradiation and external aggression.
Topics: Administration, Topical; Animals; Case-Control Studies; Cells, Cultured; DNA Repair; Environmental Exposure; Erythema; Female; Free Radical Scavengers; Humans; Hydrogen Peroxide; Hyperplasia; Inflammation; Male; Mice; Mice, Hairless; Plant Extracts; Reactive Oxygen Species; Sesquiterpenes; Skin; Skin Aging; Smoking; Swine; Tanacetum parthenium; Ultraviolet Rays | 2008 |
Parthenolide sensitizes cells to X-ray-induced cell killing through inhibition of NF-kappaB and split-dose repair.
Topics: Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Humans; NF-kappa B; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Tubulin; Tumor Suppressor Protein p53; X-Rays | 2007 |
The solution and solid state stability and excipient compatibility of parthenolide in feverfew.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Drug Compounding; Drug Stability; Drug Storage; Excipients; Humidity; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Plant Preparations; Powders; Sesquiterpenes; Solutions; Tanacetum parthenium; Technology, Pharmaceutical; Temperature; Water | 2007 |
Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones.
Topics: Algorithms; Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Hyperkinesis; Mass Spectrometry; Motor Activity; Planarians; Santonin; Sesquiterpenes; Sesquiterpenes, Eudesmane; Spectrometry, Mass, Electrospray Ionization | 2008 |
Parthenolide prevents the expression of cocaine-induced withdrawal behavior in planarians.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cocaine; Planarians; Sesquiterpenes; Stereotyped Behavior; Substance Withdrawal Syndrome | 2008 |
Parthenolide induces apoptosis in glioblastomas without affecting NF-kappaB.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Caspase 3; Caspase 7; Cell Line, Tumor; Glioblastoma; Humans; NF-kappa B; Sesquiterpenes | 2008 |
Preconditioning by sesquiterpene lactone enhances H2O2-induced Nrf2/ARE activation.
Topics: Animals; Antioxidants; Asteraceae; Enhancer Elements, Genetic; Genes, Reporter; Heme Oxygenase (Decyclizing); Hydrogen Peroxide; Lactones; NF-E2-Related Factor 2; PC12 Cells; Rats; Response Elements; Sesquiterpenes | 2008 |
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.
Topics: Aldehydes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Death; Cysteine Proteinase Inhibitors; Databases, Genetic; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; Models, Genetic; Neoplastic Stem Cells; Oligonucleotide Array Sequence Analysis; Pentacyclic Triterpenes; Sesquiterpenes; Terpenes; Triterpenes; Xenograft Model Antitumor Assays | 2008 |
Antimyeloma effects of a sesquiterpene lactone parthenolide.
Topics: Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Humans; Insulin-Like Growth Factor I; Interleukin-6; Lactones; Leukocytes; Multiple Myeloma; NF-kappa B; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2008 |
Thermosensitization by parthenolide in human lung adenocarcinoma A549 cells and p53- and hsp72-independent apoptosis induction via the nuclear factor-kappaB signal pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Hot Temperature; HSP72 Heat-Shock Proteins; Humans; Lung Neoplasms; NF-kappa B; Sesquiterpenes; Signal Transduction; Tumor Suppressor Protein p53 | 2008 |
Inhibitory effects of parthenolide on antigen-induced microtubule formation and degranulation in mast cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Degranulation; Cell Line; Cells, Cultured; I-kappa B Kinase; Immunoglobulin E; Mast Cells; Mice; Mice, Inbred C57BL; Microtubules; NF-kappa B; Nocodazole; Passive Cutaneous Anaphylaxis; Receptors, IgE; Sesquiterpenes; Tubulin Modulators | 2008 |
A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Compounding; Female; Humans; Lipids; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Sesquiterpenes; Technology, Pharmaceutical; Time Factors; Vinblastine; Vinorelbine; Xenograft Model Antitumor Assays | 2008 |
Screening biomaterials for stimulation of nitric oxide-mediated inflammation.
Topics: 2-Naphthylamine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Cell Line; Humans; Hyaluronic Acid; Inflammation; Interferon-gamma; Lipopolysaccharides; Macrophages; Materials Testing; Mice; Nitric Oxide; Nitrites; Sesquiterpenes | 2009 |
Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions.
Topics: Aged; Extracellular Matrix; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Male; Microarray Analysis; Middle Aged; Neoplastic Stem Cells; NF-kappa B; Prostate; Prostatic Neoplasms; Sesquiterpenes | 2008 |
Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression.
Topics: Androgens; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; Kallikreins; MAP Kinase Kinase Kinases; NF-kappa B; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Prostate-Specific Antigen; Proto-Oncogene Proteins c-myc; Receptors, Androgen; Serine Endopeptidases; Sesquiterpenes; Signal Transduction; Transcriptional Activation | 2008 |
Parthenolide inhibits proliferation of fibroblast-like synoviocytes in vitro.
Topics: Animals; Arthritis, Rheumatoid; Bromodeoxyuridine; Cell Line; Cell Proliferation; Fibroblasts; Humans; Hyperplasia; Phytotherapy; Rabbits; Sesquiterpenes; Synovial Membrane; Tanacetum parthenium; Tetrazolium Salts; Thiazoles | 2008 |
Antileukemic activity of aminoparthenolide analogs.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Lymphoma, Large-Cell, Anaplastic; Models, Chemical; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sesquiterpenes | 2008 |
[Parthenolide inhibits tumor necrosis factor-alpha induced catabolism of aggrecan in chondrocytes in osteoarthritis: in vitro experiment with cultured human chondrocytes].
Topics: Aggrecans; Arthroplasty, Replacement, Knee; Cells, Cultured; Chondrocytes; Endopeptidases; Enzyme-Linked Immunosorbent Assay; Femur; Glycosaminoglycans; Humans; Isoenzymes; Osteoarthritis; Postoperative Period; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Spectrophotometry; Tumor Necrosis Factor-alpha | 2008 |
IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Blotting, Western; Cell Proliferation; Cells, Cultured; Fibroblasts; Flavonoids; Humans; Immunohistochemistry; Interleukin-17; Interleukin-1beta; Interleukin-6; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Interleukin-6; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor; Stimulation, Chemical; Synovial Membrane; Tumor Necrosis Factor-alpha | 2008 |
Inhibitory effects of parthenolide on the angiogenesis induced by human multiple myeloma cells and the mechanism.
Topics: Cell Line, Tumor; Endothelial Cells; Humans; Interleukin-6; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Multiple Myeloma; Neovascularization, Pathologic; NF-kappa B; RNA, Messenger; Sesquiterpenes; Umbilical Veins; Vascular Endothelial Growth Factor A | 2008 |
Depressant-like effects of parthenolide in a rodent behavioural antidepressant test battery.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Maze Learning; Mice; Motor Activity; Olfactory Bulb; Rats; Rats, Wistar; Serotonin Antagonists; Sesquiterpenes; Social Behavior; Swimming | 2008 |
Resistance of cholangiocarcinoma cells to parthenolide-induced apoptosis by the excretory-secretory products of Clonorchis sinensis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Clonorchis sinensis; Cyclooxygenase 2; Drug Resistance; Helminth Proteins; Humans; Sesquiterpenes | 2009 |
JP-8 induces immune suppression via a reactive oxygen species NF-kappabeta-dependent mechanism.
Topics: Administration, Cutaneous; Analysis of Variance; Animals; Carrier Proteins; Cell Line; Cyclooxygenase 2; Female; Gene Expression; Hydrocarbons; Immune Tolerance; Mice; Neoplasm Proteins; NF-kappa B; Reactive Oxygen Species; RNA, Small Interfering; Sesquiterpenes; Superoxide Dismutase; Transcription Factor RelA | 2009 |
Tanacetum vulgare: antiherpes virus activity of crude extract and the purified compound parthenolide.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Herpesvirus 1, Human; Molecular Structure; Plant Extracts; Sesquiterpenes; Tanacetum; Vero Cells | 2009 |
Cardiotrophin-1 induces intercellular adhesion molecule-1 expression by nuclear factor kappaB activation in human umbilical vein endothelial cells.
Topics: Anthracenes; Butadienes; Cells, Cultured; Cytokines; Electrophoretic Mobility Shift Assay; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Gene Expression; Humans; Intercellular Adhesion Molecule-1; JNK Mitogen-Activated Protein Kinases; NF-kappa B; Nitriles; p38 Mitogen-Activated Protein Kinases; Polymerase Chain Reaction; Sesquiterpenes; Umbilical Veins | 2008 |
Modulation of DNA methylation by a sesquiterpene lactone parthenolide.
Topics: Alkylation; Animals; Antineoplastic Agents; Apoptosis; Catalytic Domain; Cell Cycle; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; Cysteine; Cytokines; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Electrophoretic Mobility Shift Assay; Female; Humans; Immunoblotting; Lactones; Mice; Mice, Nude; Models, Molecular; Neoplasms; Promoter Regions, Genetic; Sesquiterpenes; Sp1 Transcription Factor; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2009 |
Cytotoxic effects of catechol to neuroblastoma N2a cells.
Topics: Animals; Antioxidants; Apoptosis; Ascorbic Acid; Catechols; Cell Line, Tumor; Cell Survival; Curcumin; Cysteine; Cytotoxins; Deferoxamine; Glutathione; Mice; Neuroblastoma; NF-kappa B; Reactive Oxygen Species; Sesquiterpenes; Superoxide Dismutase | 2008 |
Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach.
Topics: Animals; Antigens, CD; Cell Line, Tumor; Flow Cytometry; Gene Expression Profiling; Humans; Hyaluronan Receptors; Male; Mice; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Prostate; Prostatic Neoplasms; RNA, Neoplasm; Sesquiterpenes; Transcription, Genetic | 2009 |
Existing and emerging therapeutic options for the treatment of acute myeloid leukemia.
Topics: Adenine; Adenine Nucleotides; Aminoglycosides; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Arabinonucleosides; Carbazoles; Clofarabine; Cytarabine; Dasatinib; Daunorubicin; fms-Like Tyrosine Kinase 3; Furans; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Naphthalimides; Organophosphonates; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Sesquiterpenes; Staurosporine; Stem Cell Transplantation; Thiazoles; Tretinoin | 2008 |
IKKbeta mediates cell shape-induced aromatase expression and estrogen biosynthesis in adipose stromal cells.
Topics: Adipose Tissue; Anti-Inflammatory Agents, Non-Steroidal; Aromatase; Cell Line, Tumor; Cell Shape; Cell Survival; Cells, Cultured; Chromatin Immunoprecipitation; Estrogens; Flow Cytometry; Gene Expression Regulation, Enzymologic; Genetic Vectors; Humans; I-kappa B Kinase; Immunoblotting; Lentivirus; Nitriles; Promoter Regions, Genetic; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Sesquiterpenes; Stromal Cells; Sulfones | 2009 |
Inhibition of NF-kB and metalloproteinase-9 expression and secretion by parthenolide derivatives.
Topics: 4-Butyrolactone; Cell Line; Cyclobutanes; Down-Regulation; Humans; Inhibitory Concentration 50; Matrix Metalloproteinase 9; NF-kappa B; Sesquiterpenes; Transcription, Genetic | 2009 |
Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions.
Topics: Antineoplastic Agents; Cell Proliferation; HCT116 Cells; Histone Deacetylase 1; Histone Deacetylases; Humans; Imidazoles; Models, Biological; Piperazines; Protein Binding; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-mdm2; Sesquiterpenes; Transcription, Genetic; Tumor Suppressor Protein p53; Ubiquitination; Up-Regulation | 2009 |
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.
Topics: Antimalarials; Antimetabolites, Antineoplastic; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Tumor; Colonic Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Phosphorylation; Protein Transport; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sesquiterpenes | 2009 |
Sesquiterpene lactone parthenolide ameliorates bladder inflammation and bladder overactivity in cyclophosphamide induced rat cystitis model by inhibiting nuclear factor-kappaB phosphorylation.
Topics: Analysis of Variance; Animals; Biopsy, Needle; Cyclophosphamide; Cystitis; Disease Models, Animal; Female; Immunohistochemistry; Male; NF-kappa B; Phosphorylation; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Sesquiterpenes; Urinary Bladder, Overactive | 2009 |
A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; Growth Inhibitors; Humans; In Situ Nick-End Labeling; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Oxides; Pancreatic Neoplasms; Reactive Oxygen Species; Sesquiterpenes; Xenograft Model Antitumor Assays | 2009 |
Suppression of NF-kappaB activity by parthenolide induces X-ray sensitivity through inhibition of split-dose repair in TP53 null prostate cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Radiation; Humans; Male; Models, Biological; NF-kappa B; Prostatic Neoplasms; Radiation Tolerance; RNA, Small Interfering; Sesquiterpenes; Transcription Factor RelA; Tumor Suppressor Protein p53; X-Rays | 2009 |
CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cell Movement; Cells, Cultured; Chemokines; Connective Tissue Growth Factor; Cytokines; Disease Models, Animal; Epithelial Cells; Inflammation; Kidney Tubules; Macrophages; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Sesquiterpenes; Signal Transduction; T-Lymphocytes | 2009 |
Nuclear factor-[kappa]B inhibition provides additional protection against ischaemia/reperfusion injury in delayed sevoflurane preconditioning.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Clinical Protocols; Ischemic Preconditioning, Myocardial; Male; Methyl Ethers; Myocardial Reperfusion Injury; NF-kappa B; Random Allocation; Rats; Rats, Inbred F344; Sesquiterpenes; Sevoflurane; Ventricular Function, Left; Ventricular Function, Right | 2009 |
Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1).
Topics: Animals; Antineoplastic Agents; Cell Death; Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; Humans; Lactones; Leukemia, Myeloid, Acute; Models, Chemical; NF-kappa B; Rats; Sesquiterpenes; Solubility; Water | 2009 |
Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-X Protein; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Line, Tumor; Cell Survival; Cytochromes c; Drug Synergism; Histocytochemistry; I-kappa B Kinase; Kaplan-Meier Estimate; Lung Neoplasms; Mice; Mitochondrial Membranes; NF-kappa B; Paclitaxel; Sesquiterpenes; Xenograft Model Antitumor Assays | 2009 |
Parthenolide inhibits proliferation of vascular smooth muscle cells through induction of G0/G1 phase cell cycle arrest.
Topics: Animals; Cell Proliferation; Cells, Cultured; G1 Phase; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; Resting Phase, Cell Cycle; Sesquiterpenes | 2009 |
NF-kappaB regulates androgen receptor expression and prostate cancer growth.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; NF-kappa B; Promoter Regions, Genetic; Prostatic Neoplasms; Receptors, Androgen; Sesquiterpenes; Transcription Factor RelA; Xenograft Model Antitumor Assays | 2009 |
Effect of parthenolide on proliferation and apoptosis in gastric cancer cell line SGC7901.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Humans; NF-kappa B; Sesquiterpenes; Stomach Neoplasms | 2009 |
Sesquiterpene lactone parthenolide markedly enhances sensitivity of human A549 cells to low-dose oxaliplatin via inhibition of NF-kappaB activation and induction of apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Lactones; Lung Neoplasms; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Phytotherapy; Plant Extracts; Sesquiterpenes; Tanacetum | 2010 |
[Parthenolide inhibits neuroinflammation and promotes neurogenesis in the ischemic striatum following transient middle cerebral artery occlusion in the adult rat brain].
Topics: Animals; Bromodeoxyuridine; Doublecortin Protein; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Inflammation; Ischemia; Male; Neostriatum; Neurogenesis; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2009 |
IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cell Differentiation; Female; Fibroblasts; Gene Expression Regulation; Humans; Interleukin-23; Male; Middle Aged; NF-kappa B; Osteoarthritis; Osteoclasts; RANK Ligand; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor; Synovial Membrane; Tyrphostins | 2010 |
Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro.
Topics: Acetylcysteine; Adult; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Drug Interactions; Female; Flow Cytometry; Humans; Male; Melanoma; Membrane Potential, Mitochondrial; Mice; Middle Aged; Reactive Oxygen Species; Sesquiterpenes; Skin Neoplasms; Tanacetum parthenium | 2010 |
Modulation of cell surface protein free thiols: a potential novel mechanism of action of the sesquiterpene lactone parthenolide.
Topics: Antioxidants; Blotting, Western; Cell Death; Cell Line, Tumor; Cell Membrane; Cell Survival; Drug Screening Assays, Antitumor; Enzyme Activation; Extracellular Space; Flow Cytometry; Glutathione; Humans; JNK Mitogen-Activated Protein Kinases; Lymphoma; NF-kappa B; Sesquiterpenes; Sulfhydryl Compounds; Thioredoxins | 2009 |
Inhibition of NF-kappaB by combination therapy with parthenolide and hyperthermia and kinetics of apoptosis induction and cell cycle arrest in human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Combined Modality Therapy; Humans; Hyperthermia, Induced; Lung Neoplasms; NF-kappa B; Sesquiterpenes | 2010 |
Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Enzyme Activation; Gene Expression Regulation, Enzymologic; Humans; Liver Neoplasms; Mice; Mice, Knockout; MicroRNAs; Nitric Oxide Synthase Type II; Promoter Regions, Genetic; RNA, Small Interfering; Sesquiterpenes; Trans-Activators; Transcription Factors; Transcription, Genetic; Viral Regulatory and Accessory Proteins | 2010 |
Ghrelin decreases microvascular leak during inflammation.
Topics: Animals; Capillary Permeability; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Ghrelin; Lipopolysaccharides; Mesentery; NF-kappa B; Obesity; Rats; Rats, Sprague-Dawley; Receptors, Ghrelin; Sesquiterpenes; Signal Transduction; Substance P; Systemic Inflammatory Response Syndrome; Venules; Wounds and Injuries | 2010 |
Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome.
Topics: Animals; Anti-Inflammatory Agents; Bone Marrow Cells; Caspase 1; Cell Death; Humans; Immunoblotting; Inflammation; L-Lactate Dehydrogenase; Macrophages; Mice; NF-kappa B; Nitriles; Sesquiterpenes; Sulfones | 2010 |
In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: a feasibility study.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Embryo, Nonmammalian; Feasibility Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Larva; Mesalamine; Prednisolone; Sesquiterpenes; Thalidomide; Zebrafish | 2010 |
Effect of carbamylated erythropoietin on major histocompatibility complex expression and neural differentiation of human neural stem cells.
Topics: Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cells, Cultured; Cytokines; Embryonic Stem Cells; Epidermal Growth Factor; Erythropoietin; Fetus; Fibroblast Growth Factor 2; Flow Cytometry; Gene Expression Regulation, Developmental; Histocompatibility Antigens; Humans; Immunosuppressive Agents; Nerve Tissue Proteins; Neurites; Neurons; Sesquiterpenes; Wortmannin | 2010 |
A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells.
Topics: Catalase; Cell Line, Tumor; Enzyme Activation; Forkhead Box Protein O3; Forkhead Transcription Factors; Glutathione; Humans; Male; NADPH Oxidases; Oncogene Protein v-akt; Oxidation-Reduction; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Prostatic Neoplasms; Radiation-Sensitizing Agents; Sesquiterpenes; Signal Transduction; Superoxide Dismutase; Thioredoxins | 2010 |
[Effect of parthenolide on leukemia K562 cells and its leukemia stem cells].
Topics: Apoptosis; Cell Proliferation; Humans; K562 Cells; Leukemia; Neoplastic Stem Cells; Plant Extracts; Sesquiterpenes | 2010 |
Chlamydial infection of monocytes stimulates IL-1beta secretion through activation of the NLRP3 inflammasome.
Topics: Carrier Proteins; Caspase 1; Cell Line; Chlamydia muridarum; Chlamydia trachomatis; Enzyme Inhibitors; Humans; Interleukin-1beta; Monocytes; Nitriles; NLR Family, Pyrin Domain-Containing 3 Protein; Sesquiterpenes; Sulfones | 2010 |
Angiotensin II-induced upregulation of AT(1) receptor expression: sequential activation of NF-kappaB and Elk-1 in neurons.
Topics: Angiotensin II; Animals; Cell Line; DNA; ets-Domain Protein Elk-1; Mice; Neurons; NF-kappa B; Protein Binding; Receptor, Angiotensin, Type 1; RNA, Small Interfering; Sesquiterpenes; Transcription Factor RelA; Transcription, Genetic; Up-Regulation | 2010 |
Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Nucleus; Cell Survival; Drug Synergism; Humans; I-kappa B Proteins; Lung Neoplasms; Mice; Mice, Nude; NF-kappa B; Paclitaxel; Phosphorylation; Protein Transport; Random Allocation; Sesquiterpenes; Survival Analysis; Xenograft Model Antitumor Assays | 2010 |
Natural products inhibit LPS-induced activation of pro-inflammatory cytokines in peripheral blood mononuclear cells.
Topics: Anti-Inflammatory Agents; Curcumin; Cytokines; Interleukin-1beta; Interleukin-6; Leukocytes, Mononuclear; Lipopolysaccharides; Resveratrol; Sesquiterpenes; Stilbenes; Tumor Necrosis Factor-alpha | 2010 |
Cell context-dependent activities of parthenolide in primary and metastatic melanoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; Humans; Melanoma; Neoplasm Metastasis; Neoplasm Proteins; NF-kappa B; Sesquiterpenes | 2010 |
Effects of nuclear factor-κB inhibitors on colon anastomotic healing in rats.
Topics: Anastomosis, Surgical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Enteritis; Hydroxyproline; Interleukin-6; Laparotomy; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Models, Animal; NF-kappa B; Rats; Rats, Wistar; Resveratrol; Sesquiterpenes; Stilbenes; Wound Healing | 2011 |
NF-kappaB activation enhances cell death by antimitotic drugs in human prostate cancer cells.
Topics: 2-Methoxyestradiol; Antineoplastic Agents; Apoptosis; Base Sequence; Betulinic Acid; Blotting, Western; Cell Line, Tumor; DNA Primers; Docetaxel; Estradiol; Flow Cytometry; Humans; Immunohistochemistry; Male; Mitosis; NF-kappa B; Pentacyclic Triterpenes; Prostatic Neoplasms; Sesquiterpenes; Taxoids; Triterpenes | 2010 |
Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Resorption; Cell Differentiation; Cell Survival; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Female; Humans; I-kappa B Kinase; Imidazoles; Inhibitory Concentration 50; Mice; Osteoclasts; Ovariectomy; Pentacyclic Triterpenes; Quinoxalines; Sesquiterpenes; Signal Transduction; Triterpenes | 2010 |
A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species.
Topics: Animals; Base Sequence; Carcinogens; Cell Cycle; Cell Division; DNA Primers; Electrophoretic Mobility Shift Assay; Flow Cytometry; Lung Neoplasms; Male; Mice; Mice, Nude; NF-kappa B; Nicotiana; Nitrosamines; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Sesquiterpenes; Urinary Bladder Neoplasms | 2011 |
Patch test reactivity to feverfew-containing creams in feverfew-allergic patients.
Topics: Adult; Aged; Dermatitis, Allergic Contact; Female; Humans; Male; Middle Aged; Ointments; Patch Tests; Plant Extracts; Sesquiterpenes; Tanacetum parthenium | 2010 |
Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Caspase 3; Cell Proliferation; Flow Cytometry; Humans; Immunoenzyme Techniques; In Vitro Techniques; Neoplasm Invasiveness; NF-kappa B; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Tumor Cells, Cultured | 2010 |
Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Line, Tumor; Flow Cytometry; Glutathione; Humans; Leukemia, Myeloid, Acute; Membrane Potential, Mitochondrial; Mice; Mice, Inbred Strains; Neoplastic Stem Cells; Peroxidase; Reactive Oxygen Species; RNA, Small Interfering; Sesquiterpenes; Transfection; Xenograft Model Antitumor Assays | 2010 |
The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Activation; Histone Deacetylase Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Myeloid, Acute; NF-kappa B; Sesquiterpenes; Signal Transduction; Tumor Cells, Cultured | 2010 |
MTA1 coregulator regulates LPS response via MyD88-dependent signaling.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cytokines; Gene Expression Regulation; Inflammation Mediators; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Myeloid Differentiation Factor 88; Repressor Proteins; Response Elements; Sesquiterpenes; Signal Transduction; Trans-Activators; Transcription Factor RelA; Transcription Factors; Transcription, Genetic | 2010 |
Suppression of intracellular calcium levels and inhibition of degranulation in RBL-2H3 mast cells by the sesquiterpene lactone parthenolide.
Topics: Animals; Antigens; Calcium; Cell Degranulation; Cell Line, Tumor; Immunologic Factors; Inhibitory Concentration 50; Ionomycin; Mast Cells; Plant Extracts; Rats; Sesquiterpenes; Tanacetum | 2011 |
Molecular pathways of spontaneous and TNF-{alpha}-mediated neutrophil apoptosis under intermittent hypoxia.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Hypoxia; Cell Survival; Cells, Cultured; Enzyme Inhibitors; Female; Gene Expression Regulation; Gliotoxin; Humans; Imidazoles; Immunosuppressive Agents; Interleukin-8; Male; Neutrophils; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Receptors, Interleukin-8B; Receptors, Tumor Necrosis Factor, Type II; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2011 |
Parthenolide treatment activates stress signaling proteins in high-risk acute lymphoblastic leukemia cells with chromosomal translocation t(4;11).
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Separation; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Flow Cytometry; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sesquiterpenes; Signal Transduction; Translocation, Genetic | 2010 |
Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers, Tumor; Blotting, Western; Bone Marrow; Cell Proliferation; Cells, Cultured; Drug Synergism; Enzyme Inhibitors; Flow Cytometry; Gene Expression Profiling; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; Oligonucleotide Array Sequence Analysis; Phosphatidylinositol 3-Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Sirolimus; TOR Serine-Threonine Kinases | 2010 |
Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cholangiocarcinoma; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Heme Oxygenase-1; Humans; Lactones; NF-E2-Related Factor 2; Protein Kinase C-alpha; RNA, Small Interfering; Sesquiterpenes; Signal Transduction | 2010 |
Synergistic effects of parthenolide and benznidazole on Trypanosoma cruzi.
Topics: Cell Culture Techniques; Drug Synergism; Herb-Drug Interactions; Inhibitory Concentration 50; Nitroimidazoles; Plant Leaves; Sesquiterpenes; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
NFκB inhibitors induce cell death in glioblastomas.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Astrocytes; Brain Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cisplatin; Curcumin; Doxorubicin; Drug Synergism; Glioblastoma; Humans; Leupeptins; Molecular Targeted Therapy; NF-kappa B; Nitriles; Oxides; Rats; Sesquiterpenes; Signal Transduction; Sulfones | 2011 |
Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue.
Topics: Adult; Atazanavir Sulfate; Carrier Proteins; Female; Gene Expression; HIV Protease Inhibitors; Humans; Inflammation; Interleukin-6; Intra-Abdominal Fat; Lopinavir; Male; Nelfinavir; Oligopeptides; Perilipin-1; Phosphoenolpyruvate Carboxykinase (GTP); Phosphoproteins; Pyridines; Pyrimidinones; Ritonavir; Sesquiterpenes; Subcutaneous Fat; Triglycerides; Tumor Necrosis Factor-alpha | 2011 |
Screening for Compositae sensitization with pure allergens: implications of molecular structure, strength of reaction, and time of testing.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allergens; Asteraceae; Child; Dermatitis, Allergic Contact; Female; Humans; Lactones; Male; Middle Aged; Patch Tests; Prevalence; Sesquiterpenes; Young Adult | 2011 |
In vitro anti HSV-1 and HSV-2 activity of Tanacetum vulgare extracts and isolated compounds: an approach to their mechanisms of action.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Herpesvirus 1, Human; Herpesvirus 2, Human; Plant Extracts; Sesquiterpenes; Tanacetum; Vero Cells | 2011 |
Parthenolide inhibits STAT3 signaling and attenuates angiotensin II-induced left ventricular hypertrophy via modulation of fibroblast activity.
Topics: Angiotensin II; Animals; Blotting, Western; Echocardiography; Electrophoretic Mobility Shift Assay; Fibroblasts; Hemodynamics; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Phosphorylation; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor | 2011 |
The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-κB inhibition.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Cell Line; Humans; Megakaryocyte Progenitor Cells; Mice; Mice, Inbred C57BL; NF-kappa B; Platelet Activation; Sesquiterpenes; Tanacetum parthenium | 2011 |
Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells.
Topics: Angiotensinogen; Binding Sites; Blotting, Western; Cells, Cultured; Cloning, Organism; Humans; Kidney Tubules, Proximal; NF-kappa B; Promoter Regions, Genetic; Sesquiterpenes | 2011 |
Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase.
Topics: Androgens; Animals; Blood Pressure; Dihydrotestosterone; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Hypertension; I-kappa B Kinase; Rats; Rats, Sprague-Dawley; Renal Artery; Sesquiterpenes; Vasoconstriction | 2011 |
The NFĸB pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated Erythrocytes.
Topics: Aniline Compounds; Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Calcium; Cell Size; Erythrocytes; Glutathione; Humans; I-kappa B Kinase; NF-kappa B; Nitriles; Phosphatidylserines; Protein Binding; Sesquiterpenes; Signal Transduction; Sulfones; Xanthenes | 2011 |
Parthenolide inhibits TRIF-dependent signaling pathway of Toll-like receptors in RAW264.7 macrophages.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Cell Line; Chemokine CXCL10; Interferon Regulatory Factor-3; Lipopolysaccharides; Luciferases; Macrophages; Mice; NF-kappa B; Peptide Fragments; Poly I-C; Sesquiterpenes; Signal Transduction; Toll-Like Receptors | 2011 |
Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation.
Topics: Apoptosis; Carcinoma, Hepatocellular; Caspases; Down-Regulation; Drug Screening Assays, Antitumor; Enzyme Activation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Janus Kinases; Liver Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-mdm2; Receptors, Death Domain; Sesquiterpenes; STAT3 Transcription Factor; TNF-Related Apoptosis-Inducing Ligand; Tumor Suppressor Protein p53 | 2011 |
The natural products parthenolide and andrographolide exhibit anti-cancer stem cell activity in multiple myeloma.
Topics: Andrographis; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diterpenes; Dose-Response Relationship, Drug; Humans; Molecular Structure; Multiple Myeloma; Neoplastic Stem Cells; NF-kappa B; Plant Extracts; Sesquiterpenes; Tanacetum parthenium | 2011 |
Tissue factor pathway inhibitor 2 is induced by thrombin in human macrophages.
Topics: Amino Acid Chloromethyl Ketones; Anthracenes; Antithrombins; Blotting, Western; Butadienes; Cell Line; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Enzyme Inhibitors; Flavonoids; Gene Expression; Glycoproteins; Hirudins; Humans; JNK Mitogen-Activated Protein Kinases; Lipoproteins, VLDL; Macrophages; Mitogen-Activated Protein Kinases; NF-kappa B; Nitriles; Nitrobenzenes; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Signal Transduction; Sulfonamides; Thrombin; Time Factors | 2011 |
Biosynthesis and localization of parthenolide in glandular trichomes of feverfew (Tanacetum parthenium L. Schulz Bip.).
Topics: Alkyl and Aryl Transferases; Amino Acid Sequence; Anti-Inflammatory Agents, Non-Steroidal; DNA, Complementary; Escherichia coli; Flowers; Fruit; Gene Expression Regulation, Developmental; Gene Expression Regulation, Plant; Organ Specificity; Phylogeny; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plant Stems; Plants, Medicinal; Recombinant Proteins; RNA, Messenger; RNA, Plant; Sequence Alignment; Sesquiterpenes; Tanacetum parthenium | 2011 |
Involvement of endoplasmic reticulum stress-mediated CHOP (GADD153) induction in the cytotoxicity of 2-aminophenoxazine-3-one in cancer cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum; Gene Expression Profiling; HL-60 Cells; Humans; Mice; Mice, Knockout; NF-kappa B; Nitriles; Oxazines; Sesquiterpenes; Sulfones; Thapsigargin; Transcription Factor CHOP; Tunicamycin; Up-Regulation | 2011 |
Thermosensitization and induction of apoptosis or cell-cycle arrest via the MAPK cascade by parthenolide, an NF-κB inhibitor, in human prostate cancer androgen-independent cell lines.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Division; Cell Line, Tumor; Combined Modality Therapy; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Hot Temperature; Humans; Hyperthermia, Induced; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Prostatic Neoplasms; Sesquiterpenes | 2011 |
Parthenolide induces apoptosis and cell cycle arrest of human 5637 bladder cancer cells in vitro.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 2; Diffusion Chambers, Culture; Flow Cytometry; G1 Phase; Humans; Microscopy; Neoplasm Invasiveness; Phosphorylation; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Signal Transduction; Tanacetum parthenium; Urinary Bladder Neoplasms | 2011 |
Combined effects of FLT3 and NF-κB selective inhibitors on acute myeloid leukemia in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Line, Tumor; Cyclin D1; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Nuclear Receptor Co-Repressor 2; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Thiophenes; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-I.
Topics: Acetyltransferases; Animals; Cell Line; Cell Proliferation; Chickens; Gene Expression Regulation, Neoplastic; Humans; K562 Cells; Lactones; Leukemia, Myeloid, Acute; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myb; Sesquiterpenes | 2012 |
Comparison of anti-invasive activity of parthenolide and 3-isopropyl-2-methyl-4-methyleneisoxazolidin-5-one (MZ-6)--a new compound with α-methylene-γ-lactone motif--on two breast cancer cell lines.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Female; Humans; Isoxazoles; Lactones; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Sesquiterpenes; Urokinase-Type Plasminogen Activator | 2012 |
Parthenolide attenuates LPS-induced fever, circulating cytokines and markers of brain inflammation in rats.
Topics: Animals; Biomarkers; Body Temperature; CCAAT-Enhancer-Binding Protein-beta; Cells, Cultured; Cytokines; Encephalitis; Fever; Gene Expression Regulation; Hypothalamus; Injections, Intraperitoneal; Interleukin-6; Lipopolysaccharides; Male; Mitochondria; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Sesquiterpenes; Signal Transduction; Tumor Necrosis Factor-alpha | 2011 |
Fluorinated amino-derivatives of the sesquiterpene lactone, parthenolide, as (19)f NMR probes in deuterium-free environments.
Topics: Antineoplastic Agents; Cell Line, Tumor; Crystallography, X-Ray; Deuterium; Drug Screening Assays, Antitumor; Fluorine; Glutathione; Humans; Lactones; Magnetic Resonance Spectroscopy; Molecular Probes; Molecular Structure; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship | 2011 |
Targeting radioresistant osteosarcoma cells with parthenolide.
Topics: Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Neoplastic Stem Cells; NF-kappa B; Osteosarcoma; Radiation Tolerance; Radiation, Ionizing; Reactive Oxygen Species; Sesquiterpenes | 2012 |
9β-hydroxyparthenolide esters from Inula montbretiana and their antiprotozoal activity.
Topics: Animals; Antiprotozoal Agents; Esters; Flowers; Inula; Leishmania donovani; Models, Animal; Phytotherapy; Plant Components, Aerial; Plant Extracts; Plasmodium falciparum; Rats; Sesquiterpenes; Trypanosoma brucei rhodesiense; Trypanosoma cruzi; Turkey | 2012 |
Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; bcl-X Protein; Blotting, Western; Cell Proliferation; DNA-Binding Proteins; DNA, Neoplasm; Electrophoretic Mobility Shift Assay; Humans; Lymphoma, B-Cell; NF-kappa B; Nuclear Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-rel; Sesquiterpenes; Tumor Cells, Cultured | 2012 |
Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates dextran sulfate sodium-induced colitis in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; I-kappa B Proteins; Male; Mice; Mice, Inbred BALB C; NF-kappa B; NF-KappaB Inhibitor alpha; Peroxidase; Sesquiterpenes | 2012 |
TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation.
Topics: Adult; Animals; Antibodies, Neutralizing; Biopsy; Cell Line; Chemokine CXCL16; Chemokine CXCL6; Chemokines, CXC; Chemotaxis; Cytokine TWEAK; Disease Models, Animal; Female; Folic Acid; Gene Expression Profiling; Humans; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Middle Aged; Nephritis, Interstitial; NF-kappa B; Receptors, Scavenger; Receptors, Tumor Necrosis Factor; Recombinant Proteins; RNA, Messenger; Sesquiterpenes; T-Lymphocytes; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factors; TWEAK Receptor; Up-Regulation | 2012 |
HIV-1 Tat protein impairs adipogenesis and induces the expression and secretion of proinflammatory cytokines in human SGBS adipocytes.
Topics: Adipocytes; Adipogenesis; Cytokines; Gene Expression Regulation; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Inflammation; Resveratrol; Rosiglitazone; Sesquiterpenes; Stilbenes; tat Gene Products, Human Immunodeficiency Virus; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2012 |
Parthenolide inhibits the LPS-induced secretion of IL-6 and TNF-α and NF-κB nuclear translocation in BV-2 microglia.
Topics: Animals; Cell Line; Interleukin-6; Lipopolysaccharides; Mice; Microglia; NF-kappa B; Protein Transport; Sesquiterpenes; Tanacetum parthenium; Tumor Necrosis Factor-alpha | 2012 |
Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Drug Carriers; Humans; Inhibitory Concentration 50; Lung Neoplasms; Magnetic Resonance Spectroscopy; Micelles; Paclitaxel; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Sesquiterpenes; Vitamin E | 2012 |
Combined effect of Hsp90 inhibitor geldanamycin and parthenolide via reactive oxygen species-mediated apoptotic process on epithelial ovarian cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Blotting, Western; Carcinoma, Ovarian Epithelial; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Survival; Cytochromes c; Female; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mitochondria; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Reactive Oxygen Species; Sesquiterpenes; Tumor Suppressor Protein p53 | 2012 |
Planarians in pharmacology: parthenolide is a specific behavioral antagonist of cocaine in the planarian Girardia tigrina.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cocaine; Dopamine Uptake Inhibitors; Excitatory Amino Acid Agonists; Methamphetamine; N-Methylaspartate; Nicotine; Nicotinic Agonists; Planarians; Regeneration; Seizures; Sesquiterpenes | 2012 |
Patch testing with constituents of Compositae mixes.
Topics: Allergens; Asteraceae; Dermatitis, Allergic Contact; Female; Humans; Male; Middle Aged; Patch Tests; Plant Extracts; Sesquiterpenes | 2012 |
Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Gene Expression; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Membrane Potential, Mitochondrial; NF-kappa B; Oxidative Stress; Rats; Reactive Oxygen Species; Sesquiterpenes; Thioacetamide; Tumor Necrosis Factor-alpha | 2012 |
Parthenolide induces caspase-independent and AIF-mediated cell death in human osteosarcoma and melanoma cells.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis Inducing Factor; Caspase Inhibitors; Caspases; Cell Death; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Melanoma; NADPH Oxidases; NF-kappa B; Osteosarcoma; Reactive Oxygen Species; Sesquiterpenes | 2013 |
Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma.
Topics: Antiviral Agents; Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Epstein-Barr Virus Infections; Ganciclovir; Herpesvirus 4, Human; Humans; Immediate-Early Proteins; NF-kappa B; Plants, Medicinal; Sesquiterpenes; Tanacetum parthenium; Trans-Activators | 2012 |
Biomimetic semisynthesis of arglabin from parthenolide.
Topics: Antineoplastic Agents; Biomimetics; Humans; Models, Molecular; Sesquiterpenes; Sesquiterpenes, Guaiane; Stereoisomerism | 2012 |
Culture supernatants of breast cancer cell line MDA-MB-231 treated with parthenolide inhibit the proliferation, migration, and lumen formation capacity of human umbilical vein endothelial cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-8; Matrix Metalloproteinase 9; Sesquiterpenes; Vascular Endothelial Growth Factor A | 2012 |
Parthenolide suppresses tumor growth in a xenograft model of colorectal cancer cells by inducing mitochondrial dysfunction and apoptosis.
Topics: Apoptosis; Carcinogenesis; Colorectal Neoplasms; Cytochromes c; Genes, bcl-2; HT29 Cells; Humans; Mitochondria; Neovascularization, Pathologic; Sesquiterpenes; Signal Transduction; Xenograft Model Antitumor Assays | 2012 |
Inhibition of tumor promotion by parthenolide: epigenetic modulation of p21.
Topics: Animals; Animals, Newborn; Antineoplastic Agents, Phytogenic; Cell Transformation, Neoplastic; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Down-Regulation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Neoplasms; Sesquiterpenes; Xenograft Model Antitumor Assays | 2012 |
Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis Regulatory Proteins; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Phosphorylation; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Signal Transduction; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |
Apoptosis-mediated cytotoxic effects of parthenolide and the new synthetic analog MZ-6 on two breast cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Cell Shape; DNA Replication; Drug Screening Assays, Antitumor; Female; Humans; Isoxazoles; Lipid Peroxidation; MCF-7 Cells; Oxidative Stress; Sesquiterpenes; Transcription, Genetic | 2013 |
Role of NF-κB activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Cell Line, Tumor; DNA; Electrophoretic Mobility Shift Assay; Female; Gene Expression; Humans; Interleukin-8; Matrix Metalloproteinase 9; NF-kappa B; Protein Binding; Sesquiterpenes; Vascular Endothelial Growth Factor A | 2013 |
Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Melanoma; Neoplastic Stem Cells; Sesquiterpenes; Spheroids, Cellular; Tumor Cells, Cultured | 2013 |
Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia.
Topics: Adolescent; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Bone Marrow Cells; Cell Survival; Child; Child, Preschool; Disease Models, Animal; Female; Humans; Infant; Male; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplasm Transplantation; NF-kappa B; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Secondary Prevention; Sesquiterpenes; Transplantation, Heterologous | 2013 |
Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide's anti-leukemic activity.
Topics: Cell Line, Tumor; Dipeptidases; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Humans; Leukemia; Real-Time Polymerase Chain Reaction; Sesquiterpenes | 2013 |
Biofilm inhibitors that target amyloid proteins.
Topics: Amyloidogenic Proteins; Anti-Bacterial Agents; Bacillus cereus; Bacillus subtilis; Bacterial Proteins; Benzoquinones; Biofilms; Escherichia coli; Humans; Sesquiterpenes | 2013 |
Epidermal growth factor protects squamous cell carcinoma against cisplatin-induced cytotoxicity through increased interleukin-1β expression.
Topics: Biomarkers, Tumor; Blotting, Western; Carcinoma, Squamous Cell; Chromones; Cisplatin; Cytotoxins; DNA Primers; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; ErbB Receptors; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1beta; Morpholines; NF-kappa B; Oncogene Protein v-akt; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Sesquiterpenes; Signal Transduction | 2013 |
Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Apoptosis; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Cytochromes c; Drug Combinations; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Humans; Mice; Mice, Nude; Mitochondria; Neoplasm Transplantation; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Xenograft Model Antitumor Assays | 2013 |
Reversing resistance of multidrug-resistant hepatic carcinoma cells with parthenolide.
Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluorouracil; Humans; Liver Neoplasms; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Tumor Suppressor Protein p53; Wnt1 Protein | 2013 |
NF-κB pathway contributes to cadmium-induced apoptosis of porcine granulosa cells.
Topics: Animals; Apoptosis; Cadmium; Female; Granulosa Cells; NF-kappa B; Reactive Oxygen Species; Sesquiterpenes; Swine | 2013 |
Mouse pyrin and HIN domain family member 1 (pyhin1) protein positively regulates LPS-induced IFN-β and NO production in macrophages.
Topics: Animals; Cell Line; Gene Expression Regulation; Inflammation; Interferon Regulatory Factor-1; Interferon-beta; Lipopolysaccharides; Macrophages, Peritoneal; Mice; NF-kappa B; Nitric Oxide; Nuclear Proteins; RNA, Small Interfering; Sesquiterpenes; Signal Transduction; STAT1 Transcription Factor; TNF Receptor-Associated Factor 6 | 2014 |
KEAP1 is a redox sensitive target that arbitrates the opposing radiosensitive effects of parthenolide in normal and cancer cells.
Topics: Animals; Antioxidants; bcl-X Protein; Carrier Proteins; Cell Line; Cell Line, Tumor; Epithelial Cells; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Male; Mice; Mice, Nude; Mitochondrial Proteins; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Phosphoprotein Phosphatases; Prostatic Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Random Allocation; Reactive Oxygen Species; Sesquiterpenes; Thioredoxins; Ubiquitin; Xenograft Model Antitumor Assays | 2013 |
Dual-functional abeo-taxane derivatives destabilizing microtubule equilibrium and inhibiting NF-κB activation.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; NF-kappa B; Paclitaxel; Polymerization; Sesquiterpenes; Structure-Activity Relationship; Taxoids; Tubulin; Tubulin Modulators | 2013 |
Parthenolide from Parthenium integrifolium reduces tumor burden and alleviate cachexia symptoms in the murine CT-26 model of colorectal carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Asteraceae; Body Weight; Cachexia; Colorectal Neoplasms; Disease Models, Animal; Male; Mice; Mice, Inbred BALB C; Muscle Proteins; Muscle, Skeletal; Neoplasm Transplantation; Organ Size; Phytotherapy; Plant Extracts; Sesquiterpenes; Tripartite Motif Proteins; Tumor Burden; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases | 2013 |
Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Line; Dose-Response Relationship, Drug; Immunoblotting; Lipopeptides; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitriles; Oligodeoxyribonucleotides; Poly I-C; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Sulfones; Toll-Like Receptor 9; Toll-Like Receptors; Tumor Suppressor Protein p53; Valproic Acid | 2013 |
Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; HSP70 Heat-Shock Proteins; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Microscopy, Confocal; NF-kappa B; Sesquiterpenes; Signal Transduction; Up-Regulation | 2013 |
Parthenolide enhances dacarbazine activity against melanoma cells.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Interleukin-8; Melanoma; NF-kappa B; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Skin Neoplasms; Vascular Endothelial Growth Factor A | 2013 |
Parthenolide reduces cell proliferation and prostaglandin E2 [corrected] in human endometriotic stromal cells and inhibits development of endometriosis in the murine model.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Endometriosis; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Gene Expression Regulation, Enzymologic; Humans; I-kappa B Proteins; Inflammation Mediators; Interleukin-8; Ki-67 Antigen; Mice; Mice, Inbred BALB C; Phosphorylation; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Signal Transduction; Stromal Cells; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2013 |
Parthenolide complements the cell death-inducing activity of doxorubicin in melanoma cells.
Topics: Cell Death; Cell Line, Tumor; Cell Survival; Doxorubicin; Humans; Melanoma; NF-kappa B; Sesquiterpenes; Tumor Suppressor Protein p53 | 2013 |
Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting the TRPA1 channel.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; CHO Cells; Cricetinae; Cricetulus; Drug Delivery Systems; Flowers; HEK293 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nociception; Plant Extracts; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tanacetum parthenium; Transient Receptor Potential Channels; Trigeminal Ganglion; Trigeminal Nerve; TRPA1 Cation Channel; Vasodilation | 2013 |
Parthenolide is neuroprotective in rat experimental stroke model: downregulating NF-κB, phospho-p38MAPK, and caspase-1 and ameliorating BBB permeability.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Caspase 1; Claudin-5; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Permeability; Phosphorylation; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Stroke | 2013 |
In human retinoblastoma Y79 cells okadaic acid-parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Shape; Cell Survival; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression; Glutathione; Humans; Okadaic Acid; Oxidative Stress; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; PTEN Phosphohydrolase; Reactive Oxygen Species; Retinoblastoma; Sesquiterpenes; Tumor Suppressor Protein p53 | 2013 |
Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition.
Topics: Breast Neoplasms; Cell Line, Tumor; Enzyme Activation; Female; Humans; Microtubules; NF-kappa B; Protein Processing, Post-Translational; Sesquiterpenes; Signal Transduction; Tubulin | 2013 |
Protection-group-free semisyntheses of parthenolide and its cyclopropyl analogue.
Topics: Apoptosis; Cell Line, Tumor; Cyclopropanes; Humans; Sesquiterpenes | 2013 |
Parthenolide induces apoptosis by activating the mitochondrial and death receptor pathways and inhibits FAK-mediated cell invasion.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Caspases; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; DNA Damage; Enzyme Activation; Focal Adhesion Protein-Tyrosine Kinases; Glutathione; Humans; Membrane Potential, Mitochondrial; Mitochondria; Neoplasm Invasiveness; Oxidants; Reactive Oxygen Species; Receptors, Death Domain; Sesquiterpenes; Signal Transduction | 2014 |
Age sensitivity of NFκB abundance and programmed cell death in erythrocytes induced by NFκB inhibitors.
Topics: Aging; Apoptosis; Cells, Cultured; Erythrocytes; Humans; NF-kappa B; Nitriles; Sesquiterpenes; Sulfones; Time Factors | 2013 |
St. John's Wort seed and feverfew flower extracts relieve painful diabetic neuropathy in a rat model of diabetes.
Topics: Animals; Anthracenes; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Flowers; Hyperalgesia; Hypericum; Perylene; Phloroglucinol; Phytotherapy; Plant Components, Aerial; Plant Extracts; Rats; Seeds; Sesquiterpenes; Tanacetum parthenium; Terpenes | 2014 |
Parthenolide induces superoxide anion production by stimulating EGF receptor in MDA-MB-231 breast cancer cells.
Topics: Acetophenones; Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Enzyme Inhibitors; ErbB Receptors; Female; Humans; NADPH Oxidases; NF-kappa B; Phosphorylation; Protein Tyrosine Phosphatases; Quinazolines; Sesquiterpenes; Superoxides; Tyrphostins | 2013 |
[Effects of parthenolide on high glucose-induced cell proliferation, NF-κB activation and MCP-1 expression in rat mesangial cells].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asteraceae; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Dose-Response Relationship, Drug; Glucose; I-kappa B Proteins; Mesangial Cells; NF-kappa B; NF-KappaB Inhibitor alpha; Plants, Medicinal; Rats; Sesquiterpenes | 2013 |
Synthetic α-(aminomethyl)-γ-butyrolactones and their anti-pancreatic cancer activities.
Topics: 4-Butyrolactone; Amination; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Humans; Pancreatic Neoplasms; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship | 2013 |
Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer.
Topics: Animals; Autophagy; Breast Neoplasms; Calcium; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Cell Survival; Fas-Associated Death Domain Protein; Female; Humans; Membrane Potential, Mitochondrial; Mice; NF-kappa B; Nuclear Pore Complex Proteins; Reactive Oxygen Species; RNA-Binding Proteins; Sesquiterpenes; Xenograft Model Antitumor Assays | 2013 |
Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization.
Topics: Antineoplastic Agents; Apoptosis; Biocatalysis; Cytochrome P-450 Enzyme System; Drug Discovery; Humans; Leukemia, Myeloid, Acute; Models, Molecular; Oxidation-Reduction; Sesquiterpenes; Tumor Cells, Cultured | 2014 |
Parthenolide inhibits polyethylene particle-induced mouse calvarial osteolysis in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Lactones; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Osteolysis; Polyethylene; Prosthesis Failure; Sesquiterpenes; Skull; X-Ray Microtomography | 2014 |
Parthenolide inhibits osteoclast differentiation and bone resorbing activity by down-regulation of NFATc1 induction and c-Fos stability, during RANKL-mediated osteoclastogenesis.
Topics: Animals; Bone Marrow Cells; Bone Resorption; Cathepsin K; Cell Differentiation; Cells, Cultured; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Macrophages; Male; Mice; Mice, Inbred ICR; NFATC Transcription Factors; Osteoclasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Stability; Proto-Oncogene Proteins c-fos; RANK Ligand; Sesquiterpenes | 2014 |
Parthenolide induces apoptosis via TNFRSF10B and PMAIP1 pathways in human lung cancer cells.
Topics: Activating Transcription Factor 4; Antineoplastic Agents; Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Gene Expression; Humans; Lung Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Neoplastic Stem Cells; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Sesquiterpenes; Transcription Factor CHOP; Up-Regulation | 2014 |
Analysis of gene profiles involved in the enhancement of all-trans retinoic acid-induced HL-60 cell differentiation by sesquiterpene lactones identifies asparagine synthetase as a novel target for differentiation-inducing therapy.
Topics: Asparagine; Aspartate-Ammonia Ligase; Cell Differentiation; Culture Media; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Oligonucleotide Array Sequence Analysis; Receptors, Retinoic Acid; Sesquiterpenes; Sesquiterpenes, Guaiane; Tretinoin | 2014 |
ROCK/NF-κB axis-dependent augmentation of angiotensinogen by angiotensin II in primary-cultured preglomerular vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensinogen; Animals; Cells, Cultured; Male; Muscle, Smooth, Vascular; NF-kappa B; Rats; rho-Associated Kinases; Sesquiterpenes | 2014 |
[Effect of parthenolide on serum expressions of interleukin-1beta and tumor necrosis factor-alpha in rabbits with knee osteoarthritis].
Topics: Animals; Female; Interleukin-1beta; Male; Osteoarthritis, Knee; Phytotherapy; Rabbits; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2013 |
Parthenolide exerts inhibitory effects on angiogenesis through the downregulation of VEGF/VEGFRs in colorectal cancer.
Topics: Cell Movement; Cell Survival; Colorectal Neoplasms; HCT116 Cells; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Neovascularization, Pathologic; Receptors, Vascular Endothelial Growth Factor; Sesquiterpenes; Vascular Endothelial Growth Factor A | 2014 |
New cassane-type diterpenoids of Caesalpinia echinata (Leguminosae) exhibiting NF-κB inhibitory activities.
Topics: Caesalpinia; Diterpenes; Gene Expression; Genes, Reporter; HeLa Cells; Humans; Molecular Structure; NF-kappa B; Plant Extracts; Plant Stems; Sesquiterpenes; Structure-Activity Relationship | 2014 |
Parthenium dermatitis: is parthenolide an effective choice for patch testing?
Topics: Adolescent; Adult; Asteraceae; Dermatitis, Allergic Contact; Female; Humans; Male; Middle Aged; Parthenogenesis; Patch Tests; Plant Extracts; Prospective Studies; Sesquiterpenes; Young Adult | 2014 |
Inhibition of AMPK/autophagy potentiates parthenolide-induced apoptosis in human breast cancer cells.
Topics: AMP-Activated Protein Kinases; Apoptosis; Autophagy; Breast Neoplasms; Cell Cycle Checkpoints; Female; Humans; MCF-7 Cells; Reactive Oxygen Species; Sesquiterpenes | 2014 |
Heterocyclic aminoparthenolide derivatives modulate G(2)-M cell cycle progression during Xenopus oocyte maturation.
Topics: Animals; Dose-Response Relationship, Drug; G2 Phase; Heterocyclic Compounds; Mitosis; Molecular Structure; Oocytes; Sesquiterpenes; Xenopus | 2014 |
Elucidation and in planta reconstitution of the parthenolide biosynthetic pathway.
Topics: Metabolomics; Nicotiana; Plant Proteins; Plants, Genetically Modified; Sesquiterpenes; Tanacetum parthenium | 2014 |
The oxygen radicals involved in the toxicity induced by parthenolide in MDA-MB-231 cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Humans; Hydrogen Peroxide; Mitochondria; NADPH Oxidases; Sesquiterpenes; Superoxide Dismutase; Superoxide Dismutase-1; Superoxides | 2014 |
RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Breast; Breast Neoplasms; Cell Line, Tumor; Female; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Reactive Oxygen Species; Receptor-Interacting Protein Serine-Threonine Kinases; Sesquiterpenes; Up-Regulation | 2014 |
Cell death in amastigote forms of Leishmania amazonensis induced by parthenolide.
Topics: Animals; Antiprotozoal Agents; Cell Death; Cell Membrane; Female; Inhibitory Concentration 50; Leishmania mexicana; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron; Organelles; Sesquiterpenes | 2014 |
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia.
Topics: Animals; Antineoplastic Agents; Caspases; Cell Survival; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Lethal Dose 50; Leukemia, Myeloid, Acute; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Phenylbutyrates; Sesquiterpenes; Transcriptome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Synthesis and biological evaluation of 9α- and 9β-hydroxyamino-parthenolides as novel anticancer agents.
Topics: Amines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; Mice; Molecular Conformation; Sesquiterpenes; Structure-Activity Relationship | 2014 |
Parthenolide-induced apoptosis, autophagy and suppression of proliferation in HepG2 cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Fluorescent Antibody Technique; Hep G2 Cells; Humans; Liver Neoplasms; Sesquiterpenes | 2014 |
Total syntheses of parthenolide and its analogues with macrocyclic stereocontrol.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; Neoplasms; Sesquiterpenes; Structure-Activity Relationship | 2014 |
Heck products of parthenolide and melampomagnolide-B as anticancer modulators that modify cell cycle progression.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Humans; Oocytes; Sesquiterpenes; Structure-Activity Relationship; Xenopus | 2014 |
Inhibition of intracellular signaling pathways NF-κB and MEK1/2 attenuates neuropathic pain development and enhances morphine analgesia.
Topics: Analgesics; Analgesics, Opioid; Animals; Butadienes; Disease Models, Animal; Drug Synergism; Hyperalgesia; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Morphine; Neuralgia; NF-kappa B; Nitriles; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Sciatic Nerve; Sesquiterpenes; Signal Transduction | 2014 |
PI3K/Akt regulates survival during differentiation of human macrophages by maintaining NF-κB-dependent expression of antiapoptotic Bcl-xL.
Topics: Anthracenes; Apoptosis; bcl-X Protein; Caffeic Acids; Cell Line, Tumor; Chromones; Flavonoids; Gene Expression Regulation, Developmental; Hematopoiesis; Humans; Macrophage Colony-Stimulating Factor; Macrophages; MAP Kinase Signaling System; Monocytes; Morpholines; NF-kappa B; Phenylethyl Alcohol; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Sesquiterpenes; Signal Transduction; Tetradecanoylphorbol Acetate | 2014 |
[Shenkang pill down-regulates AOPP-induced expression of inflammatory factor MCP-1 via a p38MAPK/NF-κB-dependent mechanism].
Topics: Advanced Oxidation Protein Products; Animals; Cell Line; Cell Proliferation; Chemokine CCL2; Down-Regulation; Drugs, Chinese Herbal; I-kappa B Proteins; Imidazoles; Mice; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Serum; Sesquiterpenes; Transcription Factor RelA | 2014 |
Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Culture Techniques; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Gene Expression; Humans; MCF-7 Cells; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Tanacetum parthenium | 2015 |
The synergistic effect of SAHA and parthenolide in MDA-MB231 breast cancer cells.
Topics: Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Drug Synergism; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; NF-kappa B; Sesquiterpenes; Vorinostat | 2015 |
Parthenolide inhibits pro-inflammatory cytokine production and exhibits protective effects on progression of collagen-induced arthritis in a rat model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cartilage, Articular; Chondrocytes; Cytokines; Disease Models, Animal; Interleukin-1beta; Lipopolysaccharides; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; NF-kappa B; Nitric Oxide Synthase Type II; Rats; RNA, Messenger; Sesquiterpenes; Synovial Membrane; Tumor Necrosis Factor-alpha | 2015 |
Parthenolide induces autophagy via the depletion of 4E-BP1.
Topics: Adaptor Proteins, Signal Transducing; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Autophagy; Carrier Proteins; Cell Cycle Proteins; Eukaryotic Initiation Factors; Fibroblasts; HEK293 Cells; HeLa Cells; HL-60 Cells; Humans; Mice; Phagosomes; Phosphoproteins; Phosphorylation; Plasmids; Reactive Oxygen Species; RNA, Small Interfering; Sesquiterpenes; Signal Transduction | 2015 |
Parthenolide enhances sensitivity of colorectal cancer cells to TRAIL by inducing death receptor 5 and promotes TRAIL-induced apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Death; Cells, Cultured; Colorectal Neoplasms; Drug Synergism; HCT116 Cells; HT29 Cells; Humans; Receptors, TNF-Related Apoptosis-Inducing Ligand; Sesquiterpenes; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation | 2015 |
Parthenolide inhibits cancer stem-like side population of nasopharyngeal carcinoma cells via suppression of the NF-κB/COX-2 pathway.
Topics: Antineoplastic Agents; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Gene Expression Profiling; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplastic Stem Cells; NF-kappa B; Real-Time Polymerase Chain Reaction; Sesquiterpenes; Signal Transduction | 2015 |
Suppression of tubulin detyrosination by parthenolide recruits the plant-specific kinesin KCH to cortical microtubules.
Topics: Carboxypeptidases; Cell Line; Cells, Cultured; Genes, Reporter; Kinesins; Microtubules; Nicotiana; Peptide Synthases; Plant Proteins; Plants, Genetically Modified; Sesquiterpenes; Tubulin; Tyrosine | 2015 |
Induction of apoptosis by parthenolide in human oral cancer cell lines and tumor xenografts.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; BH3 Interacting Domain Death Agonist Protein; Caspase 3; Caspase 8; Cell Line, Tumor; Female; Humans; Membrane Proteins; Mice; Mice, Nude; Mitochondria; Mouth Neoplasms; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA, Messenger; RNA, Small Interfering; Sesquiterpenes | 2015 |
Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cells.
Topics: Cell Line; Cytokines; Humans; Inflammation Mediators; Lipopolysaccharides; Sesquiterpenes; Signal Transduction; Toll-Like Receptor 4 | 2015 |
The HIV proteins Tat and Nef promote human bone marrow mesenchymal stem cell senescence and alter osteoblastic differentiation.
Topics: Acetylcysteine; Antioxidants; Autophagy; Bone Marrow Cells; Cell Differentiation; Cell Proliferation; Cellular Senescence; Gene Expression Regulation; Humans; Interleukin-6; Interleukin-8; Mesenchymal Stem Cells; Mitochondria; nef Gene Products, Human Immunodeficiency Virus; NF-kappa B; Osteoblasts; Osteocalcin; Oxidative Stress; Primary Cell Culture; Recombinant Proteins; Sesquiterpenes; Signal Transduction; Sirolimus; tat Gene Products, Human Immunodeficiency Virus | 2015 |
Induction of survivin inhibition, G₂/M cell cycle arrest and autophagic on cell death in human malignant glioblastoma cells.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Dose-Response Relationship, Drug; G2 Phase Cell Cycle Checkpoints; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; M Phase Cell Cycle Checkpoints; Sesquiterpenes; Survivin; Treatment Outcome | 2015 |
Covalent modification of human serum albumin by the natural sesquiterpene lactone parthenolide.
Topics: Cysteine; Humans; Plant Extracts; Serum Albumin; Sesquiterpenes; Tanacetum parthenium | 2015 |
Parthenolide reduces empty lacunae and osteoclastic bone surface resorption induced by polyethylene particles in a murine calvarial model of peri-implant osteolysis.
Topics: Animals; Bone Resorption; Collagen Type I; Humans; Mice; Models, Animal; Organ Size; Osteoarthritis; Osteoclasts; Osteolysis; Peptides; Polyethylene; Prostheses and Implants; Receptors, Cell Surface; Sesquiterpenes; Skull; Solubility; X-Ray Microtomography | 2015 |
Sesquiterpene lactone parthenolide attenuates production of inflammatory mediators by suppressing the Toll-like receptor-4-mediated activation of the Akt, mTOR, and NF-κB pathways.
Topics: Humans; Inflammation Mediators; Keratinocytes; Lipopolysaccharides; NF-kappa B; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction; Toll-Like Receptor 4; TOR Serine-Threonine Kinases | 2015 |
Parthenolide prodrug LC-1 slows growth of intracranial glioma.
Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Glioma; Half-Life; Kaplan-Meier Estimate; Mice; Prodrugs; Sesquiterpenes | 2015 |
Inhibitory effects of parthenolide on the activity of NF-κB in multiple myeloma via targeting TRAF6.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Multiple Myeloma; NF-kappa B; Sesquiterpenes; TNF Receptor-Associated Factor 6; Transcription Factor RelA; Ubiquitination | 2015 |
Synthesis and antileukemic activities of C1-C10-modified parthenolide analogues.
Topics: Alkenes; Animals; Antineoplastic Agents; Bone Marrow Cells; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid, Acute; Mice; Molecular Conformation; Neoplastic Stem Cells; Reactive Oxygen Species; Sesquiterpenes | 2015 |
Parthenolide Relieves Pain and Promotes M2 Microglia/Macrophage Polarization in Rat Model of Neuropathy.
Topics: Analgesics; Animals; Cell Polarity; Cells, Cultured; Chronic Disease; Hyperalgesia; Macrophages; Male; Microglia; Neuralgia; Rats; Rats, Wistar; Sciatic Neuropathy; Sesquiterpenes; Signal Transduction | 2015 |
Parthenolide accumulation and expression of genes related to parthenolide biosynthesis affected by exogenous application of methyl jasmonate and salicylic acid in Tanacetum parthenium.
Topics: Acetates; Cyclopentanes; Gene Expression Regulation, Plant; Oxylipins; Plant Growth Regulators; Salicylic Acid; Sesquiterpenes; Tanacetum parthenium | 2015 |
Syntheses and Biological Evaluation of Costunolide, Parthenolide, and Their Fluorinated Analogues.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Fluorine; Half-Life; Halogenation; Humans; Microsomes, Liver; Rats; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship | 2015 |
The NF-κB p65/miR-23a-27a-24 cluster is a target for leukemia treatment.
Topics: Animals; Apoptosis; Base Sequence; Cell Differentiation; Erythropoiesis; HEK293 Cells; Humans; Leukemia; Mice; Mice, Inbred C57BL; MicroRNAs; Molecular Sequence Data; Promoter Regions, Genetic; Sesquiterpenes; Transcription Factor RelA; Up-Regulation | 2015 |
Dimers of Melampomagnolide B Exhibit Potent Anticancer Activity against Hematological and Solid Tumor Cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Dimerization; Drug Screening Assays, Antitumor; Gliosarcoma; Hematologic Neoplasms; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Neoplasms; Primary Cell Culture; Rats; Sesquiterpenes; Structure-Activity Relationship; Tumor Stem Cell Assay | 2015 |
Repressed Ca(2+) clearance in parthenolide-treated murine brain bEND.3 endothelial cells.
Topics: Animals; Calcium; Calcium Signaling; Cell Line; Cell Membrane; Cytoprotection; Endoplasmic Reticulum Stress; Endothelial Cells; Homeostasis; Mice; Microvessels; Sesquiterpenes | 2015 |
In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Cell Line, Tumor; Drug Delivery Systems; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; Nanoparticles; Neoplastic Stem Cells; Sesquiterpenes; Stem Cell Niche; Xenograft Model Antitumor Assays | 2016 |
Determination of parthenolide in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
Topics: Administration, Oral; Animals; Calibration; Chromatography, Liquid; Drug Stability; Drugs, Chinese Herbal; In Vitro Techniques; Injections, Intravenous; Limit of Detection; Male; Rats, Sprague-Dawley; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Sesquiterpenes; Tandem Mass Spectrometry | 2016 |
Ruscogenin exerts beneficial effects on monocrotaline-induced pulmonary hypertension by inhibiting NF-κB expression.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Hemodynamics; Humans; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Platelet-Derived Growth Factor; Pulmonary Artery; Random Allocation; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Spirostans | 2015 |
The Nonartemisinin Sesquiterpene Lactones Parthenin and Parthenolide Block Plasmodium falciparum Sexual Stage Transmission.
Topics: Animals; Anopheles; Antimalarials; Artemisinins; Drug Resistance; Erythrocytes; Female; Gene Expression; Genes, Reporter; Green Fluorescent Proteins; Humans; Inhibitory Concentration 50; Life Cycle Stages; Malaria; Male; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes | 2016 |
Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M(high) melanoma cell populations.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Histone Deacetylase 1; Humans; MAP Kinase Signaling System; Melanoma; Microphthalmia-Associated Transcription Factor; Myeloid Cell Leukemia Sequence 1 Protein; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Sesquiterpenes; Transcription Factor RelA; Tumor Cells, Cultured | 2016 |
Anticancer activity and radiosensitization effect of methyleneisoxazolidin-5-ones in hepatocellular carcinoma HepG2 cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Cell Survival; DNA Damage; Hep G2 Cells; Humans; Isoxazoles; Membrane Potential, Mitochondrial; Radiation-Sensitizing Agents; Reactive Oxygen Species; Sesquiterpenes | 2016 |
Relative In Vitro Potentials of Parthenolide to Induce Apoptosis and Cell Cycle Arrest in Skin Cancer Cells.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Sesquiterpenes; Skin Neoplasms | 2016 |
Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; HeLa Cells; Humans; NADPH Oxidases; Neoplasm Proteins; Neoplasms; Sesquiterpenes; Superoxides; Tanacetum parthenium; Thioredoxin Reductase 1; Thioredoxin Reductase 2 | 2016 |
Promotion of Functional Nerve Regeneration by Inhibition of Microtubule Detyrosination.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Axons; Dose-Response Relationship, Drug; Gene Knock-In Techniques; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Mice; Mice, Inbred C57BL; Microtubules; Nerve Regeneration; Nocodazole; Paclitaxel; Peripheral Nerves; Phosphorylation; Sciatic Nerve; Sesquiterpenes; Tyrosine | 2016 |
Dehydroleucodine, a Sesquiterpene Lactone from Gynoxys verrucosa, Demonstrates Cytotoxic Activity against Human Leukemia Cells.
Topics: Antineoplastic Agents; Asteraceae; Blotting, Western; Drug Screening Assays, Antitumor; Ecuador; HeLa Cells; HL-60 Cells; Humans; Lactones; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Medicine, Traditional; Molecular Structure; Sesquiterpenes | 2016 |
Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis.
Topics: Acetophenones; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Fluorescent Dyes; Humans; Membrane Potential, Mitochondrial; Mitochondria; NADPH Oxidases; Neoplastic Stem Cells; NF-E2-Related Factor 2; Oligopeptides; Onium Compounds; Oxidative Stress; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Sesquiterpenes; Transcription Factors | 2016 |
Parthenolide induces apoptosis and autophagy through the suppression of PI3K/Akt signaling pathway in cervical cancer.
Topics: Apoptosis; Autophagy; Female; HeLa Cells; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction; Uterine Cervical Neoplasms | 2016 |
Parthenolide ameliorates Concanavalin A-induced acute hepatitis in mice and modulates the macrophages to an anti-inflammatory state.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Concanavalin A; Cytokines; Disease Models, Animal; Hepatitis; Humans; Immunity, Cellular; Inflammation Mediators; Liver; Macrophages; Male; Mice; p38 Mitogen-Activated Protein Kinases; RAW 264.7 Cells; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor; Tumor Suppressor Protein p53 | 2016 |
Pharmacological targeting of glucose-6-phosphate dehydrogenase in human erythrocytes by Bay 11-7082, parthenolide and dimethyl fumarate.
Topics: Dimethyl Fumarate; Eryptosis; Erythrocytes; Glucosephosphate Dehydrogenase; Humans; Nitriles; Sesquiterpenes; Sulfones | 2016 |
Magnesium and manganese interactively modulate parthenolide accumulation and the antioxidant defense system in the leaves of Tanacetum parthenium.
Topics: Antioxidants; Biosynthetic Pathways; Gene Expression Regulation, Plant; Magnesium; Malondialdehyde; Manganese; Metabolic Networks and Pathways; Pigments, Biological; Plant Leaves; Plant Roots; Plant Shoots; Proline; Sesquiterpenes; Tanacetum parthenium | 2016 |
Parthenolide, an NF-κB Inhibitor Ameliorates Diabetes-Induced Behavioural Deficit, Neurotransmitter Imbalance and Neuroinflammation in Type 2 Diabetes Rat Model.
Topics: Acetylcholinesterase; Animals; Avoidance Learning; Behavior, Animal; Blood Glucose; Brain Chemistry; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Exploratory Behavior; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Interleukin-6; Maze Learning; Neurotransmitter Agents; NF-kappa B; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Streptozocin; Tumor Necrosis Factor-alpha | 2017 |
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxyglucose; Female; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Male; NADP; Neoplasm Proteins; Neoplastic Stem Cells; NF-E2-Related Factor 2; Sesquiterpenes; Sirolimus; Up-Regulation | 2016 |
Synthesis of (±)-4,5-dia-Parthenolide, an Unnatural Parthenolide Stereoisomer.
Topics: Carbon-13 Magnetic Resonance Spectroscopy; Catalysis; Chromatography, High Pressure Liquid; Cyclization; Esterification; Hydroxylation; Proton Magnetic Resonance Spectroscopy; Sesquiterpenes; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism | 2016 |
Protective effect of sesquiterpene lactone parthenolide on LPS-induced acute lung injury.
Topics: A549 Cells; Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Humans; Lactones; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Protective Agents; Sesquiterpenes | 2016 |
Parthenolide Induces Reactive Oxygen Species-Mediated Autophagic Cell Death in Human Osteosarcoma Cells.
Topics: Autophagy; Caspase 3; Cell Line, Tumor; Humans; Mitophagy; Osteosarcoma; Reactive Oxygen Species; Sesquiterpenes | 2016 |
Synthesis and anti-acute myeloid leukemia activity of C-14 modified parthenolide derivatives.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Sesquiterpenes; Structure-Activity Relationship | 2017 |
Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinogenesis; Cell Proliferation; Colitis; Colorectal Neoplasms; Drug Synergism; Female; Humans; Mesalamine; Mice; Mice, Inbred BALB C; NF-kappa B; Phenylhydrazines; Sesquiterpenes; Signal Transduction | 2017 |
Functionalized Triblock Copolymer Vectors for the Treatment of Acute Lymphoblastic Leukemia.
Topics: Biocompatible Materials; Cells, Cultured; Drug Carriers; Drug Stability; Emulsions; Humans; Mesenchymal Stem Cells; Micelles; Polymers; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sesquiterpenes; Solubility; Solvents | 2017 |
An Investigation of Extracellular Histones in Pig-To-Baboon Organ Xenotransplantation.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Arteries; Blood Coagulation; Blood Platelets; C-Reactive Protein; Heart Transplantation; Heterografts; Histones; Humans; Immunosuppressive Agents; Inflammation; Inflammation Mediators; Kidney Transplantation; Liver Transplantation; NF-kappa B; Papio; Platelet Aggregation; Platelet Count; Serum Amyloid A Protein; Sesquiterpenes; Sus scrofa; Time Factors; Triiodothyronine | 2017 |
Synthesis of dual-action parthenolide prodrugs as potent anticancer agents.
Topics: Antineoplastic Agents; Apoptosis; Catalysis; Cell Line, Tumor; Chemistry Techniques, Synthetic; Cytarabine; Humans; Lactones; Melphalan; Neoplasms; Prodrugs; Sesquiterpenes | 2017 |
Parthenolide inhibits the initiation of experimental autoimmune neuritis.
Topics: Analysis of Variance; Animals; Annexin A5; Anti-Inflammatory Agents; Apoptosis; CD4-Positive T-Lymphocytes; Cell Proliferation; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Flow Cytometry; Forkhead Box Protein O3; Freund's Adjuvant; Lymph Nodes; Mycobacterium tuberculosis; Neuritis, Autoimmune, Experimental; Rats; Rats, Inbred Lew; Sciatic Nerve; Sesquiterpenes | 2017 |
Parthenolide attenuates cerebral ischemia/reperfusion injury via Akt/GSK-3β pathway in PC12 cells.
Topics: Animals; Apoptosis; Brain Ischemia; Cell Line, Tumor; Glucose; Glycogen Synthase Kinase 3 beta; Neurons; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Oxygen; PC12 Cells; Proto-Oncogene Proteins c-akt; Rats; Reperfusion Injury; Sesquiterpenes; Signal Transduction | 2017 |
Parthenolide reduces gene transcription of prosurvival mediators in U937 cells.
Topics: beta Catenin; Blotting, Western; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Osteopontin; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sesquiterpenes; TOR Serine-Threonine Kinases; Transcription Factor RelB; Transcription, Genetic; Tumor Stem Cell Assay; U937 Cells | 2017 |
Parthenolide Selectively Sensitizes Prostate Tumor Tissue to Radiotherapy while Protecting Healthy Tissues In Vivo.
Topics: Animals; Antineoplastic Agents; Chemoradiotherapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Male; Mice; Mice, Transgenic; Organ Sparing Treatments; Organs at Risk; Prostatic Neoplasms; Radiation Injuries; Radiation Tolerance; Radiation-Sensitizing Agents; Sesquiterpenes; Treatment Outcome | 2017 |
Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway.
Topics: A549 Cells; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Humans; Immunohistochemistry; Inhibitory Concentration 50; Lung Neoplasms; Male; MAP Kinase Signaling System; Middle Aged; Phosphorylation; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sesquiterpenes; STAT3 Transcription Factor | 2017 |
Synergistic anti-cancer effects of epigenetic drugs on medulloblastoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Line, Tumor; Cerebellar Neoplasms; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; Drug Synergism; Enzyme Inhibitors; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Humans; Medulloblastoma; Sesquiterpenes | 2017 |
Antineoplastic effects of CPPTL via the ROS/JNK pathway in acute myeloid leukemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Humans; Leukemia, Myeloid, Acute; MAP Kinase Signaling System; Mice; Mice, Inbred NOD; Mice, SCID; Reactive Oxygen Species; Sesquiterpenes; Xenograft Model Antitumor Assays | 2017 |
Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease.
Topics: Alanine Transaminase; Animals; Antioxidants; Diet, High-Fat; Disease Models, Animal; Liver; Male; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Sesquiterpenes; Superoxide Dismutase; Triglycerides; Tumor Necrosis Factor-alpha | 2017 |
Parthenolide attenuates 7,12-dimethylbenz[a]anthracene induced hamster buccal pouch carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis Regulatory Proteins; Benz(a)Anthracenes; Cheek; Cricetinae; Mouth Mucosa; Mouth Neoplasms; Neoplasm Proteins; Sesquiterpenes | 2018 |
Anticancer activity profiling of parthenolide analogs generated via P450-mediated chemoenzymatic synthesis.
Topics: Antineoplastic Agents; Cell Proliferation; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Sesquiterpenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
Parthenolide Promotes Differentiation of Osteoblasts Through the Wnt/β-Catenin Signaling Pathway in Inflammatory Environments.
Topics: Cell Differentiation; Cell Proliferation; Cells, Cultured; Humans; Inflammation; Osteoblasts; Sesquiterpenes; Wnt Signaling Pathway | 2017 |
Smad4 re-expression increases the sensitivity to parthenolide in colorectal cancer.
Topics: Animals; Caco-2 Cells; Colorectal Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Genetic Therapy; HCT116 Cells; HEK293 Cells; HT29 Cells; Humans; Male; Mice; Mice, Inbred C3H; Random Allocation; Sesquiterpenes; Smad4 Protein; Transfection; Xenograft Model Antitumor Assays | 2017 |
Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis.
Topics: Animals; Apoptosis; beta Catenin; Bone Neoplasms; Breast Neoplasms; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; MCF-7 Cells; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Osteoblasts; Osteoclasts; Osteogenesis; Osteolysis; Sesquiterpenes; Signal Transduction; Time Factors | 2017 |
Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
Topics: Animals; Cell Hypoxia; Colonic Neoplasms; Down-Regulation; Epithelial-Mesenchymal Transition; Female; HCT116 Cells; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; Sesquiterpenes; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |
Schizonticidal antimalarial sesquiterpene lactones from Magnolia champaca (L.) Baill. ex Pierre: microwave-assisted extraction, HPTLC fingerprinting and computational studies.
Topics: Antimalarials; Antiprotozoal Agents; Chromatography, High Pressure Liquid; Lactones; Magnolia; Microwaves; Molecular Docking Simulation; Plant Extracts; Sesquiterpenes; Spectrum Analysis | 2019 |
LPS-induced Src family kinases activity mediates IL-10 production through activation of STAT3 in peripheral blood mononuclear cells of patients with Behçet's Disease.
Topics: Adult; Behcet Syndrome; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukin-10; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Phosphorylation; Pyrimidines; Sesquiterpenes; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor; Toll-Like Receptor 4 | 2017 |
Protective effects of glutathione on oxidative injury induced by hydrogen peroxide in intestinal epithelial cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Apoptosis; Cell Line; Drug Evaluation, Preclinical; Glutathione; Hydrogen Peroxide; Interleukin-1beta; Intestinal Diseases; Intestinal Mucosa; MAP Kinase Signaling System; NF-kappa B; Oxidative Stress; Rats; Sesquiterpenes | 2018 |
Crystal Structures and Human Leukemia Cell Apoptosis Inducible Activities of Parthenolide Analogues Isolated from Piptocoma rufescens.
Topics: Apoptosis; Asteraceae; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Leukemia, Myeloid, Acute; NF-kappa B; Sesquiterpenes | 2018 |
The plant sesquiterpene lactone parthenolide inhibits Wnt/β-catenin signaling by blocking synthesis of the transcriptional regulators TCF4/LEF1.
Topics: beta Catenin; Cell Line, Tumor; HEK293 Cells; Humans; Lactones; Lymphoid Enhancer-Binding Factor 1; Promoter Regions, Genetic; Ribosomal Protein L10; Ribosomal Proteins; Sesquiterpenes; Signal Transduction; Transcription Factor 4; Transcription Factors; Transcriptional Activation; Wnt Signaling Pathway | 2018 |
Parthenolide reduces metastasis by inhibition of vimentin expression and induces apoptosis by suppression elongation factor α - 1 expression.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Death; Female; Humans; MCF-7 Cells; Peptide Elongation Factor 1; Sesquiterpenes; Tanacetum parthenium; Vimentin | 2018 |
Exploring the impact of parthenolide as anti-quorum sensing and anti-biofilm agent against Pseudomonas aeruginosa.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biofilms; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Structure, Secondary; Pseudomonas aeruginosa; Quorum Sensing; Sesquiterpenes | 2018 |
Parthenolide inhibits hydrogen peroxide‑induced osteoblast apoptosis.
Topics: Apoptosis; Cell Survival; Child; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Malondialdehyde; Osteoblasts; Oxidative Stress; Reactive Oxygen Species; Sesquiterpenes; Superoxide Dismutase | 2018 |
Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cell Line, Tumor; DNA Modification Methylases; DNA Repair Enzymes; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Glioblastoma; Humans; Mice; Mice, SCID; Rats; RNA, Small Interfering; Sesquiterpenes; Signal Transduction; Temozolomide; Transcription Factor RelA; Treatment Outcome; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2018 |
Investigating chemoresistance to improve sensitivity of childhood T-cell acute lymphoblastic leukemia to parthenolide.
Topics: Adolescent; Biomarkers; Cell Line, Tumor; Cell Survival; Child; Child, Preschool; Coculture Techniques; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Glutathione; Humans; Male; Mesenchymal Stem Cells; Oxidative Stress; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Sesquiterpenes | 2018 |
Crucial role of oxidative stress in bactericidal effect of parthenolide against Xanthomonas oryzae pv. oryzae.
Topics: Anti-Bacterial Agents; Catalase; Glutathione; Glutathione Disulfide; Oxidative Stress; Reactive Oxygen Species; Sequence Deletion; Sesquiterpenes; Xanthomonas | 2018 |
Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway.
Topics: A549 Cells; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bleomycin; Humans; Male; Mice; Mice, Inbred ICR; NF-kappa B; Pulmonary Fibrosis; Sesquiterpenes; Signal Transduction; Snail Family Transcription Factors | 2018 |
Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases.
Topics: HEK293 Cells; HeLa Cells; Hep G2 Cells; Humans; Interleukin-6; Janus Kinases; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor | 2018 |
Parthenolide in Danish biodynamic and organic milk: A new source of exposure to an allergenic sesquiterpene lactone.
Topics: Allergens; Animals; Asteraceae; Denmark; Dermatitis, Allergic Contact; Gas Chromatography-Mass Spectrometry; Humans; Milk; Organic Agriculture; Sesquiterpenes | 2018 |
Chronic low dose ethanol induces an aggressive metastatic phenotype in TRAMP mice, which is counteracted by parthenolide.
Topics: Adenocarcinoma; Animals; Disease Progression; Drug Interactions; Ethanol; Female; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Metastasis; Prostatic Neoplasms; Sesquiterpenes | 2018 |
Biodegradable, Drug-Loaded Nanovectors via Direct Hydration as a New Platform for Cancer Therapeutics.
Topics: Antineoplastic Agents; Biocompatible Materials; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Nanoparticles; Polymers; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sesquiterpenes; Water | 2018 |
Parthenolide Influences Herpes simplex virus 1 Replication in vitro.
Topics: Animals; Antiviral Agents; Caspases; Cell Survival; Chlorocebus aethiops; Herpes Simplex; Herpesvirus 1, Human; Humans; NF-kappa B; Plant Components, Aerial; Sesquiterpenes; Tanacetum; Vero Cells; Viral Proteins; Virus Replication | 2018 |
Inhibition of NF-κB Reduces Renal Inflammation and Expression of PEPCK in Type 2 Diabetic Mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gluconeogenesis; Inflammation; Insulin Resistance; Kidney; Mice; NF-kappa B; Phosphoenolpyruvate Carboxykinase (GTP); Sesquiterpenes | 2018 |
Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin D1; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Recurrence, Local; NF-kappa B; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction | 2018 |
Synthesis and biological evaluation of dithiocarbamate esters of parthenolide as potential anti-acute myelogenous leukaemia agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Esters; Heterografts; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Mice; Molecular Structure; Sesquiterpenes; Thiocarbamates | 2018 |
Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression.
Topics: A549 Cells; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Neovascularization, Pathologic; Nicotine; Real-Time Polymerase Chain Reaction; Sesquiterpenes; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A | 2018 |
The combined administration of parthenolide and ginsenoside CK in long circulation liposomes with targeted tLyp-1 ligand induce mitochondria-mediated lung cancer apoptosis.
Topics: A549 Cells; Animals; Apoptosis; Delayed-Action Preparations; Ginsenosides; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Nude; Mitochondria; Reactive Oxygen Species; Sesquiterpenes; Xenograft Model Antitumor Assays | 2018 |
MicroRNA-107 Targets IKBKG and Sensitizes A549 Cells to Parthenolide.
Topics: 3' Untranslated Regions; A549 Cells; Binding Sites; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Cell Survival; Computational Biology; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Kinase; Lung Neoplasms; MicroRNAs; Sesquiterpenes | 2018 |
Kauniolide synthase is a P450 with unusual hydroxylation and cyclization-elimination activity.
Topics: Biosynthetic Pathways; Cyclization; Cytochrome P-450 Enzyme System; Hydroxylation; Molecular Docking Simulation; Nicotiana; Saccharomyces cerevisiae; Sesquiterpenes; Tanacetum | 2018 |
Comparison of the inhibition potential of parthenolide and micheliolide on various UDP-glucuronosyltransferase isoforms.
Topics: Enzyme Inhibitors; Glucuronosyltransferase; Humans; Kinetics; Sesquiterpenes; Sesquiterpenes, Guaiane | 2019 |
TRPA1 mediates the antinociceptive properties of the constituent of Crocus sativus L., safranal.
Topics: Analgesics; Animals; Calcium Channels; Cell Line; Crocus; Cyclohexenes; Ganglia, Spinal; HEK293 Cells; Humans; Isothiocyanates; Mice; Mice, Inbred C57BL; Neurons; Nociception; Sesquiterpenes; Terpenes; TRPA1 Cation Channel; TRPV Cation Channels | 2019 |
Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Chemistry Techniques, Synthetic; Humans; Sesquiterpenes; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2019 |
Substrate promiscuity of enzymes from the sesquiterpene biosynthetic pathways from Artemisia annua and Tanacetum parthenium allows for novel combinatorial sesquiterpene production.
Topics: Artemisia annua; Metabolic Engineering; Oxidoreductases; Plant Proteins; Sesquiterpenes; Tanacetum parthenium | 2019 |
Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo.
Topics: Animals; Apoptosis; Cell Adhesion; Cell Line, Tumor; Cell Survival; Coculture Techniques; DNA Fragmentation; Humans; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; NF-kappa B p50 Subunit; Organ Culture Techniques; Osteoblasts; Osteoclasts; Osteogenesis; Prostatic Neoplasms; Rats; Sesquiterpenes; Signal Transduction; X-Ray Microtomography | 2019 |
Design and synthesis of parthenolide-SAHA hybrids for intervention of drug-resistant acute myeloid leukemia.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Molecular Docking Simulation; Molecular Structure; Sesquiterpenes; Structure-Activity Relationship; Tumor Cells, Cultured; Vorinostat | 2019 |
Design, synthesis, and cytotoxic activities of novel hybrids of parthenolide and thiazolidinedione via click chemistry.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Click Chemistry; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Sesquiterpenes; Thiazolidinediones | 2020 |
Parthenolide, a feverfew-derived phytochemical, ameliorates obesity and obesity-induced inflammatory responses via the Nrf2/Keap1 pathway.
Topics: 3T3-L1 Cells; Animals; Anti-Inflammatory Agents; Anti-Obesity Agents; Diet, High-Fat; Heme Oxygenase-1; Kelch-Like ECH-Associated Protein 1; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Obesity; Phytochemicals; RAW 264.7 Cells; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction; Tanacetum parthenium | 2019 |
Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells.
Topics: Biological Products; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Lactones; Sesquiterpenes; Signal Transduction; Tanacetum parthenium | 2019 |
Costunolide and parthenolide from Champi Sirindhorn (
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Humans; Inhibitory Concentration 50; K562 Cells; Magnolia; Plant Extracts; Sesquiterpenes; Thailand | 2021 |
Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia.
Topics: Adolescent; Adult; Aged; Antigens, CD; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dynamic Light Scattering; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Nanoparticles; NF-kappa B; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Sesquiterpenes; Young Adult | 2019 |
Screening for Compositae contact sensitization with sesquiterpene lactones and Compositae mix 2.5% pet.
Topics: Adolescent; Adult; Allergens; Asteraceae; Child; Child, Preschool; Dermatitis, Allergic Contact; Female; Humans; Lactones; Male; Middle Aged; Patch Tests; Plant Extracts; Sesquiterpenes; Young Adult | 2019 |
A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cells.
Topics: Cell Line, Tumor; Cell Proliferation; Cyclin D2; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; NF-E2-Related Factor 2; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction; Triple Negative Breast Neoplasms; Tumor Suppressor Proteins | 2020 |
Parthenolide ameliorates intracerebral hemorrhage-induced brain injury in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Edema; Brain Injuries; Cerebral Hemorrhage; Disease Models, Animal; Mice; Oxidative Stress; Rats; Sesquiterpenes | 2020 |
Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Nucleus; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Liver Neoplasms; Molecular Structure; Sesquiterpenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
The parthenolide derivative ACT001 synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson's disease in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Apoptosis; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Inflammation; Levodopa; Male; Mice; Mice, Inbred BALB C; Nerve Degeneration; Parkinson Disease; Parkinsonian Disorders; Sesquiterpenes | 2020 |
Synthesis and biological profiling of parthenolide ether analogs.
Topics: Adult; Carboxypeptidases; Enzyme Inhibitors; Ether; Humans; Microtubules; Molecular Structure; Neurons; Sesquiterpenes; Structure-Activity Relationship; Tanacetum parthenium | 2019 |
The Anti-Serotonin Effect of Parthenolide Derivatives and Standardised Extract from the Leaves of
Topics: Animals; Asteraceae; Blood Platelets; Female; Plant Extracts; Plant Leaves; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Sesquiterpenes | 2019 |
Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Dialysis Solutions; Disease Models, Animal; Drug Evaluation, Preclinical; Epithelial-Mesenchymal Transition; Female; Humans; Male; Mice; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Phosphorylation; Sesquiterpenes; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2020 |
A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment.
Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Biphenyl Compounds; Cell Proliferation; Cisplatin; Ginsenosides; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Pentacyclic Triterpenes; Sesquiterpenes; Triterpenes; Xenograft Model Antitumor Assays | 2020 |
Microtubules Increase Diastolic Stiffness in Failing Human Cardiomyocytes and Myocardium.
Topics: Adult; Aged; Colchicine; Diastole; Elasticity; Female; Heart Failure; Humans; Male; Microtubules; Middle Aged; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Protein Processing, Post-Translational; Sesquiterpenes; Stress, Mechanical; Stroke Volume; Tyrosine; Ventricular Dysfunction, Left; Viscosity | 2020 |
Identification of Parthenolide Dimers as Activators of Pyruvate Kinase M2 in Xenografts of Glioblastoma Multiforme in Vivo.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Prodrugs; Protein Kinase Inhibitors; Pyruvate Kinase; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2020 |
Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth.
Topics: 4-Butyrolactone; Apoptosis; beta Catenin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Proteolysis; Sesquiterpenes; Ubiquitin-Specific Peptidase 7; Ubiquitination; Wnt Signaling Pathway | 2020 |
Nanomagnetic liposome-encapsulated parthenolide and indocyanine green for targeting and chemo-photothermal antitumor therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Ferric Compounds; Indocyanine Green; Liposomes; Metal Nanoparticles; Photochemotherapy; Phototherapy; Sesquiterpenes | 2020 |
All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Endoplasmic Reticulum Chaperone BiP; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Micelles; Paclitaxel; Peptides; Polyethylene Glycols; Rats, Sprague-Dawley; Sesquiterpenes; Temozolomide | 2020 |
Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK.
Topics: 4-Butyrolactone; Amines; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Drug Screening Assays, Antitumor; Female; Humans; Molecular Targeted Therapy; NF-kappa B; Ovarian Neoplasms; Piperazines; Piperidines; Prodrugs; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Sesquiterpenes; Signal Transduction; Structure-Activity Relationship | 2020 |
Preparation and characterization of parthenolide nanocrystals for enhancing therapeutic effects of sorafenib against advanced hepatocellular carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Compounding; Drug Liberation; Drug Stability; Drug Synergism; Female; Hep G2 Cells; Humans; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Sesquiterpenes; Solubility; Sorafenib; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
Nano magnetic liposomes-encapsulated parthenolide and glucose oxidase for ultra-efficient synergistic antitumor therapy.
Topics: Administration, Intravenous; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Compounding; Drug Synergism; Female; Glucose Oxidase; Glutathione; HeLa Cells; Humans; Liposomes; Magnetite Nanoparticles; Mice; Sesquiterpenes; Tumor Microenvironment; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Indocyanine Green-Parthenolide Thermosensitive Liposome Combination Treatment for Triple-Negative Breast Cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Delivery Systems; Endocytosis; Female; Humans; Hydrodynamics; Indocyanine Green; Liposomes; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Photosensitizing Agents; Reactive Oxygen Species; Sesquiterpenes; Temperature; Tissue Distribution; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Burden | 2020 |
Cytokine storm in COVID-19 and parthenolide: Preclinical evidence.
Topics: Anti-Inflammatory Agents; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; Cytokines; Humans; Inflammation; Pandemics; Phytotherapy; Plant Extracts; Pneumonia, Viral; SARS-CoV-2; Sesquiterpenes; Tanacetum parthenium | 2020 |
Metabonomic study of the intervention effects of Parthenolide on anti-thyroid cancer activity.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Metabolome; Metabolomics; Reactive Oxygen Species; Sesquiterpenes; Thyroid Neoplasms | 2020 |
Compositae sensitization in Danish children and adolescents.
Topics: Adolescent; Allergens; Asteraceae; Child; Denmark; Dermatitis, Allergic Contact; Female; Humans; Male; Plant Extracts; Sesquiterpenes | 2020 |
Synthesis, cytotoxicity, and in vivo antitumor activity study of parthenolide semicarbazones and thiosemicarbazones.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carbamates; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Neoplasms, Experimental; NF-kappa B; Semicarbazones; Sesquiterpenes; Structure-Activity Relationship; Thiosemicarbazones | 2020 |
Parthenolide ameliorates tweak-induced podocytes injury.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Chemokine CXCL16; Cholesterol; Mice; Podocytes; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2020 |
Deciphering morpho-physiological and phytochemical attributes of Tanacetum parthenium L. plants exposed to C60 fullerene and salicylic acid.
Topics: Chlorophyll A; Fullerenes; Oils, Volatile; Phytochemicals; Plant Leaves; Salicylic Acid; Sesquiterpenes; Tanacetum parthenium | 2020 |
Anticancer and apoptotic activities of parthenolide in combination with epirubicin in mda-mb-468 breast cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Epirubicin; Female; Humans; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Topoisomerase II Inhibitors | 2020 |
Parthenolide inhibits human lung cancer cell growth by modulating the IGF‑1R/PI3K/Akt signaling pathway.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Forkhead Box Protein O3; Humans; Insulin-Like Growth Factor I; Lung Neoplasms; Male; Mice; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Sesquiterpenes; Signal Transduction; Xenograft Model Antitumor Assays | 2020 |
Cytotoxicity of the Sesquiterpene Lactones, Ivalin and Parthenolide in Murine Muscle Cell Lines and Their Effect on Desmin, a Cytoskeletal Intermediate Filament.
Topics: Animals; Cell Line; Cell Survival; Cytoskeleton; Desmin; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Lactones; Mice; Myoblasts, Skeletal; Myocytes, Cardiac; Rats; Sesquiterpenes | 2020 |
Synthesis and biological evaluation of parthenolide derivatives with reduced toxicity as potential inhibitors of the NLRP3 inflammasome.
Topics: Animals; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Drug Design; Humans; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Mice; Neuroglia; NLR Family, Pyrin Domain-Containing 3 Protein; Sesquiterpenes; Signal Transduction | 2020 |
Parthenolide Has Negative Effects on In Vitro Enhanced Osteogenic Phenotypes by Inflammatory Cytokine TNF-α via Inhibiting JNK Signaling.
Topics: Asteraceae; Cell Differentiation; Gene Expression Regulation, Developmental; Humans; Hydrolases; Inflammation; JNK Mitogen-Activated Protein Kinases; Lactones; MAP Kinase Signaling System; NF-kappa B; Osteoblasts; Osteogenesis; Periosteum; Phenotype; Phosphorylation; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2020 |
α-Methylene-β-Lactone Scaffold for Developing Chemical Probes at the Two Ends of the Selectivity Spectrum.
Topics: Humans; Lactones; Molecular Probes; Molecular Structure; Orlistat; Proteomics; Sesquiterpenes; Tandem Mass Spectrometry | 2021 |
Osteopontin siRNA does not confer resistance to toxic effects of parthenolide in Jurkat cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression; Humans; Jurkat Cells; Osteopontin; RNA Interference; RNA, Messenger; RNA, Small Interfering; Sesquiterpenes | 2020 |
Parthenolide increases the sensitivity of gastric cancer cells to chemotherapy.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin D1; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Stomach Neoplasms | 2020 |
Parthenolide inhibits the tumor characteristics of renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Self Renewal; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Neoplastic Stem Cells; Sesquiterpenes; Snail Family Transcription Factors | 2021 |
Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis.
Topics: Adult; Aged; Cell Survival; Dose-Response Relationship, Drug; Female; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; NF-kappa B; Sesquiterpenes | 2021 |
The role of oxidative stress in the cooperation of parthenolide and etoposide in HL-60 cells.
Topics: Apoptosis; Etoposide; HL-60 Cells; Humans; Oxidative Stress; Sesquiterpenes | 2020 |
Parthenolide plays a protective role in the liver of mice with metabolic dysfunction‑associated fatty liver disease through the activation of the HIPPO pathway.
Topics: Animals; Disease Models, Animal; Fibrosis; Hippo Signaling Pathway; Inflammation; Lipid Metabolism; Male; Metabolic Diseases; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Protective Agents; Protein Serine-Threonine Kinases; Sesquiterpenes; Signal Transduction | 2021 |
Design, synthesis and in vivo anticancer activity of novel parthenolide and micheliolide derivatives as NF-κB and STAT3 inhibitors.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Inbred Strains; Molecular Structure; Neoplasms, Experimental; NF-kappa B; Sesquiterpenes; Sesquiterpenes, Guaiane; STAT3 Transcription Factor; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
USP47 maintains the stemness of colorectal cancer cells and is inhibited by parthenolide.
Topics: Apoptosis; Carcinogenesis; Cell Line, Tumor; Colorectal Neoplasms; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Neoplastic Stem Cells; Prognosis; Protein Binding; Sesquiterpenes; Ubiquitin Thiolesterase; Ubiquitin-Specific Proteases; Up-Regulation | 2021 |
Parthenolide, bioactive compound of Chrysanthemum parthenium L., ameliorates fibrogenesis and inflammation in hepatic fibrosis via regulating the crosstalk of TLR4 and STAT3 signaling pathway.
Topics: Inflammation; Liver Cirrhosis; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor; Tanacetum parthenium; Toll-Like Receptor 4 | 2021 |
Cyclosporine A and Tacrolimus Induce Functional Impairment and Inflammatory Reactions in Endothelial Progenitor Cells.
Topics: Cardiovascular Diseases; Cell Movement; Cell Proliferation; Chemotaxis; Cyclosporine; Cytokines; Endothelial Cells; Endothelial Progenitor Cells; Humans; Immunosuppressive Agents; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Neovascularization, Pathologic; NF-kappa B; NF-kappa B p50 Subunit; Sesquiterpenes; Signal Transduction; Stem Cells; Tacrolimus; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2021 |
The effect of parthenolide on methamphetamine-induced blood-brain barrier and astrocyte alterations.
Topics: Animals; Astrocytes; Blood-Brain Barrier; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Sesquiterpenes | 2022 |
Effect of parthenolide, an NLRP3 inflammasome inhibitor, on insulin resistance in high-fat diet-obese mice.
Topics: Animals; Blood Glucose; Diet, High-Fat; Dose-Response Relationship, Drug; Insulin Resistance; Interleukin-1beta; Macrophages, Peritoneal; Male; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity; Pioglitazone; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2022 |
The effects of several abiotic elicitors on the expression of genes of key enzymes involved in the parthenolide biosynthetic pathway and its content in feverfew plant (
Topics: Biosynthetic Pathways; Plant Extracts; Salicylic Acid; Sesquiterpenes; Tanacetum parthenium | 2022 |
Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis.
Topics: Apoptosis; Humans; Proteomics; Sesquiterpenes; Thyroid Neoplasms | 2022 |
Mining and characterization of oxidative stress-related binding proteins of parthenolide in Xanthomonas oryzae pv. oryzae.
Topics: Anti-Bacterial Agents; Carrier Proteins; Chromatography, Liquid; Oryza; Oxidative Stress; Plant Diseases; Reactive Oxygen Species; Sesquiterpenes; Tandem Mass Spectrometry; Xanthomonas | 2022 |
Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Inflammation; Mice; Mice, Inbred C57BL; Multiple Sclerosis; NF-kappa B; Nuclear Receptor Subfamily 1, Group F, Member 3; Sesquiterpenes; Th17 Cells | 2022 |
Parthenolide reverses the epithelial to mesenchymal transition process in breast cancer by targeting TGFbeta1: In vitro and in silico studies.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Humans; Molecular Docking Simulation; Sesquiterpenes; Transforming Growth Factor beta1 | 2022 |
Production of Plant Sesquiterpene Lactone Parthenolide in the Yeast Cell Factory.
Topics: Furans; Lactones; NADP; Plants; Saccharomyces cerevisiae; Sesquiterpenes | 2022 |
Parthenolide ameliorates neurological deficits and neuroinflammation in mice with traumatic brain injury by suppressing STAT3/NF-κB and inflammasome activation.
Topics: Animals; Brain Injuries, Traumatic; Cytokines; Disease Models, Animal; Female; Inflammasomes; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroinflammatory Diseases; Neuroprotective Agents; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Sesquiterpenes | 2022 |
Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease.
Topics: Antiviral Agents; Coronavirus Papain-Like Proteases; COVID-19 Drug Treatment; Humans; Interferons; Lactones; Molecular Docking Simulation; Papain; Peptide Hydrolases; SARS-CoV-2; Sesquiterpenes; Sesquiterpenes, Germacrane; Ubiquitin | 2022 |
A dual-responsive "Yin-Yang" photothermal delivery system to accelerate Parthenolide anti-tumor efficacy.
Topics: Antineoplastic Agents; Gold; Humans; Hyperthermia, Induced; Liposomes; Neoplasms; Phototherapy; Sesquiterpenes; Tumor Microenvironment | 2022 |
Parthenolide modulates cerebral ischemia-induced microglial polarization and alleviates neuroinflammatory injury via the RhoA/ROCK pathway.
Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Cerebral Infarction; Humans; Microglia; Rats; rhoA GTP-Binding Protein; Sesquiterpenes; Stroke | 2022 |
First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor.
Topics: Anticholesteremic Agents; Cholesterol; Ezetimibe; Filipin; Humans; Hypercholesterolemia; Hyperlipidemias; Membrane Transport Proteins; Molecular Docking Simulation; Sesquiterpenes | 2022 |
Individual lipid transfer proteins from Tanacetum parthenium show different specificity for extracellular accumulation of sesquiterpenes.
Topics: Lipids; Sesquiterpenes; Tanacetum parthenium | 2023 |
Parthenolide targets NF-κB (P50) to inhibit HIF-1α-mediated metabolic reprogramming of HCC.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Hypoxia-Inducible Factor 1, alpha Subunit; Lactates; Liver Neoplasms; Mice; NF-kappa B; Sesquiterpenes | 2022 |
Occupational protein contact dermatitis caused by lettuce and overlap allergic contact dermatitis by parthenolide: A diagnostic approach.
Topics: Dermatitis, Allergic Contact; Dermatitis, Occupational; Hand Dermatoses; Humans; Lactuca; Patch Tests; Sesquiterpenes | 2023 |
Parthenolide Phytosomes Attenuated Gentamicin-Induced Nephrotoxicity in Rats via Activation of Sirt-1, Nrf2, OH-1, and NQO1 Axis.
Topics: Animals; Antioxidants; Gentamicins; Kidney; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Phytosomes; Rats; Sesquiterpenes; Sirtuin 1 | 2023 |
Inhibitory effect of parthenolide on peripheral nerve degeneration.
Topics: Axons; Humans; Nerve Degeneration; Nerve Regeneration; Peripheral Nervous System Diseases; Schwann Cells; Sciatic Nerve; Sesquiterpenes | 2023 |
Parthenolide targets NLRP3 to treat inflammasome-related diseases.
Topics: Animals; Dextran Sulfate; Humans; Inflammasomes; Inflammation; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Sesquiterpenes | 2023 |
Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies.
Topics: Apoptosis; Cell Line, Tumor; Humans; I-kappa B Proteins; Lymphoma; NF-kappa B; Reactive Oxygen Species; Sesquiterpenes | 2023 |
Parthenolide as a potential analgesic in the treatment of paclitaxel-induced neuropathic pain: the rat modeling.
Topics: Analgesics; Animals; Neuralgia; Paclitaxel; Rats; Sesquiterpenes | 2023 |
Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide.
Topics: Chromatography, Liquid; Desmocollins; Humans; MCF-7 Cells; Neoplasms; Proteome; Sesquiterpenes; Tandem Mass Spectrometry | 2023 |
Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition.
Topics: Animals; beta Catenin; Cadherins; Cell Movement; Endometriosis; Epithelial-Mesenchymal Transition; Female; Glycogen Synthase Kinase 3 beta; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Sesquiterpenes; Signal Transduction; Vimentin | 2023 |
Costunolide and parthenolide: Novel blood-brain barrier permeable sesquiterpene lactones to improve barrier tightness.
Topics: Blood-Brain Barrier; Endothelial Cells; Lactones; Sesquiterpenes | 2023 |